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Summary 
Agrin and its receptors complex, consisting of Lrp4 and MuSK are key regulators during 
formation, maintenance and regeneration of the neuromuscular junction. Their expression and 
localization in the CNS are less studied and their functions are unclear. The aim of my thesis 
was to investigate the role of agrin, MuSK and Lrp4 in the central nervous system during 
development, in particular during dendritogenesis and synaptogenesis, in vitro and in vivo.  
Analysis of dendritic arborization in primary cortical neurons of WT, Lrp4-knockout 
(Lrp4-KO) and MuSK-knockout (MuSK-KO) embryos revealed that Lrp4- and MuSK-KO 
neurons display fewer but longer primary dendrites and a less complex dendritic arborization 
pattern. Transfection of these neurons with full-length TM-agrin cDNA restored the dendritic 
arborization deficit in Lrp4-KO neurons, but not in MuSK-KO neurons. The C-terminal half of 
TM-agrin was sufficient for the restoration. These results show that Lrp4 and MuSK, along 
with TM-agrin, are required for the normal dendritic arborization.  
TM-agrin overexpression in WT neurons increased dendritic spine density. Therefore, 
I investigated the role of TM-agrin, Lrp4 and MuSK during synaptogenesis. Lrp4-KO neurons, 
but not MuSK-KO neurons, displayed a lower density of excitatory synapses. TM-agrin 
overexpression increased the density of excitatory synapses in Lrp4-heterozygous and WT 
neurons, but not in Lrp4-KO neurons. The TM-agrin-mediated increase of excitatory synapses 
required the presence of an insert containing four amino acids at the y-splice site (y4), but not 
the presence of the Lrp4-binding domain within TM-agrin. These results suggest an indirect 
interaction of TM-agrin with Lrp4 during formation or maintenance of excitatory synapses.  
Analysis on the inhibitory synapses revealed that Lrp4-KO neurons, but not MuSK-KO 
neurons, displayed a lower density of inhibitory synapses. Furthermore, TM-agrin 
overexpression reduced the density of inhibitory synapses in Lrp4-heterozygous and WT 
neurons. The TM-agrin-induced reduction of inhibitory synapses depended on the presence of 
a highly conserved serine-residue (S17) in the intracellular region of TM-agrin. In summary, 
TM-agrin overexpression upregulates excitatory synapses and downregulates inhibitory 
synapses requiring two different regions within the TM-agrin protein.  
Finally, I investigated the effect of TM-agrin overexpression of the adult neocortex in 
vivo using a mouse line, which conditionally expresses full-length TM-agrin in adult 
glutamatergic neurons. I observed an increase of transcript levels encoding excitatory synaptic 
proteins, as well as an increase of excitatory synapses density. Consistent with my in vitro data, 
the transcript levels of inhibitory synaptic proteins, as well as the inhibitory synapses density 
were significantly reduced in TM-agrin-overexpressing brains. Collectively, these results 
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suggest an important role of TM-agrin in regulating cortical excitatory-inhibitory balance in 
vivo. 
In conclusion, TM-agrin, Lrp4 and MuSK are essential for the formation or maintenance 
of the dendritic arborization complexity and for excitatory and inhibitory synapses during 
synaptogenesis as well as their maintenance in adult neurons, both in vitro and in vivo. My 
results also demonstrate that synaptogenesis at the NMJ and in the CNS might share common 
molecular determinants. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 5 
 
Table of contents 
Eidestattliche Versicherung/Affidavit ………….…………………………………………….. 1 
Confirmation of congruency between printed and electronic version of the doctoral thesis …. 2 
Summary …...………………………………………….……………………………………… 3 
Table of contents ………………………………………………………….………………...… 5 
List of figures ……………………………………………………….……………………….... 8 
List of tables ………………………………………………………….……………………….. 9 
Introduction 
Neurons and synapses as a core functional unit in central nervous system ……..….... 10 
Cellular and molecular components of synapses …...………………………..……… 10 
Synaptogenesis in the CNS ………………………………………………………..… 14 
Synaptogenesis at the neuromuscular junction ………..…………………………….. 18 
Agrin and its receptor complex in the central nervous system ……………….……... 21 
 Lrp4 in the central nervous system …….……………………………..……………… 23 
 MuSK in the central nervous system ………………………………………………… 24 
Aims of study ………………………………………………………….…………………….. 25 
Materials 
Animals ……...………………………………………………….…………………… 26 
Generation of antiserum against TM-agrin ……………………………..…………… 27 
Primary antibodies …..…………………………………………………….………… 28 
Secondary antibodies ………..……………………………………………….……… 29 
Buffers and solutions …..……………………………………………………….…… 29 
Media and supplements ………………………………………………………….….. 33 
Cell lines …...…………………………………………………….………………….. 33 
Oligonucleotides …………………………………………………………………..… 33 
Plasmids …...………………………………………………………………………… 35 
Methods 
Breeding strategy ……………………………………………………………………. 36 
DNA isolation from tails and genotyping ……………………………………………. 36 
Anesthesia and transcardial perfusion fixation ………………………………………. 37 
RNA extraction and quantitative reverse-transcription PCR ………………………… 38 
Subcloning of mouse TM-agrin …...………………………………………………… 38 
Brain tissue lysis and quantitative western blot analysis …………………………..… 39 
Coverslips preparation and coating …...………..…………………………………… 40 
 6 
 
Transfection of monolayer cultures ………………………………………………….. 40 
Immunocytochemistry ………………...…………………………………………….. 41 
Immunohistochemistry of freely floating fixed tissue sections ……………………… 41 
Image acquisition …………….……………………………………………………… 41 
Quantitative analysis …………………………………………………...……………. 42 
Statistical analysis ……………………………………………………………...……. 42 
Results 
Generation and validation of the antiserum against TM-agrin ……………………… 43 
TM-agrin overexpression in cortical neurons increases the density of dendritic 
protrusions, but not the dendritic arborization ………………………………………. 44 
Lrp4 is required for normal dendritic morphology ………………………………….. 45 
The C-terminal domain of TM-agrin is sufficient to rescue the complexity of dendritic 
arborization in Lrp4-KO neurons ……………………………………………………. 48 
MuSK is required for normal dendritic morphology …………..……………………. 50 
Overexpression of TM-agrin in cortical neurons increases excitatory synapses …..... 52 
Lrp4, not MuSK, controls excitatory synapses density without direct but in cis 
interaction with TM-agrin ………………………..…………………………………. 54 
APP is a candidate for the agrin/Lrp4-dependent effect on excitatory synapses 
……………………………………………………………………………………….. 57 
TM-agrin controls the density of inhibitory synapses …………………………..…… 58 
The extracellular region of TM-agrin is not required for the TM-agrin overexpression-
mediated decrease in inhibitory synapses ……………………………………………. 60 
Phosphorylation of a conserved serine-residue in agrin intracellular domain is required 
for TM-agrin-mediated reduction of inhibitory synapses …………………………… 62 
Lrp4 and TM-agrin, but not MuSK, differentially control inhibitory synapses 
………...……………………………………………………………………………... 64 
Conditional TM-agrin overexpression in adult murine cortex ………………..…….. 66 
TM-agrin overexpression affects transcript levels of several synapse-associated proteins 
……………………………………………………………………………………….. 67 
TM-agrin does not colocalize with gephyrin but colocalizes with PSD-95 in vivo …. 69 
TM-agrin controls excitatory and inhibitory synapses in vivo ……………..……….. 70 
Discussion 
TM-agrin, Lrp4 and MuSK affect dendritic arbor complexity …..…………………... 77 
 7 
 
The role of TM-agrin, Lrp4 and MuSK in excitatory synapse development and spine 
formation ……………………………………………………………………………. 80 
Domain of TM-agrin that regulates excitatory synapse development …………….... 84 
The role of TM-agrin, Lrp4 and MuSK during inhibitory synapse development 
……………………………………………………………………………………….. 85 
Domain of TM-agrin that regulates inhibitory synapse development ……………..… 86 
The effect of TM-agrin overexpression in synapse-related plasticity in adult cortex 
…………..…………………………………………………………………………… 86 
Conclusions ……………………………………………………………………………...….. 89 
Acknowledgments ...………………………………………………………………………… 90 
Bibliography ……………………………………………………………..………………..… 91 
Annexes 
 List of abbreviations ……………………………………………………………..… 104 
 List of publications …..…………………………………………………………..… 106 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 8 
 
List of figures 
Figure 1. Domain structure of agrin ……………………………………….………......…….. 20 
Figure 2. Different constructs of TM-agrin used in this study ………………………...….… 36 
Figure 3. Validation of antiserum against TM-agrin …………………….…………..…....… 43 
Figure 4. TM-agrin overexpression in cortical neurons increases density of dendritic 
protrusions, but not dendritic arborization …………………………………………...…...… 45 
Figure 5. Lrp4 is required for normal dendritic morphology ……………………..………… 47 
Figure 6. The C-terminal half of TM-agrin is sufficient to rescue the complexity of dendritic 
arborization in Lrp4-KO cortical neurons …………………………………………………… 49 
Figure 7. MuSK is required for normal dendritic morphology ……………………………… 51 
Figure 8. TM-agrin overexpression affects the number of excitatory and mEPSCs 
……………………………………………………………………………………………..… 53 
Figure 9. Lrp4, not MuSK, controls excitatory synapses density with a non-direct cis-interaction 
with TM-agrin ………………………………………………………….…………….……… 56 
Figure 10. APP is a candidate-binding partner of agrin and Lrp4 in controlling excitatory 
synapses ……………………………………………………………………...……………… 57 
Figure 11. TM-agrin controls the density of inhibitory synapses …………………………… 59 
Figure 12. The extracellular region of TM-agrin was not required for the TM-agrin 
overexpression-mediated decrease in inhibitory synapses ……………………………..…… 61 
Figure 13. Phosphorylation of a conserved serine-residue in agrin intracellular domain is 
required for TM-agrin-mediated reduction of inhibitory synapses …………………..……… 63 
Figure 14. Lrp4 and TM-agrin, but not MuSK, control inhibitory synapses ………………… 65 
Figure 15. Breeding and induction scheme of TM-agrin overexpressing mice ……………… 66 
Figure 16. Tamoxifen-induced overexpression of TM-agrin in vivo ………………………… 67 
Figure 17. A non-colocalization of TM-agrin with gephyrin and a colocalization of TM-agrin 
with PSD-95 in WT cortical sections ……………………………………………………...… 69 
Figure 18. TM-agrin overexpression did not alter bassoon puncta density and size 
……………………………………………………………………………………………..… 70 
Figure 19. TM-agrin controls excitatory synapses density in vivo ……………...…………… 71 
Figure 20. TM-agrin controls inhibitory synapses density in vivo …………...……………… 73 
 
 
 
 9 
 
List of tables 
Table 1. Primary antibodies …………………….……………..…………………………….. 28 
Table 2. Secondary antibodies …………………………………...…………………..……… 29 
Table 3. Buffers and solutions …………………………………………………………..…… 29 
Table 4. Media and supplements ………………………………………..………...………… 33 
Table 5. Cell lines ………………………………………………………………………….… 33 
Table 6. Oligonucleotides …………………………………………………….….……..…… 33 
Table 7. Plasmids ………………………………………………………….………………… 35 
Table 8. Protocols for genotyping …………………………………………………………… 37 
Table 9. Transcript levels of several synapse-associated proteins after tamoxifen administration 
in adult Cre+/TM-agrin KI and Cre+/TM-agrin WT ………………………………………… 68 
Table 10. Summary: the effect of TM-agrin, Lrp4 and MuSK in dendritic arborization and 
synaptogenesis .………………………..………….……………..……………………..…… 75 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 10 
 
Introduction 
Neurons and synapses as a core functional unit in central nervous system 
 The brain is the most complex of all biological systems. The human brain consists of 
more than 1011 neurons plus an additional 5-10 times the number of glial cells (Herculano-
Houzel, 2009). The function of this enormous number of individual cells in the brain requires 
precise and effective ways of communication. This complex communication is an essential 
component for all living organism, in particular for processing external and internal 
information. The most important communication site that distinguishes nervous system from 
other tissues in the body is a specialized functional connection, which is called synapse. The 
term synapse (from the Greek synapsis: junction point/conjunction) was coined by Sir Charles 
Scott Sherrington in 1897 to define the contact zones implicated in the transmission of 
information. Neurons communicate through chemical synapses, which are formed and 
maintained by bi-directional transfer of information between the prospective pre- and 
postsynaptic specializations required for successful synaptic transmission (Tintignac et al., 
2015; Waites et al., 2005). 
 The view of synapses as intercellular communication sites was part of the so-called 
‘neuron theory’ proposed in 1888 by Santiago Ramon y Cajal. This theory suggested a non-
continuity of cells in the CNS. The cells were thought to form a functional network by 
generating communication sites among them, which allowed unidirectional relay of 
information – but without a continuous cell membrane between the cells. Evidences supporting 
this theory had overcome the ‘reticular theory’ of the nervous system. In addition, Charles 
Sherrington showed that this specialization between nerve cells is a communication site, which 
subsequently develop into the concept of neurotransmission. This view of synapse-mediated 
communication is still accepted today, and its function, development and plasticity have 
become one of the main research fields in modern neuroscience. 
 
Cellular and molecular components of synapses 
 In general, synapses are grouped into electrical and chemical synapses. Electrical 
synapses were first observed in crayfish by Edwin Furshpan and David Potter and consist of 
two membranes continuously connected by an apparatus, termed gap-junction, which allows 
ions to pass between cells through 1.2 to 2.0 nm pores (Furshpan and Potter, 1957). This type 
of synapse can be observed in retinal neurons (Hormuzdi et al., 2004). On the other hand, 
chemical synapses are structurally composed of two elements, a presynaptic membrane bearing 
an electron-dense structure named active zone and an electro-dense region of the postsynaptic 
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membrane. The pre- and postsynaptic membranes are separated by an extracellular space, called 
synaptic cleft, demonstrating the absence of a physical continuity between the cells.  
Based on electron microscopic observations, Edward George Gray classified synapses 
as a Gray’s type 1 or an excitatory synapse and as a Gray’s type 2 or an inhibitory synapse 
(Gray, 1959). The type 1 synapse is characterized by an asymmetric thickness of the pre- and 
postsynaptic membranes with glutamate being the main neurotransmitter. In contrast, the type 
2 synapse is characterized by a symmetric thickness of the pre- and postsynaptic membranes 
with -aminobutyric acid (GABA) and glycine being the main neurotransmitters (Colonnier, 
1968).  
The type 1 synapses represent approximately 80 % of all cortical synapses. They consist 
of a presynaptic axonal bouton containing vesicles filled with the neurotransmitter glutamate, 
a 20 nm wide synaptic cleft and an electron-dense thickening of the postsynaptic membrane 
containing the corresponding neurotransmitter receptors. Type 2 synapses have flattened 
presynaptic boutons containing GABA-filled vesicles, a synaptic cleft and an electron-dense 
postsynaptic membrane, which has approximately the same thickness as the active zone and is 
therefore called “symmetric”. 
The presynaptic boutons are swellings on the axon terminations containing the 
neurotransmitter-filled vesicles and the cellular machinery for the calcium-dependent release 
of the neurotransmitter. On these boutons, the postsynaptic-facing site is called an active zone, 
a term coined in 1970 by Couteaux and Pecot-Dechavassine while observing the neuromuscular 
junction of partially contracted frog muscles by electron microscopy (Couteaux and Pecot-
Dechavassine, 1970). On the dendrites opposing the respective presynaptic boutons at 
glutamatergic type I synapses, a specialized structure was observed and named dendritic spine.  
The morphology of dendritic spines is plastic, and the transformations correlate to their 
degree of maturation (De Roo et al., 2008a; De Roo et al., 2008b; De Roo et al., 2008c; Ethell 
and Pasquale, 2005; Kasai et al., 2003). In the electron microscope, the mature dendritic spines 
appear as a dark line due to it’s high electron density. This electron-dense structure contains a 
meshwork of proteins which is named postsynaptic density (PSD). The PSD was firstly 
observed at glutamatergic synapses, as an electron-dense band with 30-60 nm thickness and 
300-400 nm diameter (Carlin et al., 1980; Harris et al., 1992). Embedded in this dense 
specialization are several other molecules which are required for synaptic transmission, such as 
cytoplasmic signaling enzymes (Kennedy, 2000), cytoskeletal components and other 
membrane-associated proteins. It has been previously shown that the area of the PSD correlates 
with the number of presynaptic vesicles (Nusser et al., 1998). 
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Subcellularly, dendritic spines host a number of membrane-bound organelles. The 
rough endoplasmic reticulum for example is primarily located in the cell body and proximal 
dendrites, but the smooth endoplasmic reticulum is predominantly located in distal dendrites 
and dendritic spines (Spacek and Harris, 1997). Moreover, the dendrites contain polyribosomes, 
which have the capacity for local proteins synthesis (Gardiol et al., 1999; Ostroff et al., 2002; 
Pierce et al., 2000). In addition, mitochondria are also localized in dendritic shafts and in some 
of the dendritic spines in which they assist the transport of ATP into dendritic spines (Li et al., 
2004). 
Two major families of scaffolding proteins are concentrated in the postsynaptic density. 
They both anchor the neurotransmitter receptors to the cytoskeleton: Shank proteins and the 
membrane-associated guanylate kinases (MAGUKs). The Shank family consists of large 
scaffolding proteins with a multidomain consisting of ankyrin repeats close to the N-terminus, 
followed by a SH3, a PDZ domain, a long proline-rich region and a sterile alpha motif domain 
(SAM) at the C-terminal which interact with NMDARs and metabotropic glutamate receptors 
(Tiffany et al., 2000). The MAGUKs are defined by a SH3- (Src-homology-3) and WW (two 
conserved TrP residues)-flanked 300 amino acid region with homology to the yeast kinase 
which catalyzes the ATP-dependent phosphorylation of GMP to GDP. In MAGUKs, this 
homology region is catalytically inactive but bears the PDZ (PSD-95/Dlg/ZO-1) domain which 
represents the binding site for many other proteins, which need to be anchored to the PSD 
(Funke et al., 2005).  
The most important member of the MAGUKs are PSD-95-related proteins. This family 
is encoded by four genes, which encode PSD-95/SAP90 (synapse-associated protein 90), PSD-
93/chapsyn110, SAP102 and SAP97. All of these proteins contain three PDZ domains, which 
consist of postsynaptic density protein-95 (PSD-95), Drosophila disc large tumor suppressor 
(DlgA) and Zonula occludens-1 protein (Zo-1). It has been shown that the PDZ domains of the 
PSD-95 bind directly to the NR2-subunit of the NMDAR (Dong et al., 2004; Kornau et al., 
1995) and also with the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor 
(AMPAR)-associated protein stargazin (Schnell et al., 2002). The interaction between PSD-95 
and AMPAR is required for the AMPAR targeting to synapses during synaptogenesis and 
during synaptic plasticity (Chen et al., 2000; Ehrlich et al., 2007; Schnell et al., 2002). Mice 
with a targeted deletion of PSD-95 showed an impairment of AMPAR-mediated synaptic 
transmission and of the maintenance of dendritic spines (Béïque et al., 2006; El-Husseini et al., 
2000). Moreover, the downregulation of PSD-95 arrests the development of dendritic spines 
(Ehrlich et al., 2007), whereas the overexpression of PSD-95 leads to multi-innervated spines 
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(Nikonenko et al., 2008). Therefore, PSD-95 is essential for the formation and maintenance of 
excitatory glutamatergic synapses.  
 In terms of functions, the scaffolding proteins play important roles during different 
stages of synapse development. During early phases of synapse development, the SAP-102 is 
required for the clustering of NMDA and AMPA receptors. Whereas during the later stages, 
PSD-95 regulates the clustering of AMPAR and the switching of NMDAR’s subunit 
composition from NR2B to NR2A (Elias et al., 2008; Petralia et al., 2005; van Zundert et al., 
2004). Thus, different scaffolding proteins regulate the clustering and composition of the 
neurotransmitter receptors depending on the stage of synapse development stages. 
Postsynaptic scaffolding molecules at inhibitory synapses consist of different molecules 
compared to the excitatory synapses. One of the most extensively studied proteins at inhibitory 
synapses is gephyrin. Originally, gephyrin, a 93-kDa protein, was purified directly and in 
stoichiometric amounts together with glycine receptors (GlyRs) from rat spinal cord (Pfeiffer 
et al., 1982). In addition, gephyrin also copurified with polymerized tubulin (Prior et al., 1992). 
Additional studies demonstrated that gephyrin is essential for the clustering of synaptic 
inhibitory neurotransmitter receptors, such as glycine and -aminobutyric acid type A (GABAA) 
receptors (Petrini et al., 2014; Pfeiffer et al., 1982; Tretter et al., 2008). 
 Structurally, gephyrin consists of three major domains: G, C and E domains. The E 
domain mediates the interaction between gephyrin and glycine receptors (GlyRs) by binding to 
the -loop of the -subunit of the GlyRs (Meyer et al., 1995; Schrader et al., 2004). Several 
serine residues within this domain control the binding affinity between both gephyrin and 
GlyRs (Bedet et al., 2006; Kim et al., 2006). Moreover, these residues regulate the cytosolic 
aggregation and clustering of gephyrin in the postsynaptic membrane (Lardi-Studler et al., 
2007). Accordingly, knockdown of gephyrin with antisense oligonucleotides in spinal neurons 
reduced the density of GlyR clusters in the membrane, suggesting a requirement of gephyrin 
for the GlyR anchorage at the inhibitory postsynaptic specializations in vitro (Kirsch et al., 
1993; Levi et al., 2004). Similar changes have been also reported in vivo in gephyrin-null mice 
(Feng et al., 1998; Fischer et al., 2000). Apparently, the E-domain within the gephyrin protein 
is responsible for the interaction between gephyrin and glycine receptors. 
In addition to GlyRs, an interaction of gephyrin with GABAAR has been previously 
described. The 2-subunit of the GABAAR interacts directly with gephyrin via a 10-amino-
acid hydrophobic motif within the intracellular domain of gephyrin (Tretter et al., 2008). This 
binding is required for the GABAAR concentration at inhibitory synapses (Tretter et al., 2008). 
Furthermore, several studies have shown that the E domain of gephyrin is important for its 
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binding to other subunits of the GABAAR, such as the 1-subunit (Mukherjee et al., 2011), 3-
subunit (Tretter et al., 2011) and 2-subunit (Alldred et al., 2005). Therefore, gephyrin is 
important for the clustering of several subunits of the GABAAR and of the GlyR in the PSD of 
inhibitory synapses. 
 Gephyrin is a phosphoprotein with 22 phosphorylation sites (in mouse and rat brains), 
which are located mostly within the C domain (Kuhse et al., 2012; Langosch et al., 1992). The 
C domain contains several residues that are modified post-translationally and has a capability 
to regulate the phosphorylation status of the gephyrin (Fuhrmann et al., 2002; Kneussel et al., 
2000). The phosphorylation of gephyrin is important for its clustering, its association with 
postsynaptic membrane and the regulation of miniature inhibitory postsynaptic currents 
(mIPSCs; Dejanovic et al., 2014). Altogether, the post-translational modification of the C 
domain of gephyrin is essential for the normal aggregation and normal function of the inhibitory 
synapses. 
 The anchoring of gephyrin in the neuronal postsynaptic membrane requires an essential 
interacting-protein, the neuron-specific dbl-like GDP/GTP exchange factor, named collybistin 
(Kins et al., 2000). Collybistin binds to the C-terminal domain of gephyrin and this binding is 
important for the aggregation of gephyrin on the membrane (Kins et al., 2000). Collybistin-
deficient mice exhibited a reduction of gephyrin and of the 2-subunit of the GABAAR 
clustering, impairment of GABAergic synaptic transmission and also of spatial learning 
(Jedlicka et al., 2009; Papadopoulos et al., 2008). The interaction of gephyrin with other 
proteins is required for the aggregation and the function of the inhibitory synapses. 
 
Synaptogenesis in the CNS 
 The formation of the complex molecular specializations mentioned in the paragraphs 
above are required for the establishment of synaptic connectivity. It is therefore conceivable 
that the formation and maintenance of these synaptic specialization is a key step during 
embryonic and postnatal development. Therefore, these processes must be very precisely 
controlled. Since in my thesis I analyzed the molecular machinery that regulates synapse 
formation, I want to introduce this process in the following paragraphs. 
 Synapses in the nervous system undergo several changes during the life of a mammalian 
organism. They are formed during embryonic and early postnatal development, maintained into 
the adult, shaped during synaptic plasticity and reformed during regeneration after damage or 
under pathological conditions. The proper formation of synaptic specializations during 
development and during synapse-related plasticity is crucial for a normal function of the adult 
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CNS. Disturbances of synapse development can lead to several neurological disorders including 
autism spectrum disorder, mental retardation, and schizophrenia – all of which have been 
collectively named “synaptopathies” (Lepeta et al., 2016). 
The formation, organization and maintenance of synapses during development involve 
a complex, yet highly orchestrated interaction of proteins, including trans-synaptic adhesion 
molecules (CAM) between the presumptive presynaptic and postsynaptic cells (Sudhof, 2018). 
The contact of the highly motile growth cone with the presumptive postsynaptic membrane 
leads to a cessation of growth and the subsequent differentiation of an ‘active zone’, which is 
characterized by docked and primed synaptic vesicles filled with the neurotransmitters and the 
molecular machinery for the calcium-mediated vesicular release. At the same time, the 
postsynaptic compartment specializes. The hallmark of this differentiation is the formation of 
aggregates containing the neurotransmitter receptors, associated or adapter proteins and 
synaptic signaling molecules. The contact sites between the active zone and postsynaptic 
density on the pre- and postsynaptic membranes are precisely aligned (Biederer et al., 2017).  
At the molecular level, the formation of synapses requires cell adhesion molecules 
(CAM), such as the cadherins, the neuroligin-neurexin complex and ephrin/Eph receptors (Graf 
et al., 2004; Inoue and Sanes, 1997; Paradis et al., 2007; Sudhof, 2018). The type 1 synapses 
are formed by the extension of a filopodia-like protrusions from the dendrite which will bind to 
the axon and transform into a postsynapse. These newly-formed synapses undergo several type 
of changes. Most of them will undergo retractions and only small portion of them will be 
maintained as functional synapses (Lohmann and Bonhoeffer, 2008). On the other hand, the 
development of inhibitory synapses is different. Here synapse formation is triggered by direct 
cell surface contact without involvement of the extension of a filopodia-like processes from the 
dendrite (Wierenga et al., 2008; Wierenga, 2017). Thus, different types of synapses undergo 
different structural and molecular changes during development and maturation.  
The clustering of receptors during synaptogenesis at type 1 synapses requires trans-
synaptic signaling, from the pre-synaptic to the post-synaptic compartment that leads to the 
activation of NMDA receptors. The activation of NMDARs alters the phosphorylation status 
more than 100 PSD proteins (Coba et al., 2009). In the case of glutamatergic synapses, it is 
known that the trans-synaptic complex between the presynaptic neurexins and postsynaptic 
neuroligin 1, neuroligin 3 and neuroligin 4 is bound to PSD-95 via the COOH-termini of 
neuroligins (Irie et al., 1997). In the case of GABAergic synapses, the interaction between 
neurexins and postsynaptic neuroligin 2 is essential (Graf et al., 2004). Thus, the trans-synaptic 
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interaction between neurexins and neuroligins is indispensable for the induction and/or 
maintenance of the excitatory and also the inhibitory synapses. 
In order to form a functional synapse, many molecular components need to be 
assembled at the site where the synaptic communication will be established. There are two 
possible scenarios of how synaptic components are assembled. Firstly, the synaptic proteins are 
synthesized in the cell body in a random and independent manner, independent of the 
axodendritic contact. Alternatively, the synaptic proteins are assembled as a complex in the cell 
body, which is subsequently transported to the contact sites. The realization of both scenarios 
seems to be true (Craig et al., 2006; Waites et al., 2005; Ziv and Garner, 2001).  
The assembly of the presynaptic specialization has been reported to be dependent on 
vesicular intermediates that will deliver most of the synaptic vesicle proteins to nascent 
synapses (Bauerfeind and Huttner, 1993). The presynaptic protein piccolo, for example, is 
transported into the active zone of the nascent synapse together with other presynaptic proteins, 
such as bassoon, syntaxin, SNAP-25 and N-cadherin, in specialized 80 nm granulated vesicles 
(Shapira et al., 2003; Zhai et al., 2001).  
The postsynaptic specializations, on the other hand, develop more gradually with 
postsynaptic proteins being individually recruited to the synaptic membrane (Sudhof, 2018). 
As mentioned previously, dendrites contain the molecular machinery for protein synthesis, 
including the endoplasmic reticulum (ER) and Golgi membranes, as well as vesicle pools which 
are filled with AMPA or NMDAR receptor subunits (Kennedy and Ehlers, 2006). This 
specialized structure opens the possibility that both cytosolic and integral membrane proteins 
can be locally synthesized, processed and inserted into nascent and mature synapses (Ju et al., 
2004; Miyata et al., 2005; Steward and Schuman, 2001; Sutton and Schuman, 2006).  
PSD-95, GAKP and Shank proteins are transported in an actin-dependent manner in 
non-synaptic clusters (Setou et al., 2000) to the postsynaptic membrane and become 
incorporated at the contact sites close to the presynaptic active zones (Gerrow et al., 2006). The 
formation and maturation of postsynaptic specializations begin with the formation of a cluster 
of PSD proteins that aggregate other proteins, such as neurologin/SynCAM capable of inducing 
presynaptic formation. Additional proteins will be added to the contact site which will trigger 
the growth and maturation of synapse (Bresler et al., 2004; Gerrow and El-Husseini, 2006; 
Marrs et al., 2001; Prange and Murphy, 2001; Washbourne et al., 2002). Collectively, the 
formation and the development of the synapses require both, the pre- and the postsynaptic sides. 
 The establishment of the contact between the pre- and postsynaptic membrane 
undergoes several alterations to modify and stabilize the respective compartments. This 
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transforms an instable structure with immature function into a stable adult synapse. In contrast 
to nascent immature synapses, mature synapses are characterized morphologically by an 
increase of clustered synaptic vesicles on the presynaptic side, pronounced postsynaptic 
densities and a shift from unstable highly motile nascent spines to stable less or non-motile 
stubby- and mushroom-type spines (Yuste and Bonhoeffer, 2004; Takeichi and Abe, 2005). 
Both newly formed and mature spines require a set of molecules that are essential for 
their normal function. These set of molecules consist of receptors, which are important for the 
neurotransmission. Two main groups of receptors are responsible for neurotransmission to 
occur at synaptic level: ionotropic receptors, which are ion channels and metabotropic receptors 
which are coupled with a G-protein pathway. Depending on the neurotransmitter released and, 
on the receptors, synapses can be further classified as excitatory or inhibitory. A synapse is 
classified as excitatory when an excitatory postsynaptic potentials (EPSPs) occurs. The EPSP 
is usually elicited by a depolarizing cation influx through the membrane in response to the 
binding of neurotransmitters to the corresponding receptors. On the other hand, a synapse is 
defined as inhibitory when the binding of neurotransmitter to the postsynaptic receptors elicits 
a hyperpolarization, usually via an influx of anions through the membrane, generating 
inhibitory postsynaptic potentials (IPSPs).  
 Newly formed synapses need to be maintained in the adult nervous system. In vivo 
imaging of mature somatosensory cortex, visual cortex and organotypic hippocampal slice 
cultures demonstrated, that synapses undergo a turnover, meaning that they remain stable only 
for variable periods of time (De Roo et al., 2008a; De Roo et al., 2008c; Holtmaat et al., 2005; 
Trachtenberg et al., 2002; Zuo et al., 2005). Mature dendritic spines are dynamic structures 
whose stability depends on neuronal activity, Hebbian-type of plasticity and homeostatic 
processes (Sjostrom et al., 2008). Spines undergo plastic changes depending on their intra- and 
extracellular conditions and on the neuronal network activity (Holtmaat et al., 2008; Holtmaat 
et al., 2005; Luscher et al., 2000; Sjostrom et al., 2008; Yuste and Bonhoeffer, 2004). Chronic 
changes of neuronal activity affect the turnover rate of synaptic proteins at mature synapses 
(Grutzendler et al., 2002; Trachtenberg et al., 2002). Higher neuronal activity reduces the half-
life from 5h to 2h, whereas lower neuronal activity increases the half-life from 5h to 20h-30h 
(Ehlers, 2003). In addition, many postsynaptic proteins undergo a great volume and exchange 
rate occurring at presumable stable synaptic structures, such as SAP90/PSD-95, SAP97, actin, 
the NR1-subunit of the NMDAR, and the GluR1-subunit of the AMPAR (Bresler et al., 2004; 
Iki et al., 2005; Nakagawa et al., 2004; Okabe et al., 2001; Sharma et al., 2006; Yao et al., 
2003). Moreover, the overall stability of dendritic spines differs throughout cortical areas and 
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experimental conditions (Grutzendler et al., 2002; Holtmaat et al., 2005; Trachtenberg et al., 
2002; Xu et al., 2007). Altogether, after being formed, synapses undergo several changes 
throughout the life, and this depends on the intra- and extracellular conditions as well as on the 
neuronal network activity. This plasticity of the synapses is essential for higher cognitive 
functions, including learning and memory.  
   
Synaptogenesis at the neuromuscular junction 
The molecular basis of synaptogenesis in the developing CNS is not entirely clear. In 
contrast, much more is known about the development of a specialized synapse outside the brain, 
the neuromuscular junction (Tintignac et al., 2015). Our laboratory and others have raised the 
hypothesis, that synaptogenesis in the CNS might share molecular determinants with 
synaptogenesis at the NMJ (Kröger and Pfister, 2009). My thesis is based on this hypothesis. 
In the following paragraphs, I will therefore introduce the NMJ and its development including 
its key determinants. Afterwards, I will summarize the current knowledge of the functions of 
these molecules in the CNS. 
The NMJ is one of the best-characterized synapses in the entire nervous system. NMJs 
are communication sites between axons of -motoneurons and skeletal muscle fibers (Tintignac 
et al., 2015). The formation, maintenance and regeneration of the NMJ require several key 
regulatory molecules. The master organizer of synaptogenesis at the NMJ is agrin. Agrin’s 
biological activity requires the binding to a receptor complex, consisting of the low-density 
lipoprotein receptor-related proteins 4 (Lrp4; Weatherbee et al., 2006; Zhang et al., 2008; Kim 
et al., 2008) and the muscle-specific kinase (MuSK; Zhang et al., 2008) 
Agrin is a large multidomain protein that belongs to the family of heparan sulfate 
proteoglycans (HSPG) because of its post-translational modification with one or more 
covalently attached heparan sulfate (HS) chains. Agrin was initially purified and cloned from 
the electric organ of the marine ray Torpedo californica (Nitkin et al., 1987; Smith et al., 1992). 
The cDNA sequence of agrin is highly conserved in many species including chick, mouse, rat 
and human (Burgess et al., 2000; Rupp et al., 1992; Rupp et al., 1991; Tsen et al., 1995; Tsim 
et al., 1992). Agrin is expressed in neuronal and non-neuronal tissues, such as endothelial cells 
of the blood-brain-barrier, astrocytes (Barber and Lieth, 1997; Kröger and Pfister, 2009; Steiner 
et al., 2014) and lymphocytes (Khan et al., 2001). 
The transcription product of the Agrn gene is an approximately 9500-nucleotide-long 
mRNA that is translated into a large multidomain protein with a molecular mass of 220 kDa. 
As mentioned above, agrin is also subject to extensive modifications, such as the attachment of 
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glycosaminoglycan side chains to the central part of agrin. These posttranslational 
modifications increase the molecular mass of native agrin to more than 500 kDa (Tsen et al., 
1995; Winzen et al., 2003).  
 According to the ‘agrin hypothesis’ (McMahan, 1990), agrin is synthesized by 
motoneurons and transported along their axons to the nerve terminal at the NMJ. It is secreted 
at the contact site between axonal growth cone and target myofiber and then stably incorporated 
into the basal lamina. Accordingly, agrin immunoreactivity is highly concentrated in the 
synaptic cleft of the NMJ (Reist et al., 1987). Basal lamina-bound agrin interacts with its 
tetrameric receptor complex, which is located on the surface of the myofiber (Glass et al., 
1996a; Glass et al., 1996b). The binding of agrin to Lrp4 (Kim et al., 2008; Zhang et al., 2008; 
Zong et al., 2012) leads to the activation of the muscle-specific kinase (MuSK) in the skeletal 
muscle fiber plasma membrane. MuSK activation initiates an intracellular signaling cascade, 
which is characterized by the phosphorylation of nicotinic acetylcholine receptors (nAChRs) 
by the downstream kinase of MuSK, the downstream of tyrosine kinase 7 (Dok-7) and a 43-
kDa receptor-associated protein rapsyn (Huganir et al., 1986; Huganir and Greengard, 1983; 
Huganir and Miles, 1989; Qu et al., 1996; Qu and Huganir, 1994; Wallace et al., 1991). This 
phosphorylation leads to the aggregation of these molecules at the NMJ, most likely by a 
diffusion-trap mechanism (Ferns et al., 1996; Glass et al., 1996a; Glass et al., 1996b).  
Agrin-induced signaling is also required for the formation of structural specializations 
of the NMJ, including junctional folds (Marques et al., 2000; Meier et al., 1997) as well as for 
the synapse-specific gene expression, such as utrophin (Grady et al., 2000; Gramolini et al., 
1998), acetylcholine-esterase (AChE) (Bezakova et al., 2001; Matthews-Bellinger and Salpeter, 
1983) as well as the expression of the -subunit of the nAChRs (Meier et al., 1997). The 
establishment of these structural and molecular specializations together with synapse-specific 
gene expression are a prerequisite for the establishment of successful synaptic transmission at 
the NMJ. 
 The agrin cDNA predicts a number of structural domains within the agrin protein, 
including domains similar to EGF, follistatin and the globular domain of the laminin  chain 
(Denzer et al., 1998). The function of these domains is mostly unknown, but the C-terminal of 
agrin regulates agrin’s synaptogenic activity at the NMJ. In particular, alternative splicing 
generates a number of agrin isoforms which differ dramatically in their synaptogenic activity 
at the NMJ. Alternative splicing occurs at several splicing sites within agrin, including two 
named “y” and “z” in mammals and “A” and “B” in chicken (Fig. 1). Alternative splicing within 
both sites theoretically generates eight isoforms, but only five of them are realized in vivo 
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(Ruegg et al., 1992). Interestingly, alternative splicing at the z site generates several isoforms 
that differ in their biological activity (Burgess et al., 1999; Gesemann et al., 1995).  Only the 
isoforms with an insert of 8, 11 or 19 (8 plus 11) amino acids are able to bind to Lrp4, activate 
MuSK and induce aggregation of nAChRs (Kim et al., 2008; Zhang et al., 2008). Agrin 
isoforms without any insert at the z/B site have no synaptogenic activity at the NMJ. The 
function of these B0/z0 isoforms is unknown. The ability of these splice variants to interact 
with Lrp4 is due to conformational change that forms a tetramer between agrin and Lrp4 (Zong 
et al., 2012).  
 Splicing at the y/A site in the LG2-domain generates agrin isoforms which contain or 
lack an insert of 4 amino acids. This splice site itself does not regulate agrin’s synaptogenic 
activity at the NMJ, but the insertion of an exon coding for 4 amino acids (KSRK) increases 
the affinity of agrin to heparin/heparan sulfate (Gesemann et al., 1995). One binding partner 
affected by the splicing at the y/A site is -dystroglycan (Gesemann et al., 1998; Hopf and 
Hoch, 1996; Scotton et al., 2006), one of the components of the dystroglycan glycoprotein 
complex (DGC). Of note, the binding of agrin to dystroglycan does not correlate with agrin’s 
binding to heparin/heparan sulfate (Gesemann et al., 1996). However, the function of this 
interaction is not known. 
  
 
Figure 1. Domain structure of agrin. Alternative first exon usage generates two isoforms of agrin, the soluble, 
secreted-form of agrin (NtA-agrin) and membrane-anchored-form of agrin (TM-agrin). At the C-terminus, agrin 
contains two splice sites, named y and z. The presence of an insert of 8, 11 or 19 (8+11) amino acid at the z-site is 
required for the binding of agrin to Lrp4 (adopted from Handara and Kröger, submitted). 
 
As mentioned above, agrin and its receptor complex consisting of the low-density 
lipoprotein receptor-related proteins-4 (Lrp4) and the muscle-specific kinase (MuSK) are the 
master organizers for the NMJ formation and maintenance. Null-mutations of any of these 
proteins exhibit perinatal lethality, i.e. these mice die during or shortly after birth (DeChiara et 
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al., 1996; Gautam et al., 1996; Weatherbee et al., 2006). In all cases, homozygous mice have 
no functional NMJs and are, therefore, not able to use their respiratory muscles. Furthermore, 
the aggregation of nAChRs in vitro after agrin incubation on myotubes from Lrp4-KO or 
MuSK-KO mice was not observed, suggesting that Lrp4 and MuSK are required for agrin’s 
effect on the nAChRs aggregation (Glass et al., 1996; Weatherbee et al., 2006). 
Several lines of evidences suggest that agrin is sufficient for NMJ development in vivo. 
Injection of agrin-secreting cells or agrin cDNA into myotubes from skeletal muscle fibers 
results in the extracellular deposition of agrin in the basal lamina at extrasynaptic sites (Cohen 
et al., 1997; Jones et al., 1997; Meier et al., 1997; Bezakova et al., 2001). This ectopically 
deposited agrin induces the formation of the postsynaptic specializations, including the 
aggregation of nAChRs, rapsyn, acetylcholine esterase (AChE), MuSK and also the 
aggregation of myonuclei, expression of the AChR -subunit and formation of junctional folds. 
Thus, agrin is not only necessary but also sufficient for the postsynaptic specialization 
formation at the NMJ. 
 
Agrin and its receptor complex in the central nervous system 
 Agrin, Lrp4 and MuSK are expressed by neurons and glial cells in the embryonic and 
adult CNS (Burgess et al., 2000; Garcia-Osta et al., 2006; Karakatsani et al., 2017; Lein et al., 
2006). However, their functions in the CNS are still only poorly understood.  
While agrin at the NMJ is synthesized as a secreted laminin-binding and basal-lamina-
associated form (NtA-agrin; Denzer et al., 1997), the majority of agrin in the CNS is the 
membrane-anchored isoform, named transmembrane-agrin (TM-agrin; Burgess et al., 2000; 
Neumann et al., 2002). Both isoforms are transcribed from the same gene, however, alternative 
first exon usage replaces the N-terminal laminin-binding domain by a single transmembrane 
region and a 28 amino acids (mouse) intracellular domain (Burgess et al., 2000; Neumann et 
al., 2002. TM-agrin is a type 2 transmembrane protein and is anchored to the plasma membrane 
of the CNS neurons (Burgess et al., 2002; Neumann et al., 2001). Subcellularly, TM-agrin is 
concentrated at synapses (Koulen et al., 1999; Ksiazek et al., 2007) and antibodies against the 
C-terminal portion of TM-agrin could be detected in the synaptic cleft. However, it is unknown 
if this agrin is anchored in the pre- or postsynaptic membrane.  
 The expression pattern and the concentration of agrin at synapses has led to the 
hypothesis, that agrin might contribute to synapse development in the CNS in a similar way as 
it does at the NMJ (Daniels, 2012; Kröger and Pfister, 2009). The following observation 
supports this hypothesis: agrin is highly expressed during the period of synapse formation and 
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remains expressed (although at a reduced levels) in the adult CNS, particularly in regions with 
increased synaptic plasticity (Burgess et al., 2000; Li et al., 1997; O'Connor et al., 1994). In the 
brain of E14 mouse, agrin is expressed in the ventricular, intermediate zone, cortical plate and 
in the cerebral vasculature. In the adult brain, the expression of agrin is restricted to brain 
regions with a high degree of synaptic plasticity (Burk et al., 2012). Seizures increase agrin 
expression level in a rapid, a region-specific and prolonged-manner (O'Connor et al., 1995). 
Likewise, after traumatic brain injury, agrin expression is increased within 7 days after the 
insult and reduced to normal levels thereafter (Falo et al., 2008). Thus, agrin is expressed in the 
developing CNS and during periods of synaptic plasticity. 
Interestingly, the absence of agrin in the CNS lead to subtle morphological abnormality 
at synapses in vitro (Gautam et al., 1999; Li et al., 1999; Serpinskaya et al., 1999). In vitro, 
CNS neurons in which the expression of TM-agrin was reduced using siRNA showed a 
reduction of excitatory synapses density compared to control (McCroskery et al., 2006). 
Moreover, agrin-deficient neuronal precursors that were transplanted into the subventricular 
zone of WT mice have the capacity to migrate along the rostral migratory stream (RMS) into 
the olfactory bulb. However, they fail to integrate correctly into the neuronal network and do 
not form synapses. Accordingly, these cells display a reduced viability (Burk et al., 2012). This 
demonstrates the requirement of agrin expression for synapse formation and, as a consequence 
for the normal integration of neurons into an existing network.  
The role of TM-agrin in the CNS has been shown by taking advantage of gain-of-
function paradigms. Overexpression of the TM-agrin, but not of NtA-agrin isoform, increases 
the number of filopodia extended from axons and dendrites of cultured cortical neurons (Annies 
et al., 2006; McCroskery et al., 2006; Ramseger et al., 2009). The formation of filopodia in 
neurons after TM-agrin overexpression involves a specific signaling cascade via lipid rafts. The 
generation of these lipid rafts is required for the activation of mitogen-activated protein kinases 
(MAPKs). It has been shown that MAPKs activation leads to the Cdc42-mediated actin filament 
reorganization (McCroskery et al., 2006; Ramseger et al., 2009). Thus, TM-agrin 
overexpression leads to an increased density of dendritic filopodia via activation of the specific 
signaling cascade. Since filopodia-like processes have been shown to be precursors of dendritic 
spines (Ziv & Smith 1996), these results suggested that TM-agrin might affect synaptogenesis 
by regulating the number of these filopodia (Annies et al., 2006; McCroskery et al., 2006; 
Ramseger et al., 2009). 
Mice in which the perinatal lethality caused by agrin deficiency was rescued by re-
expression of agrin cDNA exclusively in motoneurons, display morphological and functional 
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changes at synapses in the CNS, such as a reduction of spine density and of miniature excitatory 
postsynaptic currents (mEPSCs) frequency in the adult cortex (Ksiazek et al., 2007). However, 
agrin-deficient brains have no change of IPSCs amplitude and frequency. Moreover, agrin 
colocalized only with PSD-95, but not with the 2-subunit of the GABAAR. Collectively, these 
results demonstrate that agrin is required for the formation of a normal density of excitatory 
synapses and their maintenance in the CNS. These results also support the hypothesis that agrin 
might play a role in the developing CNS similar to its role at the NMJ. 
 
Lrp4 in the central nervous system 
Lrp4 is a type 1 transmembrane protein that is not only expressed by muscle fibers and 
aggregated at the NMJ but also expressed in the CNS, including the neocortex, hippocampus, 
cerebellum and olfactory bulb (Karakatsani et al., 2017; Lein et al., 2007; Sun et al., 2016; Tian 
et al., 2006). Lrp4 is concentrated at synapses and can be extracted from highly-purified 
postsynaptic membrane fractions from murine forebrain (Tian et al., 2006). Lrp4 belongs to the 
low-density lipoprotein receptor (LDLR) family. All proteins from this family carry a common 
structure that includes ligand binding domains, epidermal growth factor (EGF) domains, a 
membrane anchoring domain, and a cytoplasmic tail containing the NPxY motif which allows 
the direct binding of Lrp4 to PSD-95. The structure of Lrp4 itself consists of an extracellular 
region comprising eight cysteine-rich repeats (LDLa repeats), six epidermal growth factor 
(EGF)-like domains, four -propeller domains, a hydrophobic transmembrane region, and a 
cytoplasmic tail (consisting of 160 amino acids containing the NPxY motif and a PDZ domain-
binding consensus sequence, -ESQV; Chen et al., 1990; Tian et al., 2006). The NPxY motif 
facilitates signal transduction and endocytic trafficking (Gotthardt et al., 2000). Interestingly, 
Lrp4 has been shown to directly interact with the postsynaptic scaffold protein PSD-95 via the 
PDZ domain-binding consensus sequence (Tian et al., 2006; Gomez et al., 2014). In addition, 
Lrp4 binds directly to the LG3 domain of agrin via its LDLa repeats domain, the first two EGF-
like domains, and the first -propeller (Zhang et al., 2011; Zong et al., 2012). 
 A mouse line with a null mutation of Lrp4 was generated by chemical mutagenesis using 
N-ethyl-N-nitrosourea (Weatherbee et al., 2006). This chemically-induced mutation generated 
an early stop codon C terminal to the LA domains and also an alternative splice variant 
containing another premature stop codon. Mice with the Lrp4 mutation have no structural and 
functional NMJs. Moreover, the motor nerve axon from this mutant line fail to stop in the 
central region of muscle fibers, never transform into a presynaptic terminal and instead continue 
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to grow and arborize extensively (Weatherbee et al., 2006). Therefore, the mutant mice die 
perinatally due to respiratory muscle failure. 
 The absence of Lrp4 in the CNS lead to normal architecture of the cortex and 
hippocampus and no obvious change in the dendritic morphology. However, spine density on 
primary apical dendrites was reduced causing a disturbance in long-term potentiation in the 
hippocampus and in cognitive performance, such as memory deficits in the Morris water maze 
(Gomez et al., 2014; Pohlkamp et al., 2015). In addition, a reduced level of Lrp4 in hippocampal 
and cortical neurons, in vitro and in vivo, caused a less complex dendritic arborization and a 
lower density of spines and synapses (Karakatsani et al., 2017). Altogether, Lrp4 in the CNS is 
essential for the synapse formation, synapse maintenance and for normal memory functions. 
 
MuSK in the central nervous system 
 MuSK is a type I transmembrane protein that is expressed not only in skeletal muscles, 
but also in CNS neurons (Garcia-Osta et al., 2006). It belongs to a member of the large receptor 
tyrosine kinases (RTKs) family. It was initially discovered in a search for tyrosine kinases from 
the electric organ of Torpedo californica (Jennings et al., 1993), a tissue that resembles 
innervated skeletal muscle. The extracellular region of MuSK consists of several domains, such 
as a glycosylated extracellular domain, a single transmembrane helix, and a cytoplasmic region. 
Furthermore, the extracellular domain consists of three immunoglobulin-like domains (Ig1, Ig2, 
and Ig3) and a cysteine-rich domain (CRD). This CRD domain shares structural similarities to 
the CRD domain of Frizzled proteins of the Wnt receptors (Jing et al., 2009).  
Functionally, on myotube the Ig1 domain of MuSK binds to Lrp4 in an agrin-dependent 
manner (Kim et al., 2008; Zhang et al., 2011). This binding leads to an autophosphorylation of 
MuSK in the cytoplasmic region, due to a presence of a tyrosine kinase domain (Till et al., 
2002). The activation of the tyrosine kinase domain activates an intracellular signaling cascade 
which eventually leads to the formation of the postsynaptic apparatus at the NMJ, including the 
aggregation of nAChRs. The presence of the cytoplasmic adaptor protein Dok7 is essential for 
the MuSK-mediated nAChRs aggregation (Okada et al., 2006).  
The function of MuSK in the developing and adult CNS is mostly unknown. The 
presence of MuSK in hippocampus had been shown to be important for memory consolidation, 
and for the induction and maintenance of LTP (Garcia-Osta et al., 2006). Additional evidence 
for a role of MuSK in the CNS was provided by an animal model for autoimmune myasthenia 
gravis (Sabre et al., 2019). Passive immunization of mice with IgG MuSK-positive from 
patients with myasthenia gravis showed not only an impairment of the neuromuscular integrity 
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and function, but also an impairment in spatial and recognition memories (Sabre et al., 2019). 
These evidences support a role for MuSK not only in the NMJ formation and maintenance, but 
also in the CNS. 
 
Aims of study 
In my thesis, I investigated the functions of agrin, Lrp4 and MuSK during synapse formation 
and synaptic plasticity. Particularly, I analyzed if agrin and its receptor complex influence 
neuronal morphology and synaptogenesis in developing cortical neurons in vitro and in adult 
mice in vivo.  
Specifically, I investigated the following questions: 
1. Do TM-agrin, Lrp4 and MuSK play a role in dendritic arborization in cultured 
cortical neurons?  
2. Does TM-agrin overexpression affect dendritic development and synapse formation? 
3. Does the effect of TM-agrin overexpression on dendritic branching and synapse 
formation depend on the expression of Lrp4 and MuSK? 
4. Which region of TM-agrin is involved in CNS development? 
5. Does TM-agrin overexpression affect synapse development and/or maintenance in 
adult murine cortex? 
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Materials 
Animals 
 Use and care of animals were approved by German authorities according to the national 
law (TierSch§7). For this study, C57BL/6J wild-type (Charles River GmbH, Germany), 
CamKIIa-CreERT2 and TM-agrin knock-in (TM-agrin KI) were bred in the Core Facility Animal 
Models of the Biomedical Center of the LMU Munich. The Lrp4mitt or Lrp4-KO mice 
(Weatherbee et al., 2006) and MuSKtm1gdy or MuSK-KO mice (DeChiara et al., 1996) were bred 
in the animal facility of the Max-Delbrück-Center in Berlin. Animals were housed in a cage 
with maximal 5 animals on a 12/12 h light/dark cycle with access to food and water ad libitum.  
 The animal procedures were performed according to the guidelines from Directive 
2010/63/EU of the European Parliament on the protection of animals used for scientific 
purposes. All experimental procedures were approved by the local authorities of Bavaria (Az.: 
ROB-55.2-2532.Vet_02-17-82. 55.2-1-54-2532.8-160-13 and 55.1-8791-14.587) and of Berlin 
(LaGeSO; numbers T0313/97 and X9014/15). The day of the vaginal plug was considered as 
embryonic day 0.5 (E 0.5). Male and female mice were used in all of the experiments. The 
heterozygous littermates of Lrp4mitt and MuSKtm1gd mice were used as controls. 
 The CamKIIa-CreERT2 line (Erdmann et al., 2007) was maintained on C57BL/6J 
background. In this line, the fusion protein containing Cre recombinase and human estrogen 
receptor (CreERT2) was expressed under the CamKIIa promoter that shows high expression in 
excitatory neurons in the forebrain (Erdmann et al., 2007). The fusion protein is located in the 
cytoplasm and only translocated into the nucleus upon tamoxifen administration (Erdmann et 
al., 2007). In the nucleus, the Cre recombinase excises the loxP-flanked stop cassette. This 
excision will disinhibit the expression of knock-in TM-agrin in excitatory neurons, yielding an 
overexpression of TM-agrin. The homozygosity of CamKIIa-CreERT2 was generated and was 
subject to cross-breeding with the TM-agrin KI line to generate Cre+/Agrin KI and Cre+/Agrin 
WT as a control. 
 TM-agrin knock-in (TM-agrin KI) line was generated by taking advantage of the yeast 
(Saccharomyces cerevisiae) homologous recombination system (Schick, 2018). The mouse 
full-length TM-agrin-y4z0 cDNA was incorporated into a targeting backbone of the pMES 
vector and inserted in the ROSA26 locus by homologous recombination. This locus was chosen 
because it shows high efficiency for homologous recombination and mice with homozygous 
knockout of ROSA26 do not show any obvious phenotype (Zambrowicz et al., 1997). To 
investigate the effect of TM-agrin overexpression during phase of synaptic plasticity, the TM-
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agrin KI line was cross-bred with the CamKIIa-CreERT2 line and tamoxifen was applied to 
animals at 5-weeks of age. The cross-bred line was maintained on C57BL/6J background. 
 Embryos from Lrp4mitt (termed Lrp4-KO mice; MGI ID: 3707955) were prepared at 
E15. This line carries two chemically induced mutations, that lead to an early stop of translation 
at from the C-terminal to the LA domain and a splice site mutation that lead to another early 
stop codon (Weatherbee et al., 2006). The Lrp4-KO mice were a generous gift from Prof. Dr. 
Fritz Rathjen (Max-Delbrück-Center Berlin). This line was maintained on C57BL/6N 
background. 
 Embryos from MuSKtm1Gdy-mice (termed MuSK-KO mice; MGI ID:1929066) were 
prepared at E15. The MuSKtm1Gdy mice lack the exon coding for the intracellular tyrosine kinase 
domain which was replaced by a neomycin cassette (DeChiara et al., 1996). These mice also 
were a generous gift from Prof. Dr. Fritz Rathjen. The MuSK-KO line was maintained on 
C57BL/6N background. 
 
Generation of antiserum against TM-agrin 
 Antibodies specifically against murine TM-agrin are not commercially available. In 
order to investigate the specific localization of TM-agrin, we generated monoclonal and 
polyclonal antibodies against a peptide from the intracellular region of mouse TM-agrin. The 
selected sequence was LPLEHRPRQQPGASVC. This sequence of the intracellular region was 
selected and analyzed in silico by basic local alignment search tool for protein (BLASTp) for 
its specificity and for its potential immunogenicity. The BLASTp analysis showed that the 
peptide was specific and did not share any similarities with other proteins. In addition, the 
secondary structure of the selected region was analyzed to select the best epitope using the 
Welling antigenicity scale (Janin, 1979; Parker et al., 1986). Altogether, the analyses showed 
that the peptide was highly specific and immunogenic for the production of the relevant 
antibodies. 
 The peptide was commercially synthesized and purified. For the generation of the 
polyclonal antibody, three rabbits were immunized with the peptide for 128 days according to 
the standard protocol (Pineda Antikörper Service, Berlin, Germany). Before the immunization, 
pre-immune sera were collected and tested, in order to choose rabbits which had the lowest 
background immunoreactivity on brain sections. After immunization, the blood was collected, 
and the antiserum was purified by affinity chromatography. The monoclonal antibodies were 
generated using standard procedures in the monoclonal antibody facilities of the Department of 
Biology of the LMU Munich. 
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Primary antibodies 
Table 1. Primary antibodies 
Antibody Host Species Source Dilution 
Agrin Rabbit Markus Ruegg WB 1:2000 
IHC 1:500 
ICC 1:1000 
TM-agrin (specific 
against intracellular-
domain) 
Rabbit In house-made, #173 IHC 1:500 
ICC 1:1000 
TM-agrin (specific 
against intracellular-
domain) 
Mouse In house-made IHC 1:500 
ICC 1:1000 
1-subunit GABAAR Rabbit Merck:06-868 ICC 1:1000 
5-subunit GABAAR Rabbit Synaptic 
Systems:224503 
ICC 1:1000 
IHC 1:1000 
Amyloid precursor 
protein 
Rabbit Abcam:ab32136 ICC 1:1000 
IHC 1:1000 
Bassoon Mouse  Thermo 
Scientific:MA1-20689 
ICC 1:1000 
IHC 1:1000 
Collybistin Rabbit Synaptic 
systems:261003 
ICC 1:1000 
IHC 1:2000 
GABA Rabbit Sigma:A2052 ICC 1:1000 
Gephyrin Rabbit Synaptic 
Systems:147002 
ICC 1:1000 
GFP Chicken Abcam:ab13970 ICC 1:2000 
HA affinity-purified Rat Roche:11867423001 ICC 1:1000 
Neuroligin-1 Rabbit Synaptic 
Systems:129013 
ICC 1:1000 
Neuroligin-2 Rabbit Synaptic 
Systems:129203 
ICC 1:1000 
Neuronal nuclei (NeuN) Mouse Merck:mab377 ICC 1:500 
PSD-95 Mouse Merck:Mab68 ICC 1:1000 
PSD-95 Rabbit Abcam:ab18258 IHC 1:1000 
RFP Rabbit  Abcam: ab62341 ICC 1:2500 
Tau Rabbit Sigma: WB 1:1000 
Tau Mouse Merck-
Millipore:Mab3420 
WB 1:1000 
Tbr1 Mouse Santa Cruz: sc-376258 ICC 1:1000 
Tbr1 Rabbit Abcam: ab31940 ICC 1:1000 
Tbr1 Guinea Pig Synaptic 
system:328005 
ICC 1:1000 
vGAT Guinea Pig Synaptic 
systems:131005 
ICC 1:1000 
IHC 1:1000 
vGlut1 Guinea Pig Synaptic systems: 
135304 
ICC 1:5000 
IHC 1:5000 
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Secondary antibodies 
Table 2. Secondary antibodies 
Antibody Flourescence tag Source Dilution 
Goat anti-mouse IgG 
(H+L), highly cross-
adsorbed 
Alexa Fluor® 594 Thermo Fisher 
Scientific:A11032 
ICC 1:1000 
IHC 1:1000 
Goat anti-mouse IgG 
(H+L), highly cross-
adsorbed 
Alexa Fluor® 647 Thermo Fisher 
Scientific:A21236 
ICC 1:1000 
IHC 1:1000 
Goat anti-rabbit IgG 
(H+L), highly cross-
adsorbed 
Alexa Fluor® 594 Thermo Fisher 
Scientific:A11037 
ICC 1:1000 
IHC 1:1000 
Goat anti-rabbit IgG 
(H+L), highly cross-
adsorbed 
Alexa Fluor® 647 Thermo Fisher 
Scientific:A21245 
ICC 1:1000 
IHC 1:1000 
Donkey anti-rat IgG 
(H+L), highly cross-
adsorbed 
Alexa Fluor® 488 Thermo Fisher 
Scientific:A21208 
ICC 1:1000 
IHC 1:1000 
Donkey anti-chicken 
IgY (H+L) 
Alexa Fluor® 488 Thermo Fisher 
Scientific:A11039 
ICC 1:1000 
IHC 1:1000 
Donkey anti-guinea 
pig  
DyLight 649 Millipore: AP193SD IHC 1:1000 
Goat anti-mouse IgG 
(H+L) 
IRDye 800CW Li-Cor:925-32210 WB 1:20000 
Goat anti-rabbit IgG 
(H+L) 
IRDye 680LT Li-Cor:925-68021 WB 1:20000 
 
Buffers and solutions 
Table 3. Buffers and solutions 
Buffer/Solution Components Preparation / Final 
concentration 
Manufacturer 
Ampicillin stock, 100 
mg/ml 
1 g ampicillin, 
autoclaved ddH2O 
Ampicillin powder is 
dissolved in 10 ml 
ddH2O 
 
4’,6’-diamidino-2-
phenylindole (DAPI) stock 
2 mg/ml 
2 mg DAPI 
1 mL 1X PBS 
DAPI powder is 
dissolved in the 1 ml 
PBS 1 X 
 
Kanamycin stock, 100 
mg/ml 
1 g kanamycin 
Autoclaved ddH2O 
Kanamycin powder 
is dissolved in 10 ml 
autoclaved ddH2O 
 
Gel loading dye, purple (6 
X) 
- - New England 
BioLabs 
Aqua-Poly/Mount - - Polysciences, Inc 
Paraformaldehyde 16% 
(PFA 16%) 
- - Electron Microscopy 
Science 
Paraformaldehyde 4% 
(PFA 4%) 
1 volume PFA 16% 
3 volume PBS 1 X 
- - 
PBS 10 X    
PBS 1 X 1 Volume PBS 10 X 
9 Volume ddH2O 
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Poly-D-Lysine (PDL) stock 
solution, 1 mg/ml 
5 mg PDL 
ddH2O 
5 mg PDL powder is 
dissolved in 5 ml 
ddH2O, then it is 
sterilized by filtering 
 
Poly-D-Lysine (PDL) 
working solution, 0.01 
mg/ml 
500 ul PDL stock 
solution 
50 ml sterile PBS 1 
X 
500 ul of PDL stock 
solution is mixed 
with 50 ml sterile 
PBS 1 X 
 
RIPA buffer    
Electrophoresis running 
buffer 10 X , pH 8.5( Elo 
buffer 10 X) 
30.2 g of Tris-BASE 
(MW = 121.14 
g/mol), 144 g of 
Glycine (MW = 
75.07 g/mol), 10 g of 
SDS (MW = 288.38 
g/mol), ddH2O 
Tris-BASE, glycine 
and SDS are diluted 
in 900 ml ddH2O. 
The pH is adjusted to 
8.5, and then the 
ddH2O is added up to 
1 L. 
 
Elo buffer 1 X, working 
buffer 
Elo buffer 10 X 
ddH2O 
100 ml of Elo buffer 
10 X is diluted with 
900 ml ddH2O 
 
Transfer buffer 10 X 30.2 g of Tris-BASE 
(MW = 121.14 
g/mol), 144 g of 
Glycine (MW = 
75.07 g/mol), ddH2O 
Tris-BASe and 
glycine are dissolved 
in ddH2O with the 
end volume 1 L. 
 
Transfer buffer 1 X, 
working buffer 
Transfer buffer 10 X 
Ethanol 100 % 
100 ml of transfer 
buffer 1 X, 200 ml of 
ethanol 100 % and 
700 ml ddH2O 
 
SDS 20% 20 g of SDS (MW = 
288.38 g/mol) 
ddH2O 
20 g of SDS is 
dissolved in 80 ml 
ddH2O at 65°C, and 
then the volume is 
added up to 100 ml. 
 
Tris HCl 1 M pH 8.5 TrisBASE powder 
(MW = 121.1 g/mol) 
HCl 6 N 
ddH2O 
60.5 g TrisBASE is 
dissolved in 450 ml 
ddH2O. The pH is 
adjusted to 8.5 with 
HCl 6 N up to 500 
ml volume. 
 
 
EDTA 0.5 M, pH 8.0 EDTA powder (MW 
= 372.24 g/mol) 
NaOH 32% 
ddH2O 
18.61 g of EDTA is 
dissolved in 80 ml 
ddH2O. The pH is 
adjusted with NaOH 
32%. The volume is 
adjusted up to 100 
ml. 
 
NaCl 1 M NaCl powder (MW = 
58.44 g/mol) 
ddH2O 
22.22 g of NaCl is 
dissolved in 500 ml 
ddH2O. 
 
Tris-Acetate-EDTA (TAE) 
buffer, 1 X 
1 volume of TEA 
buffer 50 X 
ddH2O 
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LB broth    
LB Agar    
SDS-PAGE protein sample 
buffer 4 X 
Tris-HCl 1 M pH 
8.5, SDS 20 %, 100 
% glycerol, -
mercaptoethanol 100 
%, bromophenol 
blue, ddH2O 
5 mM of Tris-HCl 
pH 8.5, SDS 0.25 % 
(v/v), glycerol 25 % 
(v/v), -
mercaptoethanol 8 
%, bromophenol 
blue 0.25 % 
 
APS 10 % Ammonium 
persulfate (MW = 
228.2 g/mol) 
APS 20 % (w/v)  
Differentiation/maintenance 
medium 
Neurobasal medium 
Penicillin-
Streptomycin 1 X 
GlutaMAX™ 1 X 
B27 Supplement 
(Gibco®) 1 X 
  
Dissecting buffer HBSS 50 mL 
1 M HEPES 500 ul 
1 M HEPES was 
added into cold 
HBSS, with the end 
concentration 100 
uM 
 
Tissue lysis buffer Tris-HCl pH 7.5 
EDTA 
PMSF 
cOmplete™ Protease 
inhibitor cocktail 
(Co-Ro Roche) 
Tris-HCl 10 mM pH 
7.5 
EDTA 10 mM 
PMSF 0.5 mM 
1 tablet of protease 
inhibitor cocktail per 
50 mL 
 
SDS sample buffer 4 X for 
S2 (supernatant-2) fraction 
1 M Tris-HCl pH 8.5 
Sodium dodecyl 
sulfate (SDS) 
Glycerol 
2-mercaptoethanol 
Bromophenol blue 
Tris-HCl 5 mM pH 
8.5, SDS 1 %, 
glycerol 25 %, 2-
mercaptoethanol 8 
%, bromophenol 
blue 0.25 %  
 
SDS sample buffer 4 X for 
M (crude membrane) 
fraction 
1 M Tris-HCl pH 8.5 
Sodium dodecyl 
sulfate (SDS) 
Glycerol 
2-mercaptoethanol 
Bromophenol blue 
Urea 
Tris-HCl 5 mM pH 
8.5, SDS 1 %, 
glycerol 25 %, 2-
mercaptoethanol 8 
%, bromophenol 
blue 0.25 %, Urea 8 
M 
 
Proteinase K, stock 10 
mg/ml 
1 g of proteinase K 
powder 
ddH2O 
1 g of proteinase K 
powder is dissolved 
in 100 ml ddH2O. 
The storage is -20 °C 
Carl Roth, catalogue 
number 7528 
Odyssey® blocking buffer 
(TBS) 
  Li-Cor 
TBS 10 X, pH 8.0 Tris-BASE (MW = 
121.14 g/mol), NaCl, 
ddH2O 
Tris-BASE 100 mM 
and NaCl 1.5 M are 
mixed in 900 ml 
ddH2O. The pH is 
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adjusted to 8.0, then 
the volume is added 
up to 1 L. 
TBST 1 X TBS 10 X, pH 8.0 
Tween® 20, ddH2O 
 
TBS 1 X, Tween® 
20 0.1 % (v/v), 
ddH2O is added up to 
1 L. 
 
WB staining solution TBST 1 X, horse 
serum 
horse serum 5 % 
(v/v) is added to 10 
ml of TBST 1 X 
 
ICC blocking solution Bovine serum 
albumin (BSA), 
triton X-100, PBS 1 
X 
BSA 2 % (m/v) is 
dissolved in PBS 1 
X, triton X-100 0.2 
% (v/v) in PBS 1 X. 
 
Sodium citrate buffer Trisodium citrate 
(dihydrate), ddH2O 
Trisodium citrate 10 
mM, pH 8 
 
IHC blocking solution Normal Goat Serum 
(NGS), Triton X-
100, PBS 1X 
NGS 5 % (v/v), 
Triton X-100 0.3 % 
(v/v), PBS 1 X 
 
IHC staining solution Bovine serum 
albumin (BSA), 
triton X-100, PBS 1 
X 
NGS 2.5 % (v/v), 
Triton X-100 0.1 % 
(v/v), PBS 1 X 
 
Tamoxifen powder - - Sigma-Aldrich, Cat. 
No. T5648 
Corn oil - - Sigma-Aldrich, Cat. 
No. C8267 
Tamoxifen for 
intraperitoneal injection 
Tamoxifen powder, 
corn oil 
Tamoxifen powder is 
dissolved in corn oil 
(2 mg/ml) 
 
Ketamine/xylazine mixture 
for perfusion 
Ketamine 
hydrochloride 10 %, 
xylazine 
hydrochloride 2 %, 
NaCl 0.9 % 
  
Lipofectamine® 2000 - - Thermo Fisher 
Scientific 
SV Total RNA Isolation 
System 
- - Promega 
Reverse-transcription    
Denaturing agarose gel Formamide, 
Formaldehyde 37 %, 
Ethidium bromide 
  
MOPS buffer MOPS, Na-acetate, 
EDTA 
MOPS free acid 20 
mM, Na-acetate 5 
mM, EDTA 1mM 
 
Anesthesia solution Ketamine 
hydrochloride 10 %, 
Xylazine 
hydrochloride 100 
mg/ml, sterile 
physiological saline 
1 mL ketamine 
hydrochloride, 0.25 
mL xylazine 
hydrochloride, 2.5 
sterile physiological 
saline solution 
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Zyppy™ plasmid midiprep 
kit 
- - Zymo Research 
Plasmid Midi kit - - Qiagen 
 
 
Media and supplements 
Table 4. Media and supplements 
Medium Manufacturer 
HBSS, no calcium, no magnesium (Gibco™) Thermo Fisher Scientific 
HEPES 1M (Gibco™) Thermo Fisher Scientific 
Neurobasal, serum free medium Thermo Fisher Scientific 
B-27 supplement Thermo Fisher Scientific 
GlutaMAX™ supplement Thermo Fisher Scientific 
 
Cell lines 
Table 5. Cell lines 
Bacterial Strains Manufacturer/Source 
Top10 Chemically-competent 
E. coli TOP10 
Invitrogen/Thermofisher 
HEK 293T cells Kind gift of Dr. Alex Lepier 
 
Oligonucleotides 
Table 6. Oligonucleotides 
Sequence name Application Gene to be 
annealed 
Sequence 
prAS15 Genotyping  TM-agrin 
knock-in 
allele 
forward 
TACTCCTCTACAATGGGCAG 
prAS104 Genotyping  TM-agrin 
knock-in 
allele 
reverse 
GCCACAACTCCTCATAAAGA 
prAS116 Genotyping CamKIIa-
CreERT2 
transgene 
forward 
GGTTCTCCGTTTGCACTCAGGA 
prAS118 Genotyping CamKIIa-
CreERT2 
transgene 
reverse 
GCTTGCAGGTACAGGAGGTAGT 
oIMR1084 Genotyping CamKIIa-
Cre 
transgene 
forward 
GCG GTC TGG CAG TAA AAA CTA TC 
oIMR1085 Genotyping CamKIIa-
Cre 
GTG AAA CAG CAT TGC TGT CAC TT 
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transgene 
reverse 
oiMR9020 Genotyping Rosa26 WT 
locus 
forward 
AAGGGAGCTGCAGTGGAGTA 
oiMR9021 Genotyping Rosa26 WT 
locus 
reverse 
CCGAAAATCTGTGGGAAGTC 
L4Hpmf Genotyping Lrp4-WT GGTGAGGAGAACAGCAATGT 
43Br_FP Genotyping Lrp4-KO TCCCAGGGTCAGTGTAACGATG 
NsK-1 Genotyping MuSK WT ATGCCGCCCGAGTCTATCTTCTAC 
NsK-2 Genotyping MuSK WT-
KO 
TTCTCCTGGCAAACAATCAACTGG 
Neo3 Genotyping MuSK KO CATAGCCTGAAGAACGAGATCAGCAGC 
Bassoon left qRT-PCR Bsn TTTAACCCAACACCGCATCT 
Bassoon right qRT-PCR Bsn GCCGCTTAGTTTGGCAGTT 
GluR1-subunit of 
AMPAR left 
qRT-PCR Gria1 AGGGATCGACATCCAGAGAG 
GluR1-subunit of 
AMPAR right 
qRT-PCR Gria1 TGCACATTTCCTGTCAAACC 
NR1-subunit of 
NMDAR left 
qRT-PCR Grin1 AGGGATCGACATCCAGAGAG 
NR1-subunit of 
NMDAR right 
qRT-PCR Grin1 AGCAGAGCCGTCACATTCTT 
Synaptophysin 
left 
qRT-PCR Syp CAAGGCTACGGCCAACAG 
Synaptophysin 
right 
qRT-PCR Syp TCGTGGGCTTCACTGACC 
1-subunit of 
GABAAR left 
qRT-PCR Gabra1 GCCCACTAAAATTCGGAAGC 
1-subunit of 
GABAAR right 
qRT-PCR Gabra1 CTTCTGCTACAACCACTGAACG 
Gephyrin left qRT-PCR Gphn TGGTCTCATCAGTTATTCCCATC 
Gephyrin right qRT-PCR Gphn CGAGAAATGATGGAGTCTGGA 
Munc13-1 left qRT-PCR Unc13a CAATGCCTTGGCAGATGATA 
Munc13-1 right qRT-PCR Unc13a GGGTCTTCAAAGGAACACTGG 
Munc13-2 left qRT-PCR Unc13b TGCCTTGGCAGATGATAATG 
Munc13-2 right qRT-PCR Unc13b AGCCCAAATAGGTCCAGTGA 
HPRT left qRT-PCR Hprt TCCTCCTCAGACCGCTTTT 
HPRT right qRT-PCR Hprt CCTGGTTCATCATCGCTAATC 
Munc13-3 left qRT-PCR Unc13c TCTGACACCAAGACAATGTGC 
Munc13-3 right qRT-PCR Unc13c CCTCCTGCATGAAAATATTGCT 
PSD-95 left qRT-PCR Dlg4 ACTCCTGCTCCAGCTTCGT 
PSD-95 right qRT-PCR Dlg4 GCTCCCTGGAGAATGTGCTA 
Dystroglycan left qRT-PCR Dag1 CCAGGCAGTGTTGAAAACCT 
Dystroglycan 
right 
qRT-PCR Dag1 CCAGGCAGTGTTGAAAACCT 
Synaptotagmin-1 
left 
qRT-PCR Syt1 ACCTTACTCAACTGGCATTTGTT 
Synaptotagmin-1 
right 
qRT-PCR Syt1 AGACTGCGGATGTTGGTTGT 
Neuroligin-1 left qRT-PCR Nlgn1 CTATCGGCTTGGGGTACTTG 
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Neuroligin-1 
right 
qRT-PCR Nlgn1 CAAGGAGCCCGTAGTTTCCT 
Neuroligin-2 left qRT-PCR Nlgn2 CCTACGTGCAGAACCAGAGC 
Neuroligin-2 
right 
qRT-PCR Nlgn2 TCGCCTCGTCACGTTTTT 
 
Plasmids 
The full-length mouse TM-agrin-y4z0 cDNA was inserted into the multiple cloning 
sites (MCS) of a pMES-yeast-cassette vector (Schick, 2018). The pMES vector was chosen 
because it contains IRES-GFP, which enables visually the identification of transfected cells. 
All the constructs (Fig. 2, Table 7) used in this study were routinely sequenced (GATC Biotech, 
Konstanz, Germany) and were subjected to diagnostic restriction digest to exclude mutations. 
 
Table 7. Plasmids 
Plasmid Name Vector backbone Reporter/Tag 
Proteins 
Source 
Mouse TM-Agrin-y4z0 
(pAS12) 
pMES IRES-GFP, HA-tag, 
myc-tag 
Dr. Schick 
pMES - IRES-GFP Dr. Schick 
Mouse TM-Agrin-y4z8 pAS12 IRES-GFP, HA-tag, 
myc-tag 
Self-made/Genscript 
Biotech Corporation 
Mouse TM-agrin-y0z0 pAS12 IRES-GFP, HA-tag, 
myc-tag 
Restriction enzymes 
and ligation 
miRNA Lrp4 pCAG-RFP RFP Karakatsani, 2017 
miRNA control pCAG-RFP RFP Karakatsani, 2017 
Ch TM-agrin-y4z8 
(chTM-agrin) 
pGFPN-1 Fused-GFP Porten, 2007 
TMFD8 chTM-agrin Fused-GFP Porten, 2007 
TMFD6 chTM-agrin Fused-GFP Porten, 2007 
EC-FL-Agrin chTM-agrin Fused-GFP Porten, 2007 
pGFPN-1  GFP Clontech 
S17A TM-agrin-y4z0 pAS12 IRES-GFP, HA-tag, 
myc-tag 
Genscript Biotech 
Corporation 
S17D TM-agrin-y4z0 pAS12 IRES-GFP, HA-tag, 
myc-tag 
Genscript Biotech 
Corporation 
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Figure 2. Different constructs of TM-agrin used in this study. TM-agrin-y4z8 is expressed mainly by the 
motoneurons. TM-agrin-y4z0 is the main isoform that is expressed by neurons in the CNS. TM-agrin-y0z0 is 
expressed by non-neuronal cells including glial cells. The FD8 construct lacks the C-terminal half of agrin, the 
FD6 construct lacks the C-terminus upstream of the 7th-follistatin-like domain and the EC construct lacks the 
entire extracellular domain (adapted from Handara and Kröger (2019), submitted). 
 
Methods 
Breeding strategy  
 To investigate the effect of TM-agrin overexpression during the period of synaptic- 
plasticity, the TM-agrin knock-in line was cross-bred with CamKIIa-CreERT2 line. For 
breeding and maintenance of the colony, male CamKIIa-CreERT2 (homozygous)/TM-agrin KI 
(heterozygous) was bred with female CamKIIa-CreERT2 (WT)/TM-agrin KI (WT) mice. 
 
DNA isolation from tails and genotyping 
Adult mice were tailed 3 weeks after birth, whereas tails from embryos were dissected 
right before the cortical neuron preparation. The tails were lysed with the tail lysis buffer and 
Proteinase K in a shaker at 55oC overnight. After lysis, the DNA was purified using 
isopropanol. The purified DNA was genotyped by following the protocols (Table. 8). The 
CamKIIa-CreERT2 allele was analyzed with primer prAS116 and prAS118, whereas the TM-
agrin knock-in allele was analyzed using primer prAS15 and prAS104. The WT allele for 
Rosa26 was analyzed using primer oiMR9020 and oiMR9021.  
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Table 8. Protocols for genotyping 
Allele Primers Denaturation Annealing Elongation Cycles Note 
TM-
agrin 
knock-in 
prAS15 
prAS104 
95oC, 30s 55.1oC, 
60s 
72oC, 90s 40 
cycles 
DMSO; product 
size 1376 bp 
CamKIIa
-CreERT2 
prAS1162 
prAS118 
95oC, 15s 62oC, 45s 72oC, 45s 35 
cycles 
Product size 
375 bp 
WT 
Rosa26 
locus 
oIMR9020 
oIMR9021 
1. 94oC, 20s 
2. 94oC, 15s 
1. 65oC, 
15s 
2. 60oC, 
15s 
1. 68oC, 10s 
2. 72oC, 10s 
1. 10 
cycles 
(-0.5oC 
/ cycle) 
2. 28 
cycles 
2 steps PCR, 
product size 297 
bp 
Lrp4mitt L4Hpfmf 
43Br_FP 
94oC, 15 s 58oC, 15 s 72oC, 20 s 40 
cycles 
HpyCH4V 
digestion 37oC 
overnight, 
mutant product 
227bp, WT 
product 132bp + 
69bp 
MuSK-
KO 
Nsk1 
Nsk2 
Neo3 
94oC, 30 s 66oC, 40 s 72oC, 60 s 40 
cycles 
WT product 
446bp, mutant 
product 300bp 
 
Anesthesia and transcardial perfusion fixation 
 Mice were anesthetized by intraperitoneal injection of anesthesia solution, containing 
ketamine/xylazine cocktail (final concentration of ketamine is 10 mg/ml and of xylazine is 0.2 
mg/ml in sterile normal saline). The injected volume was 0.1 ml per 10 g bodyweight. The 
withdrawal reflex was assessed by pinching the toe. The absence of the reflex indicates that the 
mice were well anesthetized and were eligible for the whole-body perfusion fixation procedure. 
To this end, the chest and abdominal cavities were opened to expose the heart and the liver. 
The needle was connected to a peristaltic pump and inserted into the left ventricle through the 
apical tip of the heart. The right atrium was then cut to let the blood flow out. Before the 
perfusion with the fixative, the blood in the vascular system was drained out and washed with 
cold 0.9% NaCl for 5 min or until the there was no blood coming out from the right atrium and 
the liver turned pale. After this washing step, the mice were perfused with cold 4% PFA for 10 
min until the whole bodies appeared stiff. The indication of a successful perfusion was 
twitching of the tail and the heart appeared blanched. The brains were dissected and post-fixed 
by immersion in 4% PFA overnight at 4oC. After post-fixation, the brains were washed with 
1X PBS and then embedded in 4% agar dissolved in 1X PBS. The brain in agar was cut 
coronally freely floating with the thickness 40 μm using a vibratome (Leica, Wetzlar, 
Germany). The sections were stored in cryo-protectant solution (30 % glycerol, 30 % ethylene 
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glycol, in 0.05 M Na-Phosphate buffer, pH 7.4) at -20oC until processed for 
immunohistochemistry. 
 
RNA extraction and quantitative reverse-transcription PCR 
 The RNA from the cortices was extracted two weeks after the induction of TM-agrin 
overexpression by tamoxifen administration. The mice were sacrificed by cervical dislocation. 
The brains were immediately extracted, and the cortices were dissected in cold PBS using the 
stereo binocular microscopy (Leica MZ6 with KL1500 LCD lamp. Schott AG, Mitterteich, 
Germany) and snap-frozen in liquid nitrogen. 
 Thirty mg of cortical tissue were ground with microtube-fitting pestles (Eppendorf 
micropestles, Sigma-Aldrich, Germany) on ice and the RNA was extracted using the SV Total 
RNA Isolation System kit (Promega, Mannheim, Germany) according to the protocol provided 
by the manufacturer. The RNA integrity was analyzed by denatured agarose gel electrophoresis 
using the intensity of the rRNA bands (28s rRNA band is twice as strong as the 18s rRNA 
band). The concentration and purity were assessed using a Nanodrop spectrophotometer 
(Thermo Fisher, Germany). The RNA was then reverse transcribed into cDNA using the 
Quantitect Reverse Transcription kit (Qiagen, Hilden, Germany). 
 Analysis of synapse-associated gene expression levels was performed using the cDNA. 
The oligonucleotides for this analysis were designed using the online Universal Probelibrary 
Assay Design Center (Table 6, Roche & Diagnostics). As the internal control (housekeeping 
gene), the Hypoxanthine-guanine-phosphoribosyltransferase (HPRT) gene was used.  
 Twenty microliters of reaction mixtures were added into each well of a 96-well plate 
and analyzed in a Light Cycler 480 (Roche Diagnostic, Unterhaching, Germany), using the 
Sybr green dye (SensiMix SYBR No-ROX Mastermix, Bioline, Luckenwalde, Germany). All 
genes were tested in technical triplicates. The specificity and efficiency of the reactions were 
analyzed with the melting curves assay. The specificity was indicated by a single peak in the 
melting curve and by a single band in the agarose gel analysis. The qPCR results were analyzed 
by double delta Ct (Ct-value) analysis.  
 
Subcloning of mouse TM-agrin 
 The plasmid, pAS12, encoding full-length mouse TM-agrin-y4z0 was a kind gift from 
Dr. Anna Schick (LMU Munich). The full-length mouse NtA-agrin-y0z0 was a kind gift from 
Prof. Dr. Markus Ruegg (Biocenter, Basel, Switzerland). For generating the TM-agrin-y0z0, 
the plasmids were digested with SfiI and MfeI for 1 hour at 37oC, and the products were run in 
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1% agarose gel. The expected products were two bands, with the size of 12kb and 1kb. The 
smaller size bands were then swapped and mixed with the bigger size bands, and then ligated 
with the Quick Ligation™ kit (New England Biolabs, Frankfurt am Main, Germany). The 
ligation product was then used for bacterial transformation (Top10 Chemically Competent E. 
coli, Thermofisher Scientific). The transformed bacteria were inoculated into LB medium 
containing ampicillin and cultured overnight at 37oC in the shaker at 150 rpm. After overnight 
incubation, a mini-prep was performed, and the plasmid was sequenced using the corresponding 
primers (Table 6). 
 The mouse TM-agrin-y4z8 isoform, serine-to-alanine TM-agrin-y4z0 and serine-to-
aspartic acid TM-agrin-y4z0 were obtained by site-directed mutagenesis, outsourced to 
Genscript (New Jersey, USA). All final products of the cloning procedures were sequenced 
(GATC Biotech, Konstanz, Germany) to verify the sequence and to detect the mutations. 
   
Brain tissue lysis and quantitative western blot analysis 
 For the preparation of adult mouse brain lysate, mice were sacrificed by cervical 
dislocation and the cortices were immediately dissected in cold 1X PBS and then snap-frozen 
in liquid nitrogen under a stereo microscope (Leica MZ6 with KL1500 LCD lamp, Schott). The 
tissue was gently homogenized in 10 w/v lysis buffer on ice using a glass pestle tissue grinder. 
After homogenization, lysates were centrifuged at 2500 x g for 30 min at 4oC. The supernatant 
(S1-fraction) was collected and centrifuged at 34.000 x g for 30 min at 4oC. The supernatant 
from the previous centrifugation was termed the S2-fraction. The S2-fraction was then 
denatured by adding 4X SDS sample buffer and heated at 95oC for 3 min. The pellet of the 
second centrifugation (crude membrane fraction/M-fraction) was denatured by adding 4X SDS 
sample buffer with 8 M urea, and then heated at 37oC for 10 min.  
 The proteins from the M-fractions were separated on 10% polyacrylamide gels by 
electrophoresis. The protein samples and a protein ladder (PageRuler prestained protein ladder, 
Thermo Scientific) were separated in running buffer at constant 80V and were transferred to 
nitrocellulose membranes (Protran, Schleicher & Schuell, Germany) at constant 140mA for 2h. 
The membranes were then incubated in blocking buffer (TBS Odyssey blocking buffer, Li-Cor, 
Germany) for 1h at RT. After blocking, the membranes were incubated with primary antibodies 
in 5% horse serum TBS-T for 3h at RT. The membranes were then washed three times 10min 
each in TBS-T and incubated with the secondary antibodies for 1h. After the last incubation, 
the membranes were washed three times for 10min. Tau protein was used as loading control. 
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Images from the WB membrane were obtained using the near-infrared fluorescent 
Odyssey Imaging system (Li-Cor, Bad Homburg, Germany), with the Image Studio Lite 
software (version 4.0). The analysis of the western blots was carried out by quantifying the 
pixel density of each bands using the Fiji Software (Schindelin et al., 2012). The pixel density 
of the protein of interests was subject to background subtraction and was normalized to the 
pixel density of tau protein as the loading control.  
 
Coverslips preparation and coating  
 Round glass coverslips of 18 mm diameter were treated with solution containing 4 
pellets of NaOH in 10 ml Milli-Q water and 35 ml of ethanol 70 % overnight on a shaker. The 
coverslips were then extensively washed with Milli-Q water and incubated with a solution 
containing 1 M HCl overnight on a shaker. The next day, the coverslips were washed with water 
and stored in absolute ethanol at 4oC or processed for the dry heat sterilization (160oC for 2 
hours) in the oven. One day before the cell culture preparation, the coverslips were coated with 
poly-D-lysine (PDL) working solution overnight, then washed with sterile water and dried 
under the laminar flow hood. 
 
Transfection of monolayer cultures 
 Primary neuronal culture of E15 cortices from wildtype, Lrp4-KO and MuSK-KO were 
prepared by trypsinization and trituration with fire-polished Pasteur pipettes in dissecting 
medium under sterile condition (Handara et al., 2019; Karakatsani et al., 2017). The density of 
the dissociated cells was determined with trypan blue using a Neubauer chamber. The cells 
were seeded at a density of 100.000 cells per well (12-well plate, growth area 3.8 cm2/well) in 
1.5 mL maintenance medium and maintained for 14 days in vitro. The maintenance medium 
was changed on DIV 7 by replacing half of the old with fresh maintenance medium. 
 Cells were transfected on DIV 12 with Lipofectamine 2000 (Invitrogen, Karlsruhe, 
Germany) and incubated for two additional days before the fixation. For each well, two 
solutions for the transfection were prepared. The first solution contained 500 ng of plasmid 
DNA in 50 l of neurobasal medium and the second solution contained 0.5 l Lipofectamine 
in 50 l of neurobasal medium. Both solutions were incubated for 5 min after mixing and then 
added to the well.  
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Immunocytochemistry  
 For routine staining, coverslips were washed once with warm PBS and then fixed with 
4 % PFA in PBS for 10 min at RT. For the analysis of the NR1-subunit of the NMDA receptor, 
the coverslips were fixed with -20 oC methanol for 10 min. Fixation was blocked with ICC 
blocking solution for 60 min at RT. The coverslips were incubated with the primary antibodies 
in blocking solution at 4oC overnight. On the next day, they were washed three times with 1X 
PBS and then incubated at 4oC with the secondary antibodies in the blocking solution for 2 
hours. The coverslips were counter-stained with 0.1 g/ml DAPI in 1X PBS for 10 min at RT. 
The coverslips were then mounted onto glass slides using Aqua-Poly/Mount (Polysciences, 
Hirschberg, Germany). All incubation steps were performed on a rotating shaker. 
 
Immunohistochemistry of freely floating fixed tissue sections 
 For the immunohistochemistry (IHC) of synaptic proteins, fixed freely floating brain 
sections were washed with 1X PBS. To unmask the antigens due to the methylene bridge 
generated by the PFA fixation, the antigenic epitopes were retrieved by heating the tissue at 
85oC with 10 mM sodium citrate buffer for 15 min. The sections were blocked with IHC 
blocking solution for 1 hour at RT and then incubated with primary antibodies in IHC staining 
solution for 48 hours at 4oC. Thereafter, the sections were incubated with the secondary 
antibodies in the IHC staining solution for 1 hour at RT. Finally, they were mounted on glass 
slide in Fluoroshield™ mounting medium containing DAPI (Sigma-Aldrich, Taufkirchen. 
Germany). 
 
Image acquisition  
Images of monolayer cultures were obtained with an Axio ImagerM2 epiflourescence 
microscope (Carl Zeiss, Oberkochen, Germany). The images were acquired using the 40x water 
immersion objective. Images of fixed tissue sections were acquired using a Leica SP8X WLL 
upright confocal microscope (Leica, Wetzlar, Germany). Single confocal images from brain 
sections were obtained from cortical layer 2/3 in the region of the S1/S2 cortex. The images 
were acquired using an objective with the following specification HC PL APO 40x/1.30 oil 
CS2, working distance 0.24 mm. Images obtained with this objective lens were acquired with 
the digital zoom factor 3 x and a size of 1024 x 1024 pixel. 
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Quantitative analysis 
The dendritic length of cortical neurons in μm was determined using the Fiji Simple 
Neurite Tracer plugin (Longair et al., 2011). The number of primary dendrites emerging from 
the soma as well as the dendritic branch tip numbers were counted manually. Axons were 
excluded from the analysis. For analyses of the dendritic branching pattern, images were 
converted into 8-bit format and subjected to the thresholding for creating binary images. Sholl 
analysis was performed using the Sholl analysis plugin of the Fiji imaging program (Ferreira et 
al., 2014). 
Binary images were also analyzed for the synaptic puncta quantification. The synaptic 
puncta density was counted using the Analyze Particle toolbox of the Fiji software. The number 
of puncta labeled by antibodies against excitatory synapse-associated proteins per 20 m was 
determined on dendrites outside a radius of 50 m distance from the soma. In contrast, punctate 
immunoreactivity labeled by antibodies against inhibitory synapses-associated proteins per 20 
m was determined on dendrites within a radius of 50 m from the soma (Klenowski et al., 
2015). 
 
Statistical analysis 
Results are presented as mean +/- SEM. Unless stated otherwise, n represents the 
number of neurons or the number of brain sections analyzed and N represents the number of 
independent experiments, corresponding to the number of embryos/mice. With the assumption 
of normal distribution and homoscedasticity, significance was calculated with GraphPad Prism 
vs.8 (GraphPad Software, San Diego, California) using the unpaired t-test or the one-way 
ANOVA test with the Tukey’s multiple comparison test. Data were evaluated for normal 
distribution using d’Agostino Pearson omnibus normality test and for homoscedasticity using 
Browne-Forsythe’s test. Data that did not fulfil the assumption were investigated using the 
equivalent non-parametric tests, such as the Mann-Whitney rank sum test or the Kruskal-
Wallis-test with Dunn’s correction for multiple comparisons test. Outliers were analyzed by 
iterated Grubbs’ test and were excluded. The results from qRT-PCR and WB were analyzed by 
the non-parametric test Mann-Whitney rank sum test. The type 1 statistical error was set to 5%, 
meaning that a p-value of < 0.05 was set as the level of statistical significance. ‘n.s’ was 
determined as p > 0.05, ‘*’ as p < 0.05, ‘**’ as p < 0.01 and ‘***’ as p < 0.001. 
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Results 
Generation and validation of the antiserum against TM-agrin 
 To investigate the selectivity and the specificity of the newly generated antiserum 
against the intracellular sequence of TM-agrin, I transiently transfected full-length mouse TM-
agrin cDNA cloned into pMES vector under the cytomegalovirus (CMV) promoter into 
HEK293-T cells. The pMES vector contains an internal ribosome entry site (IRES) and the 
sequence coding for GFP to visualize the transfected cells.  As a control, I used the empty pMES 
vector (control vector) encoding only the IRES-driven GFP. Two days after transfection, I 
confirmed the expression of TM-agrin using the antiserum in transfected cells. Only GFP-
positive cells were stained with this antiserum, supporting the specificity of the antiserum for 
full-length mouse TM-agrin (Fig. 3A,B). Cells transfected with control vector were not stained, 
confirming the specificity of the antiserum for intracellular region of mouse TM-agrin. The 
antiserum was also tested in primary cortical neuron cultures, after transfection with plasmid 
containing full-length TM-agrin. I observed that the antiserum was specific against mouse TM-
agrin, by reporting a strong signal in TM-agrin transfected neurons (Fig. 3C,D) 
 
 
Figure 3. Validation of the antiserum against TM-agrin. HEK293 cells (A, B) or cortical neurons (C, D) were 
transfected with control (A, C) or full-length mouse TM-agrin (B, D). Arrows in A and B indicate transfected cells 
(GFP-positive cells, green). Only cells transfected with TM-agrin cDNA were stained by the antiserum against 
intracellular region of TM-agrin (red). Untransfected cells can be seen by the blue DAPI staining in A and B; scale 
bar 50 m. 
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TM-agrin overexpression in cortical neurons increases the density of dendritic 
protrusions, but not the dendritic arborization 
 In primary cortical neuron culture, we recently reported an increase in the density of 
dendritic protrusions and complexity of dendritic arborization following overexpression of 
Lrp4 (Karakatsani et al., 2017). In order to investigate whether TM-agrin similarly affects the 
density of dendritic protrusions and of the dendritic arborization pattern, I transfected full-
length TM-agrin-y4z8 into cultured cortical neurons and determined the number of primary 
dendrites (Fig. 4D) and the total dendritic branch tip number (TDBTN, Fig. 4E). I did not 
observe any differences in the number of primary dendrites and of the TDBTN between neurons 
transfected with the TM-agrin compared to neurons transfected with the control vector. 
However, TM-agrin overexpression increased the density of filopodia-like dendritic protrusions 
(Fig. 4F) similar to what has been previously reported (Annies et al., 2006; Porten et al., 2010). 
In addition, I observed a reduction in primary dendrite length in neurons transfected with TM-
agrin compared to neurons transfected with the control vector (dashed line in Fig. 4B’,C’; 
quantification in Fig. 4G). These results suggest a functional interaction between TM-agrin and 
Lrp4 during dendrite formation or maturation in embryonic cortical neurons in vitro. Moreover, 
my results are in line with the previously reported increase of dendritic complexity after Lrp4 
overexpression (Karakatsani et al., 2017). 
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Figure 4. TM-agrin overexpression in cortical neurons increases density of dendritic protrusions, but not 
dendritic arborization. TM-agrin punctate staining (A) is widely distributed in the neuronal cell body and in 
neurites of transfected cortical neuron (white arrows). TM-agrin-y4z8 overexpression did not alter dendritic 
arborization complexity (B, C), number of primary dendrite (D) and TDBTN (E) but increased the density of 
dendritic protrusions (F) and shortened primary dendrites (dashed line in B’, C’ and in G for quantification). B’ 
and C’ are magnifications from selected region of interest in B and C; statistical analysis: unpaired t-test (D, E), 
Mann-Whitney test (C, D); scale bar 50 m (A-C); scale bar 25 m (B’, C’). Note that the neuron in panel A is 
identical with the neuron in Fig. 3D. 
 
Lrp4 is required for normal dendritic morphology 
 Neurons with a reduced level of Lrp4 upon miRNA transfection have a less complex 
dendritic arborization, reduced density of dendritic protrusions and longer primary dendrites 
(Karakatsani et al., 2017). To investigate if these changes were a microRNA-related artefact or 
directly caused by the reduced level of Lrp4 expression, I analyzed the dendritic morphology 
of cultured cortical neurons from Lrp4-KO embryos. No differences in neuronal density and 
neuronal composition in cultures from Lrp4-heterozygous embryos compared to cultures from 
Lrp4-KO embryos (Fig. 5A-E) were observed. However, Lrp4-KO neurons displayed a less 
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complex dendritic arborization compared to Lrp4-heterozygous neurons (Fig. 5F,G), including 
a significant reduction in the number of primary dendrites (Fig. 5J), TDBTN (Fig. 5K), 
dendritic protrusions density (Fig. 5L) and an increased length of the primary dendrite (Fig. 
5M). These results show that knockdown of Lrp4 using miRNA and genetic ablation of Lrp4 
expression have the same phenotype, demonstrating that the altered dendritic complexity is not 
a miRNA-related artefact. 
In order to investigate the functional interaction between Lrp4 and TM-agrin during 
dendritic arborization, I transfected Lrp4-KO neurons with a full-length TM-agrin-y4z8. TM-
agrin overexpression in Lrp4-KO neurons rescued all parameters considered in the analysis of 
dendritic complexity (Fig. 5J-M). Moreover, Sholl analysis (Fig. 5N), Schoenen ramification 
index (Fig. 5O) and maximal number of branching (Fig. 5P) confirmed the lower dendritic 
arborization complexity of Lrp4-KO neurons and the rescue by overexpressing TM-agrin. 
Congruently, TM-agrin overexpression restored dendritic arborization to a level comparable to 
that reported in Lrp4-heterozygous neurons (Fig. 5N–P). In summary, these results demonstrate 
that TM-agrin expression level controls normal dendritic arborization complexity and that this 
activity requires the expression of Lrp4.  
 47 
 
 
Figure 5. Lrp4 is required for normal dendritic morphology. (A-E) Cellular density, neuronal density and 
neuronal composition are comparable in Lrp4-heterozygous and in Lrp4-KO neuronal cultures. Viable cells 
density (DAPI-positive, blue, C), neuronal density (NeuN-positive, green, D) and neuronal composition (GABA-
positive, red, E); statistical analysis: unpaired t-test; scale bar 25 m (B). (F-M) Lrp4-KO neurons and TM-agrin 
overexpression in Lrp4-KO neurons affect the morphology of cortical neurons, which were indicated by number 
of primary dendrites (J), TDBTN (K), density of dendritic protrusions (L) and length of primary dendrite (M); 
statistical analysis: one-way ANOVA with Tukey’s multiple comparison test (J, L); Kruskal-Wallis with Dunn’s 
multiple comparisons test (K, M); scale bar 50 m (G). (N-P) Less complex dendritic arborization in Lrp4-KO 
neurons is shown in Sholl plot (N), Schoenen Ramification Index (O) and maximal number of branching (P); 
statistical analysis: Kruskal-Wallis test with Dunn’s multiple comparison test. 
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The C-terminal domain of TM-agrin is sufficient to rescue the complexity of dendritic 
arborization in Lrp4-KO neurons 
 Agrin is a large molecule and consists of several domains which could potentially 
interact with other proteins (Fig. 1). In order to determine which domain of agrin is required for 
the rescuing the dendritic arborization pattern in Lrp4-KO neurons, I transfected Lrp4-KO 
cortical neurons with different constructs of TM-agrin, including different full-length splice 
variants (TM-agrin-y4z0 and -y0z0) and a construct that lacks half of the C-terminal domain 
and is fused with GFP (FD8; Fig. 2 for details of the deletion constructs). Dendritic arborization 
in Lrp4-KO neurons was restored after transfection with full-length TM-agrin-y4z8 (Fig. 6A), 
TM-agrin-y4z0 (Fig. 6B) and TM-agrin-y0z0 (Fig. 6C), demonstrating that these splice variants 
contain the region necessary to restore dendritic arborization. In contrast, transfection with the 
FD8 construct lacking the C-terminal half of TM-agrin did not affect the dendritic arborization 
complexity of Lrp4-KO neurons (Fig. 6D). These observations were confirmed by 
quantification of the number of primary dendrites (Fig. 6E) and TDBTN (Fig. 6F) for each 
condition. In summary, the C-terminal half of TM-agrin was required for the establishment of 
the normal dendritic arborization pattern in Lrp4-KO neurons. However, a direct interaction 
between Lrp4 and TM-agrin was apparently not required, since isoforms which do not directly 
bind to Lrp4 (TM-agrin-y4z0, TM-agrin-y0z0) were as efficient as those, which directly 
interact with Lrp4 (TM-agrin-y4z8).  
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Figure 6. The C-terminal half of TM-agrin is sufficient to rescue the complexity of dendritic arborization in 
Lrp4-KO cortical neurons. (A-D) Transfection of Lrp4-KO neurons with TM-agrin-y4z8 (A), TM-agrin-y4z0 
(B), TM-agrin-y0z0 (C), but not FD8 (D), restored dendritic arborization. Transfection of TM-agrin lacking half 
C-terminal could not restore number of primary dendrites (E) and TDBTN (F) in Lrp4-KO neurons; statistical 
analysis: Kruskal-Wallis with Dunn’s multiple comparison test; scale bar 50 m (B). 
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MuSK is required for normal dendritic morphology  
 At the developing NMJ, agrin requires MuSK for inducing the formation of synaptic 
specializations. Since MuSK is expressed in the CNS (Garcia-Osta et al., 2006), I investigated 
whether MuSK is required for normal dendritic arborization. To this end, I analyzed cultures 
of cortical neurons from MuSK-KO embryos and compared to the cultures from MuSK-
heterozygous neurons. I observed no significant differences in cellular density, neuronal density 
and neuronal composition between MuSK-heterozygous and MuSK-KO cortical neuron 
cultures (Fig. 7A–E). Similar to Lrp4-KO neurons, MuSK-KO neurons displayed a less 
complex dendritic arborization pattern (Fig. 7G) compared to MuSK-heterozygous neurons 
(Fig. 7F). MuSK-KO neurons had fewer primary dendrites (Fig. 7J), a lower TDBTN value 
(Fig. 7K), a lower density of dendritic protrusions (Fig. 7L) and longer primary dendrites (Fig. 
7M). The reduced dendritic arborization complexity in MuSK-KO neurons is reflected in the 
Sholl plot (Fig. 7N). Collectively my results suggest that, in addition to Lrp4 and TM-agrin, 
MuSK is also required for the establishment of the normal dendritic arborization, normal 
density of dendritic branches and normal length of primary dendrites. 
Interestingly, TM-agrin overexpression in MuSK-heterozygous neurons and in MuSK-
KO neurons (Fig. 7H,I) did not alter the dendritic morphology. However, TM-agrin 
overexpression increased the density of dendritic protrusions in neurons from both conditions. 
This demonstrates that the TM-agrin-mediated effect on dendritic protrusion density was not 
dependent on MuSK expression (Fig. 7L). In conclusion, TM-agrin overexpression in MuSK-
KO neurons had no effect on dendritic arborization and on dendritic length, but it rescued the 
decreased dendritic protrusion density of neurons from MuSK-deficient neurons. This result 
stands in favor of an agrin-MuSK interaction-independent mechanism in controlling dendritic 
protrusion density. 
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Figure 7. MuSK is required for normal dendritic morphology. (A-E) Cellular density, neuronal density and 
neuronal composition are comparable in MuSK-heterozygous (A) and MuSK-KO (B) cortical neuronal culture. 
Viable cells (DAPI-positive cells, blue, C), neuronal density (NeuN-positive cells, green, D) and neuronal 
composition (GABA-positive cells, red, E); statistical analysis: unpaired t-test; scale bar 25 m (B). (F-N) The 
absence of MuSK in neurons affects the complexity of dendritic arborization and TM-agrin overexpression did 
not affect dendritic arborization in MuSK-heterozygous and MuSK-KO neurons, as had been indicated by number 
of primary dendrites (J), TDBTN (K) and length of primary dendrite (M). TM-agrin overexpression increased the 
density of dendritic filopodia in MuSK-heterozygous and MuSK-KO neurons. Sholl plot (N) showed the less 
complex dendritic arborization in MuSK-KO neurons; statistical analysis: Kruskal-Wallis test; scale bar 50 m 
(G). 
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Overexpression of TM-agrin in cortical neurons increases excitatory synapses 
 The colocalization of TM-agrin with the post-synaptic density protein PSD-95 in vitro 
(McCroskery et al., 2009) and in vivo (Ksiazek et al., 2007) suggested the possibility that TM-
agrin might be required to aggregate excitatory synapse-associated proteins. To address this 
question, I overexpressed TM-agrin-y4z8 in cortical neurons and analyzed the density of puncta 
containing the presynaptic vesicular glutamate transporter-1 (vGlut1) and of several 
postsynaptic proteins, including PSD-95 and the NR1-subunit of the NMDA receptor (NR1). I 
observed an increased density of vGlut1 (Fig. 8B,C), PSD-95 (Fig. 8E,F) and NR1 puncta (data 
not shown) on the dendritic segments at least 50 m away from the cell bodies in TM-agrin-
overexpressing neurons, compared to neurons transfected with the control vector (Fig. 8A,D). 
These results show that TM-agrin overexpression has the complementary effect to agrin 
deficiency: the former increased the density of excitatory synapses whereas the latter decreased 
it. 
To investigate if agrin influences the formation of functional synapse, 
electrophysiological experiments were performed together with our collaborators, Dr. Hetsch 
and Prof. Rathjen from the MDC Berlin. Whole cell voltage clamp recordings were obtained 
from cortical neurons in a microisland culture system in the presence or absence of soluble 
agrin-y4z8. This microisland culture system is useful to investigate the basic mechanism of 
synaptic transmission and at the same time avoids neuronal network activity. Furthermore, the 
incubation of neurons with the soluble agrin-y4z8 isoform is a feasible approach since it is 
difficult to transfect a single neuron in a microisland culture system. Analysis of the spike traces 
(Fig. 8G) showed an increase in the frequency (Fig. 8H) and the amplitude (Fig. 8I) of miniature 
excitatory postsynaptic currents (mEPSCs). The increase in the number of dendritic pre- and 
postsynaptic specializations together with the electrophysiological data strongly suggest a role 
for TM-agrin in the formation and/or maintenance of pre- and postsynaptic specializations of 
excitatory synapses. It also suggests that the puncta observed on dendrites of cortical neurons 
after staining with antibodies against excitatory synapse-associated proteins, represent 
functional synapses. 
 To investigate if TM-agrin splice variants differ in their ability to increase the density 
of dendritic excitatory synapses, I transfected cortical neurons with cDNA constructs coding 
for different TM-agrin splice variants and analyzed the dendritic PSD-95 puncta density. As 
detailed above, transfection with TM-agrin-y4z0 cDNA significantly increased the density of 
PSD-95 puncta (Fig. 8N). In contrast, transfection of neurons with TM-agrin-y0z0 did not affect 
the density of PSD-95 compared to the neurons transfected with the empty vector. Thus, the 
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presence of the four amino acids at the y-splice site (y4) appeared to be critical for the increase 
puncta density of PSD-95 (Fig. 8N) and NR1 (Fig. 8O). Interestingly, the presence of eight 
amino acids at the z-splice site was not required for this increase (Fig. 8M-O). This supports 
the hypothesis that TM-agrin splice variant y4 controls excitatory synapses density, 
independent of the z splice variant and, therefore, independent of a direct binding to Lrp4. 
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Figure 8. TM-agrin overexpression affects the number of excitatory synapses and mEPSCs. (A-F) TM-agrin 
overexpression increases the density of vGlut1 (A-C) and PSD-95 (D-F)); statistical analysis: Mann-Whitney test 
(C, F, H, I); scale bar 50 m. (G-I) Soluble agrin incubation on cortical neurons in a microisland culture system 
increases the frequency (H) and amplitude (I) of miniature excitatory postsynaptic currents (mEPSCs), the 
mEPSCs were recorded at a holding potential -70 mV in the presence of tetrodotoxin (TTX). The number in the 
bars in (H) indicates the number of analyzed neurons. (J-O) Transfection of TM-agrin-y4z8 (K) and TM-agrin-
y4z0 (L), but not of TM-agrin-y0z0 (M) increased PSD-95 (N) and NR1 (O) puncta density; statistical analysis: 
Kruskal-Wallis test with Dunn’s multiple comparison test (N, O); scale bar 50 m. 
 
Lrp4, not MuSK, controls excitatory synapses density without direct but in cis 
interaction with TM-agrin 
 Since transfection of TM-agrin isoforms that did not directly interact with Lrp4 
increased the density of dendritic excitatory synapses, I wanted to investigate whether Lrp4 
expression was required for the formation of excitatory synapses.  To this end, I analyzed PSD-
95 puncta density in neurons from Lrp4-KO and Lrp4-heterozygous embryos. Interestingly, 
Lrp4-KO neurons had a lower PSD-95 puncta density compared to Lrp4-heterozygous neurons 
(Fig. 9A–E), suggesting that Lrp4 expression is required for the establishment of the normal 
excitatory synapse density. Moreover, TM-agrin overexpression in Lrp4-KO neurons failed to 
increase the density of PSD-95 puncta (Fig. 9D,E), on the other hand, it increased the PSD-95 
puncta density in Lrp4-heterozygous neurons. This demonstrates that the expression of Lrp4 is 
required for the TM-agrin overexpression-mediated increase of the puncta density containing 
PSD-95. 
Analysis of voltage clamp experiments (in collaboration with Dr. Hetsch and Prof. 
Rathjen) showed that incubation of Lrp4-KO neurons with the soluble agrin-y4z8 did not exert 
any effect on the mEPSCs frequency (Fig. 9G) and amplitude (Fig. 9H). In contrast, addition 
of soluble purified agrin-y4z8 to the WT neurons increased the mEPSCs frequency and 
amplitude (Fig. 8G–I). These results demonstrate that Lrp4 expression is necessary for the 
development/maintenance of the normal density and function of excitatory synapses. Since the 
increase of the number of excitatory synapses after transfection of TM-agrin was achievable 
with the isoform that did not directly interact with Lrp4, it must be considered that TM-agrin 
might need to interact indirectly via an additional binding partner with Lrp4 in order to exert 
its effect on excitatory synapses density. 
 In order to understand if this effect of TM-agrin was occurring in cis (i.e. in the same 
cell) or in trans (i.e. by an interaction between two cells), I overexpressed TM-agrin and at the 
same time knockdown Lrp4 (Lrp4-KD) by microRNA (miRNA-Lrp4) in the same WT cortical 
neuron (Fig. 9I–K). Lrp4-knockdown alone significantly reduced PSD-95 puncta density (Fig. 
9K) similarly to the level observed in Lrp4-KO neurons (Fig. 9E; see also Karakatsani et al., 
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2017). Co-transfection of TM-agrin and miRNA-Lrp4 could not increase the PSD-95 puncta 
density compared to neurons transfected with TM-agrin and miRNA-scrambled, suggesting 
that Lrp4 expression in the same neuron was essential for the TM-agrin-mediated effect on the 
increased density of excitatory synapses. Therefore, a cis-interaction between TM-agrin and 
Lrp4 is likely to be necessary for the increase of excitatory synapses after TM-agrin 
overexpression. 
 To investigate if MuSK is required for the formation of excitatory synapse-associated 
specializations, I analyzed the density of puncta containing PSD-95 in MuSK-KO neurons. 
MuSK-KO neurons displayed no significant changes in the density of PSD-95 puncta compared 
to MuSK-heterozygous neurons (Fig. 9L–P). Consistently, the overexpression of TM-agrin in 
MuSK-heterozygous (Fig. 9N) and MuSK-KO neurons (Fig. 9O) increased the density of PSD-
95 puncta (Fig. 9P), similarly to the effect of TM-agrin overexpression in WT neurons. This 
demonstrates that MuSK expression is apparently not required for the formation or maintenance 
of excitatory synapses or for the TM-agrin-mediated increase in the excitatory synapse density. 
In conclusion, while MuSK expression does not seem to be required for TM-agrin-
mediated formation/maintenance of excitatory synapses, Lrp4, on the other hand, is required 
and might indirectly interact with TM-agrin to regulate the density of dendritic excitatory 
synapses. 
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Figure 9. Lrp4, not MuSK, controls excitatory synapses density with a non-direct cis-interaction with TM-
agrin. (A-H) Lrp4-KO neurons (B) showed a reduced PSD-95 puncta density compared to Lrp4-heterozygous 
neurons (A). TM-agrin overexpression increased PSD-95 puncta density only in Lrp4-heterozygous neurons (C), 
but not Lrp4-KO neurons (D). Agrin incubation on Lrp4-KO neurons did not change the trace of mEPSCs (F) as 
analyzed in mEPSCs frequency (G) and amplitude (H, during recording, the voltage was holded at -70 mV, number 
in the bar indicates number of analyzed neurons, collaboration with Dr. Hetsch and Prof. Rathjen); statistical 
analysis for E: Kruskal-Wallis test with Dunn’s test for multiple comparison (omnibus test), Lrp4-heterozygous 
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vs Lrp4-KO was tested with unpaired t-test. (I-K) WT neurons with miRNA-Lrp4 knockdown showed reduced 
PSD-95 puncta density. TM-agrin overexpression increased the PSD-95 puncta density when co-transfected with 
miRNA-scrambled (I) but not when co-transfected with miRNA-Lrp4 (J, K); statistical analysis: Kruskal-Wallis 
test with Dunn’s test for multiple comparison. (L-P) No difference in the density of PSD-95 puncta density between 
MuSK-heterozygous neurons (L) compared to MuSK-KO neurons (M). TM-agrin overexpression in MuSK-
heterozygous (N) and in MuSK-KO neurons (O) increased PSD-95 puncta density; statistical analysis: Kruskal-
Wallis test with Dunn’s test for multiple comparison; scale bar 50 m. 
 
APP is a candidate for the agrin/Lrp4-dependent effect on excitatory synapses  
The results reported above led to the conclusion that Lrp4 expression is necessary for 
the formation of a normal density of excitatory synapse-like specializations and required for the 
TM-agrin-mediated effect on excitatory synapses. Since agrin splice variants that do not bind 
to Lrp4, i.e. without an eight, eleven or nineteen amino acid insert at the z-site, increased the 
density of excitatory synapses, I hypothesized that an indirect interaction between both proteins 
via a third protein might be required for the Lrp4-dependent TM-agrin-mediated effect. A well-
characterized partner of both Lrp4 and agrin at the NMJ is the amyloid precursor protein (APP; 
Choi et al., 2013). To investigate whether APP is affected by TM-agrin overexpression in 
cortical neurons, I analyzed APP puncta density in WT neurons following TM-agrin 
overexpression. Interestingly, TM-agrin overexpression significantly increased APP puncta 
density (Fig. 10E), but only when a cDNA coding for TM-agrin-y4 was transfected (Fig. 
10B,C). This result is very preliminary, but it supports a potential interplay of APP in the 
agrin/Lrp4-dependent effect on excitatory synapses formation or maintenance. Clearly, more 
refined experiments are required to substantiate this hypothesis. 
 
 
Figure 10. APP is a candidate-binding partner of agrin and Lrp4 in controlling excitatory synapses. APP 
puncta density was increased after TM-agrin-y4z8 (B) and TM-agrin-y4z0 overexpression. TM-agrin-y0z0 
overexpression had no effect on the APP puncta density (D, E); statistical analysis: one-way ANOVA with Dunn’s 
multiple comparison test; scale bar 50 m. 
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TM-agrin controls the density of inhibitory synapses 
 In order to assess whether TM-agrin overexpression also affects the density of inhibitory 
synapses, I analyzed the effect of TM-agrin overexpression on the distribution of several 
inhibitory synapse-associated proteins. Transfection of WT neurons with the full-length TM-
agrin-y4z8 cDNA decreased the density of puncta containing the presynaptic vesicular GABA 
transporter (vGAT; Fig. 11A–C), as well as of the postsynaptic protein collybistin (Fig. 11D,E), 
the 1-subunit of the GABAA receptor (Fig. 11G-I), gephyrin (Fig. 11M) and neuroligin-2 (Fig. 
11N). Interestingly, no difference was observed in the density of puncta containing the non-
synaptic 5-subunit of the GABAA receptor (Fig. 11J–L), demonstrating that the effect of TM-
agrin was specific to the synaptic GABAergic receptors and its associated scaffolding proteins. 
These results stand in favor of TM-agrin being able to control inhibitory synapse density. 
Moreover, TM-agrin appears to affect excitatory and inhibitory synapses in opposite ways, i.e. 
TM-agrin overexpression increased the density of excitatory synapses and decreased the density 
of inhibitory synapses.  
To investigate if TM-agrin overexpression affects the density of a synaptic marker that 
is located in both types of synapses (excitatory and inhibitory synapses), I analyzed the effect 
of TM-agrin overexpression on the density of immunoreactive puncta containing the pan-
synaptic marker bassoon. I observed that TM-agrin overexpression did not alter the density of 
bassoon puncta (Fig. 11O-Q). This result congruently supports my previous observations that 
the TM-agrin overexpression regulated the density of excitatory and inhibitory synapses in the 
opposite directions. 
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Figure 11. TM-agrin controls the density of inhibitory synapses. TM-agrin overexpression decreased 
presynaptic inhibitory protein vGAT (A, B, C), postsynaptic inhibitory proteins, collybistin (D, E, F), the 1-
subunit of the GABAAR (G, H, I), but not the 5-subunit of the GABAAR (J, K, L). Gephyrin (M) and neuroligin-
2 (N) puncta densities were also reduced after TM-agrin overexpression; statistical analysis: Mann-Whitney test 
(F, I), unpaired t-test (C, L, M, N); scale bar 50 m. (O-Q) TM-agrin overexpression did not change the density 
of pan-synaptic marker bassoon; statistical analysis: Mann-Whitney test (Q); scale bar 50 m. 
 
The extracellular region of TM-agrin is not required for the TM-agrin overexpression-
mediated decrease in inhibitory synapses  
 The increase of excitatory synapses after TM-agrin overexpression is regulated by the 
extracellular region of TM-agrin, specifically by the presence of four amino acids at the y-splice 
site, whereas the presence of eight amino acids at the z-splice site does not appear to be 
essential. To investigate if the different splice variants of TM-agrin differentially affect 
inhibitory synapses, I analyzed the effect of several splice variants of TM-agrin on gephyrin 
puncta density. Following overexpression of TM-agrin-y4z8 (Fig. 12B), TM-agrin-y4z0 (Fig. 
12C) and TM-agrin-y0z0 (Fig. 12D) in WT cortical neurons, gephyrin puncta density was 
reduced compared to neurons transfected with the control vector (Fig. 12A). Thus, the TM-
agrin-mediated reduction of inhibitory synapses does not depend on C-terminal splicing of TM-
agrin. 
Transfection of neurons with truncated constructs, i.e. the deletion of the C-terminal 
half of TM-agrin (FD8, Fig. 12E), the 7th-follistatin-like domain (FD6) or the entire 
extracellular domain of TM-agrin (EC-TM-agrin, Fig. 12F) decreased gephyrin puncta 
density similar to the level after transfection with full-length TM-agrin cDNA. Therefore, TM-
agrin overexpression reduced gephyrin puncta density independently of the entire extracellular 
region of TM-agrin. This suggests that this effect depends on TM-agrin’s intracellular and/or 
the transmembrane region.  
To investigate if the presence of the extracellular region of agrin affects the function of 
inhibitory synapse, the frequency and amplitude of miniature inhibitory postsynaptic currents 
(mIPSCs) were investigated in the presence and absence of soluble agrin (with collaboration 
with Dr. Hetsch and Prof. Rathjen, MDC Berlin). Voltage clamp experiments, in which the 
cortical neurons were incubated with purified soluble agrin-y4z8, showed no changes in the 
frequency (Fig. 12I) and the amplitude (Fig. 12J) of the mIPSCs. Consistent with the 
transfection results, the effect of TM-agrin overexpression on the density and function of the 
inhibitory synapses appears to be dependent on the presence of either the intracellular and/or 
the transmembrane region of the TM-agrin. 
 
 61 
 
 
Figure 12. The extracellular region of TM-agrin was not required for the TM-agrin overexpression-
mediated decrease in inhibitory synapses. (A-G) Gephyrin puncta reduction after TM-agrin overexpression was 
not dependent on TM-agrin splice variants -y4z8 (B), -y4z0 (C), -y0z0 (D), half C-terminal of TM-agrin (E), 7th 
follistatin-like domain (FLD) and the whole extracellular region (F, EC-TM-agrin; in panel G, number of 
independent experiments for each group is 3). (H-J) Incubation of cortical neurons with full-length purified soluble 
agrin-y4z8, which lacking of intracellular and transmembrane region of TM-agrin, showed no difference on the 
mIPSCs traces (H) compared to the control, as indicated in the analysis of the frequency (I) and amplitude (J) of 
miniature inhibitory postsynaptic currents (mIPSCs, number in the bar represents number of analyzed neurons, 
under collaboration with Dr. Hetsch and Prof. Rathjen); statistical analysis: ordinary one-way ANOVA with 
Dunn’s multiple comparison test (G), Mann-Whitney test (I, J); scale bar 50 m. 
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Phosphorylation of a conserved serine-residue in agrin intracellular domain is required 
for TM-agrin-mediated reduction of inhibitory synapses  
 To investigate which part of TM-agrin is required for the decrease of inhibitory synapses 
after TM-agrin overexpression, I analyzed the amino acid sequence of the intracellular region 
of TM-agrin and compared it among several vertebrate species using a multiple sequence 
alignment program (Clustal Omega, https://www.ebi.ac.uk/Tools/msa/clustalo/). This analysis 
revealed a conserved motif in the TM-agrin intracellular domain containing a serine residue at 
position 17 (S17) in human and mouse.  
In order to predict whether the S17 residue was phosphorylated, based on the amino 
acid sequence and the predicted secondary structure of TM-agrin (Blom et al., 1999; Blom et 
al., 2004), I performed in silico analysis of the intracellular amino acid sequence using the 
online open-access platform Netphos3.1 (http://www.cbs.dtu.dk/services/NetPhos). This 
analysis confidently confirmed that serine 17 is a potential phosphorylation site within TM-
agrin’s intracellular region (Fig. 13) and predicts TM-agrin as a substrate for cyclin-dependent 
kinase 1 (CDK1; encoded by the cdc2 gene). 
Given these results, I hypothesized that this serine residue might act as phosphorylation 
site of TM-agrin and that this phosphorylation is functionally important for the reduction of 
inhibitory synapse puncta density after TM-agrin overexpression. To test this hypothesis, I 
transfected cortical neurons with TM-agrin cDNA constructs containing point mutations in the 
TM-agrin cDNA. These mutations were generated by substituting serine with the non-
phosphorylatable alanine residue (S17A, Fig. 13) or with the phosphomimetic aspartic acid 
residue (S17D, Fig. 13). Overexpression of S17A-TM-agrin did not reduce the density of 
puncta of the inhibitory synapse-associated proteins gephyrin (Fig. 13C-G), the 1-subunit of 
the GABAAR (Fig. 13H), collybistin (Fig. 13I) and neuroligin-2 (Fig. 13J). In contrast, 
transfection of the S17D-TM-agrin cDNA significantly reduced the puncta density of all 
inhibitory synapse-associated proteins. These results demonstrate that the presence of S17 in 
the intracellular part of TM-agrin is required for the formation or maintenance of inhibitory 
synapses. 
Together these data suggest that the reduction of inhibitory puncta density indeed 
requires the presence and the phosphorylation of S17 in TM-agrin. However, further 
experiments are needed to formally validate the phosphorylation of TM-agrin and its effect on 
inhibitory synapses. 
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Figure 13. Phosphorylation of a conserved serine-residue in agrin intracellular domain is required for TM-
agrin-mediated reduction of inhibitory synapses. (A) Multiple sequence alignment analysis of intracellular 
region of TM-agrin revealed an unknown conserved amino acid motif (green box) and a conserved intracellular 
serine-residue at position 17 (S17, red box, in human and mouse) among species in vertebrate.  (‘*’ conserved site; 
‘:’ conservative replacement; ‘.’ semi-conservative replacement; ‘ ‘ non-conservative replacement). (B) Different 
constructs containing point-mutation of serine-to-alanine (S17A, non-phosphorylated mutant) and of serine-to-
aspartic-acid (S17D, phosphomimetic-mutant) were generated for further analysis. (C-J) The presence and the 
phosphorylation of S17 in TM-agrin cDNA is required for TM-agrin overexpression-mediated decrease of 
gephyrin, the 1-subunit of the GABAAR, collybistin and neuroligin-2 puncta density; statistical analysis: 
Kruskal-Wallis test with Dunn’s multiple comparison test (G-I); scale bar 50 m. (K) Serine residue at the 
position-17 is predicted to be a potential phosphorylation site (above the threshold line, pink-colored line) 
according to the in silico analysis of amino acid sequence (Netphos3.1).  
 64 
 
Lrp4 and TM-agrin, but not MuSK, differentially control inhibitory synapses  
Previously, I showed that Lrp4 is necessary to control excitatory synapse density (Fig. 
9). To investigate if Lrp4 is also necessary for inhibitory synapse formation or maintenance, I 
analyzed the puncta density of inhibitory synapses in Lrp4-KO neurons. The density of 
gephyrin (Fig. 14B,E) and of the 1-subunit of the GABAAR (Fig. 14 G,J) in Lrp4-KO neurons 
were significantly reduced compared to Lrp4-heterozygous neurons (Fig. 14A,F), supporting a 
role of Lrp4 in inhibitory synapses formation and/or maintenance. TM-agrin overexpression in 
Lrp4-heterozygous neurons consistently reduced gephyrin (Fig. 14C,E) and the 1-subunit of 
the GABAAR (Fig. 14C,E) puncta density, similarly to the effect in WT neurons (Fig. 11). 
Moreover, no additional reduction of gephyrin (Fig. 14D) and of the 1-subunit of the 
GABAAR puncta density (Fig. 14I) were observed following TM-agrin overexpression in Lrp4-
KO neurons. These results suggest that in contrast to the formation of excitatory synapses where 
the expression of Lrp4 is required, Lrp4 seems not to be required for the TM-agrin-mediated 
reduction of inhibitory synapses. Thus, in the case of inhibitory synapses, Lrp4 and TM-agrin 
act independently of each other. 
Previously, I showed that MuSK is not required for the formation of excitatory synapses 
(Fig. 9). To investigate if MuSK affects the formation of inhibitory synapses, I investigated the 
density of puncta containing inhibitory synapses markers in MuSK-KO neurons and compared 
their density to the density of puncta on dendrites from MuSK-heterozygous neurons. MuSK-
heterozygous neurons showed a comparable puncta density containing gephyrin (Fig. 14K) or 
the 1-subunit of the GABAAR (Fig. 14P) compared to MuSK-KO neurons (Fig. 14L). These 
results suggest that MuSK expression is not required for the formation of inhibitory synapses. 
Moreover, TM-agrin overexpression similarly decreased gephyrin puncta density in MuSK-
heterozygous (Fig. 14M,P) and MuSK-KO neurons (Fig. 14N,P), demonstrating that TM-agrin 
does not need MuSK expression to reduce the density of inhibitory synapses. These results 
stand in favor of MuSK not being required for controlling inhibitory synaptic density, similar 
to the observations regarding the TM-agrin-overexpression-mediated effect on excitatory 
synapses. 
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Figure 14. Lrp4 and TM-agrin, but not MuSK, control inhibitory synapses. (A-J) Lrp4-KO neurons showed 
lower density of gephyrin (E) and the 1-subunit of the GABAAR (J) compared to Lrp4-heterozygous neurons. 
TM-agrin overexpression decreased gephyrin (D) and the 1-subunit of the GABAAR (I) puncta density in Lrp4-
heterozygous neurons which did not decrease further in Lrp4-KO neurons. (K-P) MuSK-heterozygous neurons 
(K) showed comparable gephyrin (O) and the 1-subunit of the GABAAR (P) puncta density compared to MuSK-
KO neurons (L). TM-agrin overexpression reduced gephyrin and the 1-subunit of the GABAAR puncta density 
in MuSK-heterozygous (M) and MuSK-KO neurons (N); statistical analysis: Kruskal-Wallis test with Dunn’s 
multiple comparison test (E, J), one-way ANOVA with Dunn’s multiple comparison test (O, P); scale bar 50 m. 
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Conditional TM-agrin overexpression in adult murine cortex 
 In order to investigate whether TM-agrin expression levels affect the 
formation/maintenance of synapses in vivo, I took advantage of a conditional TM-agrin knock-
in (KI) mouse model. In this mouse line, the overexpression of TM-agrin is regulated in a time- 
and space-specific manner, by exploiting the loxP/cre-ERT2 inducible system (Erdmann et al., 
2007; Metzger et al., 1995; Schwenk et al., 1998). A knock-in mouse line with a floxed stop 
cassette upstream of the TM-agrin cDNA was crossed with a mouse line expressing cre-ERT2 
under the CamKIIa promoter. This results in the overexpression of TM-agrin upon tamoxifen 
application. The CamKIIa promoter of the Cre recombinase provides spatial specificity to the 
Cre expression, i.e. in glutamatergic neurons of the neocortex and hippocampus (Fig. 15). 
 
Figure 15.  Breeding and induction scheme of TM-agrin overexpressing mice. A. Breeding strategy of 
generating the CamKIIa-Cre+/-//TM-agrinfl/- (Cre+/TM-agrin KI). B. Induction scheme of TM-agrin 
overexpression under tamoxifen administration. Tamoxifen in corn oil was injected intraperitoneally three times 
into 5-week-old mice. Two weeks after the last tamoxifen administration, the mice were sacrificed for further 
analyses. 
 
To validate the system of the inducible TM-agrin overexpression, I injected tamoxifen 
intraperitoneally three times in Cre+/-/TM-agrinfl/- (Cre+/TM-agrin KI) and Cre+/-/TM-agrin-/- 
(Cre+/TM-agrin WT) mice at the age of 5-weeks. Two weeks after the last injection, I observed 
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a significant increase in agrin puncta density (Fig. 16C) and puncta size (Fig. 16D), protein 
level (Fig. 16E,F) and transcript level (Fig. 16G). On the protein level, TM-agrin was 
approximately 8-fold overexpressed. This set of data confirms that in the conditional TM-agrin 
overexpressing mice, injection of tamoxifen induces a significant increase of TM-agrin mRNA 
and protein. 
 
 
Figure 16. Tamoxifen-induced overexpression of TM-agrin in vivo. Tamoxifen administration in Cre+/TM-
agrin KI increased the TM-agrin puncta density (C), size (D). In WB analyses, the ratio of the pixel densities 
between mutant and control were normalized to the expression level of the tau protein (E, F). The ratio of agrn 
transcript level in mutant and in control mice was normalized to the transcript level of hprt (G). Panel A’ and B’ 
represent higher magnifications of the areas indicated in panel A and B, respectively; N indicates number of mice; 
statistical analysis: unpaired t-test (C, D, F), Mann-Whitney test (G); scale bar 50 m (B, B’). 
 
TM-agrin overexpression affects transcript levels of several synapse-associated proteins 
 In order to understand whether TM-agrin overexpression affects synapse-associated 
proteins in vivo, I performed qRT-PCR analyses of several synaptic protein transcripts. 
Transcript levels of several pan-synaptic proteins, bsn (bassoon), syp (synaptophysin) and 
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vamp2 (synaptobrevin), were not altered after TM-agrin overexpression in vivo (Table. 9). 
Interestingly, transcript levels of excitatory synapse-associated proteins, such as dlg4 (PSD-95) 
and grin1 (the NR1-subunit of the NMDAR), were significantly increased (Table. 9, green). 
On the other hand, the transcript levels of the inhibitory synapse-associated proteins, including 
gphn (gephyrin) and gabra1 (the 1-subunit of the GABAAR), were significantly decreased 
(Table. 9, red). These results are in line with the changes observed in cultures of embryonic 
cortical neurons in vitro and suggest that the TM-agrin overexpression affects these proteins on 
the transcript level. 
 
Table 9. Transcript levels of several synapse-associated proteins after tamoxifen 
administration in adult Cre+/TM-agrin KI and Cre+/TM-agrin WT. 
TM-agrin overexpression did not change pan-synaptic markers transcript levels (bsn, syp and 
vamp2), increased transcript levels of dlg4 and grin1 (green-colored) and reduced transcript 
levels of gphn and gabra1 (red-colored); statistical analysis: Mann-Whitney-Test. 
 
Gene 
Protein 
8-week-old mice 
  
Fold 
difference p-value 
Mean ± Standard error of the mean 
(SEM) 
Cre+/Agrin WT 
(N) 
Cre+/Agrin KI 
(N) 
Presynaptic Proteins 
Bsn 
Bassoon 
11,90 ± 3,7 
(N=3) 
10,08 ± 7,38 
(N=4) 0,23 0,4 
Syp 
Synaptophysin 
27,22 ± 6,41 
(N=3) 
24,41 ± 23,63 
(N=3) 0,9 0,7 
Vamp2 
Synaptobrevin 
7,11 ± 0,80 
(N=3) 
6,012 ± 2,96 
(N=4) 0,85 0,63 
Postsynaptic and Scaffolding Proteins 
Dlg4 
PSD-95 
72,97 ± 31,11 
(N=5) 
165,6 ± 61,16 
(N=8) 2,27 0,04 
Gphn 
Gephyrin 
0,07 ± 0,002 
(N=5) 
0,002 ± 0,0003 
(N=5) 0,04 0,03 
Ionotrophic Receptors 
Grin1 
NR1-NMDAR 
25,65 ± 5,56 
(N=6) 
69,64 ± 5,57 
(N=3) 2,71 0,02 
Gabra1 
1-GABAAR 
35,81 ± 3,02 
(N=3) 
5,67 ± 3,10 
(N=5) 0,24 0,04 
*The qRT-PCR was carried out under a supervision by Dr. Schick. 
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TM-agrin does not colocalize with gephyrin but colocalizes with PSD-95 in vivo 
Several changes reported in the qRT-PCR analysis (table 9) suggested that TM-agrin 
might differentially regulate the expression level of excitatory and inhibitory synapse-
associated proteins in vivo. To investigate the spatial distribution of TM-agrin in relation to 
excitatory and inhibitory synapses in sections of cortices from wildtype adult mice, I analyzed 
the distribution of TM-agrin with respect to the distribution of gephyrin or of PSD-95. I 
observed that TM-agrin did not colocalize with gephyrin (Fig.  17A,A’). On the other hand, 
TM-agrin puncta partially colocalized with PSD-95 puncta (Fig. 17B,B’). These results 
demonstrate that TM-agrin is concentrated at least at a subset of excitatory synapses, but not at 
inhibitory synapses. 
 
 
Figure 17. A non-colocalization of TM-agrin with gephyrin and a colocalization of TM-agrin with PSD-95 
in WT cortical sections. (A, A’) TM-agrin puncta distribution (green) does not colocalize with gephyrin puncta 
(red). (B, B’) TM-agrin puncta (green) colocalizes with PSD-95 puncta (red, white head arrow), A’ and B’ panels 
are the magnifications of the corresponding panel A and B; scale bar 25 m. The images were taken as a single 
focal plane. 
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TM-agrin controls excitatory and inhibitory synapses in vivo  
In order to confirm the changes observed in the transcript levels, I analyzed the 
distribution of the corresponding proteins by performing immunohistochemical analyses in 
TM-agrin KI mice. In agreement with the lack of changes on the transcript level (Table. 9) and 
in agreement with the in vitro data (Fig. 11O–Q), the pan-synaptic protein marker, bassoon, 
was not affected in terms of puncta density or puncta size in TM-agrin overexpressing brains 
(Fig. 18A–D). 
 
 
Figure 18. TM-agrin overexpression did not alter bassoon puncta density and size, statistical analysis: 
unpaired t-test (C, D); scale bar 25 m. 
 
In contrast, a significant increase of presynaptic excitatory vGlut1 puncta density was 
observed in Cre+/TM-agrin KI neocortical sections compared to the control Cre+/TM-agrin 
 71 
 
WT (Fig. 19A-D). Similarly, excitatory postsynaptic PSD-95, the NR1- and the NR2B-subunit 
of the NMDAR puncta density were also significantly increased (Fig. 19E-P). Together, these 
data suggest that TM-agrin overexpression in adulthood in vivo increases the density of 
excitatory pre- and postsynaptic synapses in a similar way as it does in cultures of cortical 
neurons. 
 
 
Figure 19. TM-agrin controls excitatory synapses density in vivo. TM-agrin overexpression in adulthood 
increased the puncta density of vesicular glutamate transporter-1 (A-C), PSD-95 (E-G), the NR1-subunit of the 
NMDAR (I-K) and the NR2B-subunit of the NMDAR (M-O); statistical analysis: Mann-Whitney test (C, G, H, 
K, O, P), unpaired t-test (D, L); scale bar 25 m. 
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In order to confirm the changes at the transcript levels of inhibitory synapse-associated 
proteins, the distribution of the corresponding proteins in Cre+/TM-agrin KI neocortices was 
analyzed. I observed a significant reduction in the density of puncta containing presynaptic 
protein vGAT (Fig. 20A–D) as well as postsynaptic gephyrin (Fig. 20E–H), collybistin (Fig. 
20I–L) and the 5-subunit of the GABAAR (Fig. 20M-O), demonstrating a reduction in 
transcript and protein levels of the inhibitory synapses after TM-agrin overexpression in 
adulthood in vivo. 
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Figure 20. TM-agrin controls inhibitory synapses density in vivo. TM-agrin overexpression in adulthood in vivo 
reduced the puncta density containing vesicular GABA transporter (A-C), gephyrin (E-G), collybistin (I-K) and 
the 5-subunit of the GABAAR (M-O). WB analysis on the membrane fraction did not show significant reduction 
on the gephyrin protein level (Q, R); statistical analysis: unpaired t-test (C, G, O, P), Mann-Whitney test (D, H, K, 
L, R); scale bar 25 m. 
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Collectively, these data confirm that the overexpression of TM-agrin in neurons in vitro 
and in vivo differentially regulates the formation/maintenance of synapses. On one side, the 
overexpression of TM-agrin increases the transcript and protein levels of excitatory synapse-
associated proteins. On the other side, TM-agrin’s overexpression reduces the transcript and 
protein levels of inhibitory synapse-associated proteins. 
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Discussion 
 Several lines of evidence have demonstrated the essential role of agrin, MuSK and Lrp4 
during formation, maintenance and regeneration of the NMJ (Tintignac et al., 2015). However, 
the role of these organizers in the CNS is poorly understood even though they are present in the 
CNS and concentrated at synapses (Kröger and Pfister, 2009). The widespread expression of 
these molecules, the diversity of their isoforms and the developmental regulation of their 
expression in neuronal and non-neuronal cells complicate the analysis of their functions and 
interactions. In my thesis, I carried out gain- and loss-of-function experiments, in order to better 
understand the role of agrin and its receptor complex during dendritic development and 
synaptogenesis in neocortical neurons in vitro and in vivo. My results are summarized in Table 
10. Since the complete knockout of either agrin, Lrp4 or MuSK is lethal, their specific function 
in the CNS remains largely to be unveiled. Although knockout or overexpressing these proteins 
is a non-physiologically situation, these approaches in general are considerably useful to 
investigate the interplay of agrin and its partners and their possible roles in developmental 
processes and in adulthood.  
 
Table 10. Summary: the effect of TM-agrin, Lrp4 and MuSK in dendritic arborization 
and synaptogenesis 
1. Differences of Lrp4-KO and MuSK-KO neurons compared to Lrp4-heterozygous or 
MuSK-heterozygous neurons 
Phenotype Lrp4-KO MuSK-KO 
Dendritic arbor 
complexity 
Reduced complexity 
compared to Lrp4-
heterozygous 
Reduced complexity 
compared to MuSK-
heterozygous 
Excitatory synapses Reduced excitatory 
synapses compared to 
Lrp4-heterozygous 
Unaffected compared to 
MuSK-heterozygous 
Inhibitory synapses Reduced inhibitory 
synapses compared to 
Lrp4-heterozygous 
Unaffected compared to 
MuSK-heterozygous 
 
2. The effect of TM-agrin overexpression on Lrp4-heterozygous and MuSK-heterozygous 
compared to heterozygous neurons transfected with GFP only 
Phenotype Lrp4-heterozygous plus 
TM-agrin 
MuSK-heterozygous plus 
TM-agrin 
Dendritic arborization 
complexity 
Unaffected  Unaffected  
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Excitatory synapses Increased excitatory 
synapses  
 
Increased excitatory 
synapses  
Inhibitory synapses Reduced inhibitory 
synapses 
Reduced inhibitory 
synapses 
 
3. The effect of TM-agrin overexpression on wildtype neurons 
Phenotype Wildtype neurons + TM-agrin 
Dendritic arborization 
complexity 
Unaffected  
Pan-synaptic marker Unaffected 
Excitatory synapses Increased excitatory synapses which depends on the y4, 
not the z8. 
 
Inhibitory synapses Reduced inhibitory synapses which depends on the 
presence and the phosphorylation of S17 residue. 
 
4. The effect of TM-agrin overexpression on Lrp4-KO and MuSK-KO neurons  
Phenotype Lrp4-KO + TM-agrin MuSK-KO + TM-agrin 
Dendritic arborization 
complexity 
Restored complexity 
similar to Lrp4-
heterozygous  
No effect; the complexity 
remained less complex 
similar to MuSK-KO 
Excitatory synapses No increased of excitatory 
synapses; density similar 
to transfected Lrp4-KO 
neurons, lower compared 
to Lrp4-heterozygous 
n.a. 
Inhibitory synapses No further reduction of 
inhibitory synapses; 
density similar to 
transfected Lrp4-KO  
n.a. 
 
5. The effect of soluble agrin incubation in neurons microisland culture compared to non-
treated neurons 
Phenotype Wildtype neurons plus 
soluble agrin 748 
Lrp4-KO neurons plus 
soluble agrin 748 
mEPSCs frequency and 
amplitude 
 
Increased compared to 
neurons without agrin 
treatment 
Unchanged compared to 
neurons without agrin 
treatment 
Number/area of 
VGluT1+2/AMPAR or 
VGluT1+2/PSD95 puncta 
Increased compared to 
neurons without agrin 
treatment 
n.d. 
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mIPSCs frequency and 
amplitude 
 
Unchanged compared to 
neurons without agrin 
treatment 
Unchanged compared to 
neurons without agrin 
treatment 
 
6. The effect of TM-agrin-y4z0 overexpression in brains from adult mice in vivo 
Phenotype TM-agrin overexpressing adult brains 
Pan-synaptic marker Unaffected 
Excitatory synapses Increased transcript and protein levels of excitatory 
synapse-associated proteins. 
 
Inhibitory synapses Reduced transcript and protein levels of inhibitory 
synapse-associated proteins.  
 n.d.: not determined; n.a.: not applicable 
 
TM-agrin, Lrp4 and MuSK affect dendritic arbor complexity 
 I investigate the role of TM-agrin, Lrp4 and MuSK on dendritic arborization in cortical 
neurons in vitro. To this end, I compared the effect of an overexpression of the neuronal TM-
agrin in WT neurons, in Lrp4-KO neurons and in MuSK-KO neurons with the effect of an 
overexpression in neurons from the corresponding heterozygous embryos. After transfection 
with TM-agrin, neurons from WT embryos showed no differences in dendritic arborization 
(number of primary dendrites extending from the cell body and total dendritic branch tip 
number) compared to neurons transfected with control vector encoding GFP. However, neurons 
transfected with TM-agrin have significantly shorter primary dendrites. My results are 
compatible to previous studies where agrin knockdown by shRNA in hippocampal neurons led 
to an increase in dendritic length (McCroskery et al., 2006). In contrast, incubation of 
hippocampal neurons with recombinant agrin increased dendritic branching and dendritic 
elongation, whereas inhibiting agrin’s translation by antisense oligonucleotides showed the 
opposite effect (Ferreira, 1999; Mantych and Ferreira, 2001). Potential explanations why I did 
not observe any change in the dendritic branching pattern after TM-agrin overexpression could 
be due to differences in the type of the neurons analyzed (cortical vs hippocampal neurons) or 
due to the isoforms of agrin used to transfect the neurons. In my experiments, I prepared primary 
cultures of embryonic neocortical neurons, whereas in the previous studies the analyses were 
mostly carried out in cultures of hippocampal neurons. Furthermore, I transfected the 
transmembrane-form of agrin whereas the other studies incubated with recombinant soluble 
agrin. In any case, my results show that TM-agrin controls dendritic length in cultures from 
cortical neurons. The exact mechanism of how TM-agrin influences the length of dendrites 
remains to be determined. 
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 Interestingly, the reduction of Lrp4 expression via miRNA lead to a similar phenotype 
in cortical neurons (Karakatsani et al., 2017) as the genetic deletion of Lrp4 expression. In both 
cases, the neurons have a lower density of dendritic spines and a lower number but longer 
primary dendrites (Karakatsani et al., 2017). Since the miRNA technique has several 
disadvantages, such as off-target effects (Singh et al., 2011), the possibility remained that the 
effect of Lrp4 knockdown was due to non-physiological side effects. However, genetic deletion 
of Lrp4 gene affected dendritic arborization in neocortical neurons in the same way as neuron-
specific knockdown of Lrp4 by miRNA in vitro and in vivo (Karakatsani et al., 2017). This 
clearly demonstrates that the miRNA effect was specific and suggests that the altered dendritic 
arborization pattern was not due to off target effects of the miRNA. On the other hand, mice 
lacking Lrp4 in the adult CNS showed no gross anatomical changes in adult neocortex, 
hippocampus and cerebellum (Gomez et al., 2014; Pohlkamp et al., 2015). It should be noted, 
however, that the effect of Lrp4 knockdown and overexpression in cortical neurons in vitro on 
the number of primary dendrites disappeared overtime as the neurons matured, suggesting the 
activation of compensatory or redundant mechanisms in vivo which maintained the dendritic 
tree structure (Karakatsani et al., 2017). Indeed, compensatory mechanisms for Lrp4 have been 
previously described during skeletal muscle development, such as functional compensation via 
Lrp1, which shares a high degree of homology with Lrp4 (Lane-Donovan et al., 2014; Li et al., 
2010). Similar to Lrp1, Lrp4 is concentrated in the PSD fraction similar to Lrp4. Moreover, due 
to their homologous structure, another LDLR family member, Lrp10, might similarly 
compensate the effect that was observed after Lrp4 manipulation in vivo (Brodeur et al., 2012; 
Lane-Donovan et al., 2014). In summary, Lrp4 is required for the normal dendritic arborization 
in the developing neurons, but its function in vivo in mature neurons might be compensated by 
functionally redundant proteins.  
 While Lrp4 is involved in regulating the dendritic arborization pattern, the question 
remains open whether MuSK is also involved. I showed that the absence of MuSK in cortical 
neurons led to a reduction of the number of primary dendrites and of the total dendritic branch 
tip number. This is the first evidence demonstrating a critical function of MuSK in regulating 
dendritic tree complexity and opens the questions of how MuSK regulates the dendritic 
morphology. One possible explanation is the interaction of MuSK with Wnt morphogens via 
its Frizzled-like/cysteine-rich domain. It was previously shown that the Frizzled-like domain in 
MuSK interacts with Wnt morphogens to maintain NMJ structural integrity (Messeant et al., 
2015). Moreover, pharmacological Wnt inhibition led to a reduction of the dendritic 
arborization in cultured cortical neurons (Hiester et al., 2013; Remedio et al., 2016). Thus, 
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MuSK could affect the formation of the normal dendritic arborization pattern by being a 
receptor for Wnt proteins during CNS development. 
 Interestingly, while TM-agrin overexpression could restore the dendritic arborization 
deficit in Lrp4-KO neurons, it had no such effect in MuSK-KO neurons. This suggests that 
MuSK, but not Lrp4, is required for the TM-agrin-induced changes in dendritic arborization. 
Of note, agrin is not able to directly bind to MuSK (Glass et al., 1996a). This suggests that in 
the developing CNS, TM-agrin might require additional proteins mediating the TM-agrin – 
MuSK interaction in order to regulate dendritic arborization. These proteins remain to be 
identified. 
The C-terminal half of TM-agrin was essential for rescuing the loss of the dendritic 
arborization complexity in Lrp4-KO neurons. This effect was independent of the C-terminal 
splicing isoforms and thus independent of a direct agrin-Lrp4 interaction. In fact, all of the 
splice variants of TM-agrin restored dendritic arborization complexity observed in Lrp4-
deficient neurons. Several molecules of the agrin signaling cascade have been shown to affect 
dendritic arborization. For example, agrin could regulate dendritic arborization via its 
interaction with dystroglycan (Bijata et al., 2015). Supporting this hypothesis, the C-terminal 
half of agrin, the binding domain between agrin and dystroglycan, was required for the TM-
agrin-mediated effect on dendritic arborization restoration in Lrp4-KO neurons. Alternatively, 
agrin’s effect could also be mediated by several other molecules, possibly interacting with 
agrin’s glycosaminoglycan side chains. For example, a previous report has shown a 
neuroprotective effect of the GAG-side chains, promoting dendritic arborization (Dudas et al., 
2008). In addition, the effect of agrin on dendritic arborization could be mediated by the 
activation of the mitogen-activated protein kinase (MAPK) pathway, which has been reported 
to be important for regulating dendritic tree complexity (Jan and Jan, 2010) and which has been 
shown to be reduced in agrin-deficient brains (Ksiazek et al., 2007). Thus, agrin regulates 
dendritic arborization under certain conditions and this function requires its half C-terminus 
and potentially an interaction with other molecules. 
Interestingly, neurons from Lrp4-KO and MuSK-KO mice displayed longer primary 
dendrites compared to control neurons suggesting a negative correlation between dendritic 
arborization complexity and length of primary dendrites, i.e. the more complex the dendritic 
arborization, the shorter the dendritic length. A similar observation has been reported in Lrp4-
miRNA-treated neurons (Karakatsani et al., 2017). This suggests that both parameters, the 
dendritic arborization and the dendritic length, might depend on each other. However, further 
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investigations are clearly needed to assess whether these parameters are causally and 
functionally related.   
 Together these results stand in favor of multiple mechanisms through which TM-agrin 
might regulate dendritic complexity. Conclusions on how agrin controls dendritic tree 
morphology should be taken carefully, since TM-agrin overexpression in WT neurons did not 
cause any changes in dendritic arborization. Therefore, the effect of agrin on dendritic 
complexity might only take place selectively under specific conditions, such as when the 
conditions for dendritic arborization development is not optimal, as in the case in neurons which 
lack of Lrp4-expression. 
 
The role of TM-agrin, Lrp4 and MuSK in excitatory synapse development and spine 
formation 
 To investigate the effect of neuronal agrin during the development of excitatory 
synapses, I quantified the density of excitatory pre- and postsynaptic-related proteins after TM-
agrin overexpression in WT neocortical neuronal cultures. I observed a significant increase in 
the density of the excitatory presynaptic marker vGlut1, as well as of postsynaptic markers 
PSD-95 and the NR1-subunit of the NDMA receptor. This observation is in line with previous 
loss-of-function experiments where the agrin-deficiency in hippocampal cultures and in mice 
in vivo reduced the density of dendritic spines, PSD-95 puncta density and frequency and 
amplitude of mEPSCs (Ksiazek et al., 2007; McCroskery et al., 2009). However, only a 30% 
loss of synaptic density was observed in agrin-deficient brains, suggesting that compensatory 
mechanisms are activated to take over the function of agrin during synapse formation and/or 
maintenance (Ksiazek et al., 2007). Moreover, previous studies reported an impairment of 
excitatory synapse formation after blockade of agrin’s translation with antisense 
oligonucleotide (Bose et al., 2000; Ferreira, 1999). In contrast, synaptic puncta analysis in 
cultures from agrin-deficient cortical and hippocampal neurons did not show any change in the 
number of synapses (Li et al., 1999; Serpinskaya et al., 1999). The reason for this discrepancy 
is unknown. However, since the effect of overexpression or of the knockdown was only 
quantitative in the range of 30 %, the possibility exists that this minimal effect escaped the 
analysis. In any case, the vast majority of evidence stands in favor of TM-agrin playing a role 
in the formation or maintenance of excitatory synapses.  
 Analysis of Lrp4-KO neurons showed that Lrp4 is required for spinogenesis and 
excitatory synapses formation. In Lrp4-KO neurons, the density of dendritic spines and of PSD-
95 puncta were lower compared to wildtype neurons. Thus, Lrp4 expression is required for the 
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formation of excitatory synapses and dendritic spines. A function of Lrp4 in controlling the 
formation of dendritic spines and excitatory synapses has been previously suggested using a 
knockdown approach in vitro (Karakatsani et al., 2017) and in vivo (Gomez et al., 2014; 
Pohlkamp et al., 2015). In vitro, the reduction of Lrp4 level in hippocampal and cortical neurons 
led to a reduction of the spine density and of the puncta density containing PSD-95, whereas 
the overexpression displayed the opposite phenotypes (Karakatsani et al., 2017). In all cases, 
Lrp4 deficiency led to an approximately 50% reduction of mEPSCs frequency, impairment of 
the hippocampal LTP and of a longer latency of learning of the mutant mice to reach the 
platform in the Morris water maze test (Gomez et al., 2014). My results together with the 
previously published evidence confirm Lrp4 as a key player during spinogenesis, 
synaptogenesis and synaptic plasticity.  
To investigate whether TM-agrin and Lrp4 cooperate in regulating spinogenesis and 
synaptogenesis, I overexpressed TM-agrin in Lrp4-KO neurons. The overexpression of TM-
agrin under these conditions showed no increase in PSD-95 puncta density compared to TM-
agrin overexpression in WT cortical neurons. Therefore, it can be concluded, that Lrp4 
expression is necessary to control excitatory synapse density, and that TM-agrin might 
cooperate with Lrp4 to exert its effect on excitatory synapses. 
 Overexpression of TM-agrin together with Lrp4 miRNA in the same WT neuron 
showed that the knockdown of Lrp4 level abolished the TM-agrin-mediated increase of 
excitatory synapses. Based on the previous observation that agrin requires Lrp4 to exert its 
effect on excitatory synapses. I conclude that the presence of Lrp4 in the same neuron, which 
overexpresses TM-agrin, is required for controlling excitatory synapses. The increase of 
excitatory synapses that was exerted by TM-agrin overexpression in miRNA-Lrp4 treated cells 
and is therefore very likely due to a trans interaction between TM-agrin and synaptic or non-
neuronal Lrp4 in non-transfected cells. Alternatively, the effect might be caused by the residual 
Lrp4, which is still expressed at a low-level in the knockdown experiments. Therefore, the 
presence of Lrp4 in the same cells appears to be required for the TM-agrin overexpression-
mediated effect in regulating the excitatory synapses.  
 In the CNS, Lrp4 is expressed in neuronal and non-neuronal cells, such as glial cells 
(Lein et al., 2006; Sun et al., 2016; Tian et al., 2006). Neuronal and glial Lrp4 might have 
different functions during CNS development. Astroglial Lrp4 modulates synaptic transmission 
at glutamatergic synapses by acting as a glutamatergic transmission modulator via suppression 
of ATP/adenosine through adenosine A1 receptor on glutamatergic neurons (Sun et al., 2016). 
The genetic deletion of Lrp4 in astrocyte leads to an increase secretion of ATP which then 
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suppresses the glutamatergic transmission in the hippocampus (Sun et al., 2016). Interestingly, 
the absence of astroglial Lrp4 has no effect on the dendritic spine density in the hippocampus 
(Sun et al., 2016).  
Several lines of evidences showed that neuronal Lrp4 affects synapses. Neuronal Lrp4 
expression levels regulate the development of excitatory synapses (Karakatsani et al., 2017). 
Moreover, Lrp4 is concentrated in synaptosomal fractions and has been described to play a 
critical role in synaptogenesis and synaptic-related plasticity (Gomez et al., 2014; Karakatsani 
et al., 2017; Mosca et al., 2017; Pohlkamp et al., 2015). Interestingly, the absence of Lrp4 in 
the CNS does not disturb the overall anatomical organization of the brain (Gomez et al., 2014). 
Instead, neuronal Lrp4 might account for controlling synapse density, synaptic function as well 
as hippocampal LTP (Gomez et al., 2014; Pohlkamp et al., 2015). Further evidence 
strengthening the hypothesis of a role of neuronal Lrp4 in synapse formation and/or 
maintenance such as that the knockdown of Lrp4 in neurons resulted in lower dendritic spine 
density, fewer excitatory synapse-like specializations and fewer presynaptic cells labelled by 
trans-synaptic tracing with rabies virus (Karakatsani et al., 2017). Furthermore, mice without 
Lrp4 displayed impairment in cognitive tasks related to learning and memory (Gomez et al., 
2014). Overall, these evidences suggest that neuronal Lrp4 is required for the formation or 
maintenance of the excitatory synapses, whereas the astroglial Lrp4 is important for modulating 
the glutamatergic synaptic transmission. 
 I did not observe a change in the development of excitatory synapses, i.e. PSD-95 puncta 
density, in MuSK-KO neurons. Thus, MuSK expression is apparently not required for the 
formation of the normal density of excitatory synapses. However, MuSK-KO neurons showed 
fewer dendritic spines compared to control neurons. These contradictory observations could be 
explained by the fact that MuSK might establish the structural anatomy of excitatory synapses 
but does not recruit PSD-95 into the newly formed spines. Previous evidence suggested that the 
presence of PSD-95 does not always correlate with the presence of dendritic spines, meaning 
that the spines without PSD-95 are subject to be modified, being retracted compared to those 
that contain PSD-95 (Cane et al., 2014). Furthermore, the downregulation of the PSD-95 
expression level does not affect dendritic spines formation (Woods et al., 2011).  
TM-agrin overexpression in MuSK-KO neurons increased the density of excitatory 
synapses compared to the corresponding control neurons. Therefore, in contrast to Lrp4, MuSK 
expression is apparently not required for the TM-agrin overexpression-mediated increase of 
excitatory synapses. TM-agrin was still able to exert its effect on excitatory synapses formation 
in the absence of MuSK. In conclusion, the mechanism of dendritic spine and excitatory 
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synapses formation in the CNS does not require MuSK suggesting a different molecular 
mechanism for TM-agrin activity during synaptogenesis in the CNS and at the NMJ. 
 Besides a less complex dendritic tree, Lrp4- and MuSK-KO neurons have lower 
densities of dendritic protrusions compared to control neurons. It has been hypothesized that 
immature dendritic filopodia-like protrusions evolve into dendritic mature mushroom-like 
protrusions, which eventually transform into contact sites between pre- and post-synaptic 
excitatory specializations (McCroskery et al., 2006; Miermans et al., 2017). Previous studies 
reported that TM-agrin overexpression in various cell types causes the formation of filopodia-
like protrusions (Annies et al., 2006; McCroskery et al., 2006; Ramseger et al., 2009) and it 
was hypothesized that these protrusions might be precursors for dendritic spines. Thus, TM-
agrin might enhance synapse formation by promoting these filopoda-like protrusions. In my 
experiments, the overexpression of TM-agrin increased the density of dendritic protrusions in 
neocortical neuronal culture, independently of the presence of Lrp4 and MuSK. This confirmed 
that TM-agrin is able to induce filopodia-like processes. Moreover, the induction of filopodia-
like processes by TM-agrin depends on the formation of lipid rafts and requires the activation 
of MAPK and Fyn kinases (Ramseger et al., 2009). In addition, the filopodia formation induced 
after TM-agrin overexpression in SH-SY5Y neuronal cells requires Cdc42, the Rho family 
GTPase (McCroskery et al., 2006). The impetus of Cdc42 has been shown to be able to further 
activate MAP kinase pathway (Kang et al., 2008). The formation of the filopodia-like 
protrusions required the 7th-follistatin-like domain (Porten et al., 2010), whereas the formation 
of excitatory synapses required a 4 amino acid insertion at splice site y. Thus, the formation of 
filopodia-like protrusions and the formation of excitatory synapses might be controlled by 
different domains within TM-agrin. This would suggest that the TM-agrin-mediated formation 
of the filopodia-like protrusions might not be related to the formation of excitatory synapses. 
Therefore, the physiological role of dendritic filopodia-like protrusions remains unclear and 
needs to be further investigated. 
 
Domain of TM-agrin that regulates excitatory synapse development 
 Agrin is a large multidomain protein. However, little is known about the function of 
individual domains in the developing CNS. In my study, I showed that specific splice variants 
of TM-agrin regulate excitatory synapse development. The increase of excitatory synapses was 
observed after transfection of TM-agrin-y4z8 and TM-agrin-y4z0, but not of TM-agrin-y0z0. 
Therefore, the TM-agrin overexpression-mediated increase of excitatory synapses required the 
four amino acid insert at the y-splice site of the LG2 domain. The importance of the LG2 
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domain for TM-agrin’s interaction with chick ciliary neurons has been shown previously 
(Burgess et al., 2002). Interestingly, the presence of eight amino acids at the z-site, which is 
essential for the effective binding between agrin and Lrp4, was not required for excitatory 
synapse formation. The current finding at the same time rejected also our hypothesis in which 
TM-agrin-mediated filopodia-like processes act as the precursors of excitatory synapses. These 
two events are induced by two different domains: the y-splice site for the excitatory synapse 
formation and the 7th-follistatin-like domain for the filopodia-induce activity. This finding is 
the first evidence for a role of the y-splice site of agrin and allows us to gain insights into new 
functions of agrin mRNA splicing in neocortical excitatory synapse development: while the 
formation of cholinergic specialization at the NMJ is regulated by agrin-y4z8, glutamatergic 
synapses in the CNS appear to be regulated by agrin-y4z0.  
The TM-agrin-mediated-increase of excitatory synapses required the expression of 
Lrp4. However, it did not require direct binding of TM-agrin to Lrp4. Thus, the formation of 
the NMJ and of excitatory synapses in the CNS differ in their requirement of a direct interaction 
of Lrp4 and TM-agrin. I hypothesize that there might be an indirect interaction between both 
molecules. In principle, this could be mediated by several candidate molecules. One potential 
candidate is the amyloid precursor protein (APP). APP, Lrp4 and agrin have been shown to 
cooperate and bind to each other during synaptogenesis and maintenance of the NMJ (Choi et 
al., 2013; Cotman et al., 2000). APP and agrin share a heparin/heparan-sulfate binding domain: 
the E2 domain of APP is required for APP’s binding to heparansulfate, whereas the presence 
of four amino acid insert at y-splice site of agrin increases the binding affinity of TM-agrin with 
heparansulfate (Gesemann et al., 1996). In addition, Lrp4 binds directly to APP via its 
extracellular domain (Pohlkamp et al., 2015). Therefore, it is possible that TM-agrin together 
with APP and Lrp4 form a complex which regulates the formation of excitatory synapses in the 
CNS, possibly via the intracellular domain containing PDZ-containing domain of Lrp4 (Tian 
et al., 2006). 
To investigate the hypothesis of an agrin/APP interaction, I analyzed APP puncta 
density following overexpression of distinct TM-agrin splice variants. TM-agrin-y4z8 and TM-
agrin-y4z0, but not TM-agrin-y0z0, increased the density of APP puncta on dendrites. This 
suggests that the presence of the four amino acid insert at the y-splice site, but not the Lrp4-
binding domain itself, was required for the increase of APP puncta density after TM-agrin 
overexpression in vitro. A similar effect of TM-agrin overexpression was observed in the case  
of the excitatory synapse markers PSD-95 and NR1, further supporting the idea that APP 
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cooperates with TM-agrin and Lrp4 to increase the density of excitatory synapse-associated 
specializations. 
 
The role of TM-agrin, Lrp4 and MuSK during inhibitory synapse development 
 Since the pan-synaptic marker bassoon did not display any change following TM-agrin 
overexpression in vitro, I hypothesized that the increase in excitatory synapse density might be 
accompanied by a similar decrease of inhibitory synapses. This would indicate that TM-agrin 
controls inhibitory synapse formation as well. In agreement with the hypothesis, I observed a 
reduction in the density of synaptic puncta containing inhibitory specializations, such as vGAT, 
gephyrin, collybistin and the 1-subunit of the GABAAR, after TM-agrin overexpression in 
vitro. Moreover, overexpression of TM-agrin affected only synapse-associated proteins, but not 
extrasynaptic inhibitory-associated protein, such as the 5-subunit of the GABAAR. These 
results demonstrate that TM-agrin overexpression specifically altered excitatory and inhibitory 
synapse density and that both type of synapses were affected in the opposite direction, i.e. an 
increase of excitatory- and a decrease of inhibitory synaptic specializations, without influencing 
the distribution of the inhibitory extrasynaptic neurotransmitter receptors. Since inhibitory 
neurotransmitter receptors exist in synaptic as well as in extrasynaptic pools, it remains to be 
determined, if agrin selectively affects either one of these pools or if it affects the relative 
distribution of proteins between both pools. 
 The effect of TM-agrin overexpression on inhibitory synapses was independent of the 
presence of MuSK. Thus, similar to the effect of TM-agrin overexpression on excitatory 
synapses, MuSK was not required for the TM-agrin-mediated effect to downregulate inhibitory 
synapses in neocortical cultures. Surprisingly, Lrp4 acted in an opposite manner compared to 
TM-agrin, i.e. TM-agrin-overexpression and Lrp4-deficiency reduced the density of inhibitory 
synapses. This would support the hypothesis that both molecules, Lrp4 and TM-agrin, control 
inhibitory synapse formation via independent mechanisms. Moreover, Lrp4-deficient brains in 
vivo were previously reported to have a significant reduction of the 2-subunit of the GABAAR 
expression level in the hippocampus (Gomez et al., 2014), suggesting a crucial function of Lrp4 
in regulating the formation and/or maintenance of inhibitory synapses, in vitro and in vivo. 
 
Domain of TM-agrin that regulates inhibitory synapse development 
 In my thesis, I provide evidence that the presence of the conserved serine 17 was 
necessary for the TM-agrin-mediated effect on inhibitory synapses. Point mutation of serine to 
aspartic acid (phosphomimetic mutation) could reduce inhibitory synapse density, whereas the 
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point mutation of serine to alanine (an amino acid that cannot be phosphorylated) showed no 
reduction. This demonstrates the importance of serine 17 for inhibitory synapse formation and 
further suggests that the phosphorylation of serine 17 might regulate TM-agrin’s effect on 
inhibitory synapses. 
Phosphorylation is a common post-translational modification, which controls the 
function of many proteins. Gephyrin itself, for example, is subject to post-translational 
phosphorylation and this modification regulates the aggregation of gephyrin at synapses via 
putative extracellular signal regulated kinase 1/2 and glycogen synthase kinase 3 (Battaglia et 
al., 2018; Bausen et al., 2010; Kuhse et al., 2012; Tyagarajan et al., 2011). Mutating serine 17 
to alanine or aspartic acid did not affect excitatory synapse density (data not shown), 
demonstrating that the serine-residue influenced specifically inhibitory synapses. This stands 
in favor of opposing effects of TM-agrin overexpression on glutamatergic and GABAergic 
synapses, with two different domains within TM-agrin being responsible for excitatory and 
inhibitory synapse formations.  
 
The effect of TM-agrin overexpression in synapse-related plasticity in adult cortex  
 In wildtype mice, immunoreactivity with an antibody specific for TM-agrin in the 
cortices colocalized with a subset of excitatory synapses, but not with inhibitory synapses. This 
is consistent with previously published data (Ksiazek et al., 2007) which showed a 
colocalization of PSD-95 with a pan-specific anti-agrin antiserum and an absence of 
colocalization with the 2-subunit of the GABAAR. The absence of a colocalization of TM-
agrin and gephyrin suggests that the reduction of inhibitory synapses after TM-agrin’s 
overexpression does not require the concentration of TM-agrin at inhibitory synapses. It seems 
likely, therefore, that the activation of an intracellular signaling cascade possibly via serine 17 
phosphorylation is sufficient for the formation of the postsynaptic specialization of inhibitory 
synapses. In addition, I observed that not all of the PSD-95 puncta colocalized with TM-agrin, 
suggesting that only specific isoforms of TM-agrin are concentrated at excitatory synapses or 
that only a subset of excitatory synapses is immunopositive for TM-agrin. Further studies are 
clearly required to elucidate the molecular mechanisms and the intracellular signaling cascades 
activated by TM-agrin which regulate the density of excitatory and inhibitory synapses in vivo. 
Agrin is not only essential during NMJ development, but also for stabilizing synaptic 
specializations at adult NMJ (Samuel et al., 2012). It has previously been shown also that agrin 
expression is upregulated following traumatic brain injury (Falo et al., 2008), suggesting a role 
of agrin also during periods of synaptic-plasticity in the adult brain. To learn if TM-agrin might 
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similarly be involved in synapse maintenance in the adult brain, I characterized mice that 
conditionally overexpressed TM-agrin-y4z0 after tamoxifen administration, under the control 
of the CamKIIa promoter, which is selectively expressed in glutamatergic neurons of the 
neocortex (Schick, 2018). Following validation of TM-agrin overexpression by analyzing TM-
agrin transcript and protein levels, I investigated the expression of synapse-associated proteins. 
I observed a significant increase in vGlut1, PSD-95, the NR1-subunit of the NMDAR transcript 
levels. This increase in mRNA levels was accompanied by a concomitant increase in their 
dendritic puncta densities. Both changes occurred in adult mice 14 days after tamoxifen-
induced TM-agrin overexpression. In addition, Anna Schick showed that spine head size and 
PSD-95 puncta intensity were specifically increased in the apical dendrite of pyramidal neurons 
of the neocortex and hippocampus of TM-agrin-overexpressing mice (Schick, 2018). These 
morphological changes at excitatory synapses were in agreement with a previous publication 
showing that agrin-deficient brain had fewer dendritic spines and a reduction of mEPSCs 
frequency, suggesting that these mice have fewer functional excitatory synapses (Ksiazek et al., 
2007). Together these results support a critical role of TM-agrin not only during synaptogenesis 
in the developing brain, but also in the maintenance of synapses in the adult brain in vivo. 
 Analysis of the inhibitory synapse density has shown that TM-agrin overexpression led 
to a decrease of both pre- and postsynaptic inhibitory synaptic proteins, such as vGAT, gephyrin 
and collybistin. Although these results were in line with my in vitro evidence, they represent a 
discrepancy to the lack of changes at inhibitory synapses as well as in mIPSCs frequency and 
amplitude in agrin-deficient brains (Ksiazek et al., 2007). My identification of serine 17 as an 
essential part of TM-agrin required for the downregulation of inhibitory synapses might offer 
an explanation for this discrepancy. The mouse line with an agrin-deficient brain was generated 
by crossing agrin knockout mice with a mouse line in which NtA-agrin was expressed 
selectively in HB9-positive neurons, i.e. motoneurons (Ksiazek et al., 2007). This rescued the 
perinatal lethality of the mice and allowed the analysis of agrin-deficient brains. The agrin 
knockout mice were generated by inserting a neomycin cassette downstream of exon 5, leading 
to a deletion of exons 6-33. However, exon 1-5 might still be transcribed (Lin et al., 2001). 
Accordingly, these mice might still express a truncated TM-agrin protein containing the 
intracellular and the transmembrane domains of TM-agrin. Since this part of TM-agrin was 
sufficient for the downregulation of inhibitory synapses, the distribution and expression of 
inhibitory synapse-associated proteins might not be observed in this agrin-deficient brain. 
Along the same line: the identification of serine 17 as essential for TM-agrin’s downregulation 
also explains, why the addition of soluble agrin, in which the intracellular domain is not present, 
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to cortical microisland cultures showed no effect on the frequency and the amplitude of mIPSCs 
(Handara et al., 2019). 
Interestingly, unlike the unaffected extrasynaptic inhibitory component during 
synaptogenesis in vitro, TM-agrin overexpression in vivo affected all inhibitory synapse-
associated proteins, including the extrasynaptic 5-subunit of the GABAAR. One possible 
explanation why this subunit was affected in vivo but not in vitro could be that TM-agrin might 
exert different effects on GABAergic synapses depending on the developmental status (i.e. 
developing vs adult neurons) of the synapses. Moreover, it should be kept in mind that the exact 
role of the extrasynaptic 5-subunit of the GABAAR during synapse development and 
adulthood is not entirely clear (Brady and Jacob, 2015), which precludes a precise interpretation 
of how TM-agrin might differentially regulate synaptic and extrasynaptic inhibitory 
neurotransmitter receptors. 
  In agreement with the in vitro result, the density of puncta labeled by the pan-synaptic 
protein bassoon was also not altered in vivo following TM-agrin overexpression. Therefore, the 
opposing effects of TM-agrin overexpression on excitatory and inhibitory synapses might keep 
the total number of synapses at a relatively constant level, suggesting a possibly role of TM-
agrin in the maintenance of an adequate excitatory/inhibitory balance. 
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Conclusion 
In summary, both Lrp4 and MuSK are required for normal dendritic arborization and 
TM-agrin affects dendritic arborization by acting in concert with MuSK. TM-agrin’s effect on 
excitatory synapses requires Lrp4, whereas the TM-agrin-mediated downregulation of 
inhibitory synapse does not require Lrp4. MuSK appears not to be involved at all in synapse 
development. Two different regions of TM-agrin affect the control of the two types of synapses: 
the presence of four amino acids at the y-splice site of TM-agrin is essential for excitatory 
synapse regulation, whereas the presence of the conserved intracellular serine residue 17 
regulates the inhibitory synapses. Together these data unveil specific and selective roles for 
TM-agrin, Lrp4 and MuSK in dendritic arborization and synapse formation during development 
in vitro and in the adult CNS in vivo. Moreover, my results further support the hypothesis that 
the formation and maintenance of the neuromuscular junction and of synapses in the CNS share 
common molecular determinants. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 90 
 
Acknowledgments 
 
I would like to thank my Ph.D. supervisor, Prof. Stephan Kröger, for the opportunity to 
conduct my research project in his lab. Thank you for all the supports and the exchange of ideas. 
Importantly, thank you for the patience to teach me how to give a scientific talk, write a thesis 
and create a scientific poster. Moreover, I am also grateful to have the freedom to explore and  
conduct my Ph.D. project.  
Furthermore, I would like to thank Prof. Magdalena Götz and the Graduate School HELENA 
at the Helmholtz Center München for the funding during my Ph.D and also for supporting me 
to participate in several workshops, conferences and lab-exchanges. 
Thank you Prof. Fritz Rathjen for the opportunity to do experiments at the MDC Berlin. 
Thank you for providing and organizing the breeding of the Lrp4-KO and the MuSK-KO mice.  
I am so grateful to have a wonderful colleagues Laura Gerwin, Anna Schick, Martina 
Bürkle, Ilaria Vitali and Johannes Geisinger. Thank you so much for all the advises, cares 
and great time together. For Martina and Ilaria, thank you so much for your technical 
assistances! Martina, thank you for teaching me how to speak german. Ilaria, thank you for 
critically reading my whole thesis and also for providing the figure 15a. 
Thank you Ines Mühlhahn for your help in the cloning lab. Tatiana Simon-Ebert, thank you 
for organizing the plug-check of the mice. Thank you Chu-Lan Lao, Sergio Gascon, Corinna 
Haupt, Elisa Murenu and Riccardo Bocchi, for the opinions and all the discussions. 
Thank you Sarah Rossmanith, Hedwig Barbey and Michel Knörr for being presence in the 
lab and your inputs during the lab meetings. 
I would like to thank Elsa Melo, Lana Polero, Eva-Maria Bushart and Suada for their 
administrative supports. 
Also, I thank my fellow friends Iris Marti and Marie-Claire Ung. Thank you for your supports 
during my Ph.D. period. 
Last but not least, thank you so much to my parent (papa Budi, mama Regina, tante Linda), 
sisters (Monna, Maria, Xessyl, Novi), brothers (Ano and Cello) and cousins (ci Feni and ci 
Lia). Thank you for always being there, although we’re physically separated for almost 10.901 
km away. I love you all! 
 
 
Gerry  
 91 
 
Bibliography 
Alldred, M.J., Mulder-Rosi, J., Lingenfelter, S.E., Chen, G., Luscher, B., 2005. Distinct 
gamma2 subunit domains mediate clustering and synaptic function of postsynaptic 
GABAA receptors and gephyrin. J Neurosci 25, 594-603. 
Annies, M., Bittcher, G., Ramseger, R., Loschinger, J., Woll, S., Porten, E., Abraham, C., 
Ruegg, M.A., Kröger, S., 2006. Clustering transmembrane-agrin induces filopodia-like 
processes on axons and dendrites. Mol Cell Neurosci 31, 515-524. 
Barber, A.J., Lieth, E., 1997. Agrin accumulates in the brain microvascular basal lamina during 
development of the blood-brain barrier. Dev Dyn 208, 62-74. 
Battaglia, S., Renner, M., Russeau, M., Come, E., Tyagarajan, S.K., Levi, S., 2018. Activity-
Dependent Inhibitory Synapse Scaling Is Determined by Gephyrin Phosphorylation and 
Subsequent Regulation of GABAA Receptor Diffusion. eNeuro 5. 
Bauerfeind, R., Huttner, W.B., 1993. Biogenesis of constitutive secretory vesicles, secretory 
granules and synaptic vesicles. Curr Opin Cell Biol 5, 628-635. 
Bausen, M., Weltzien, F., Betz, H., O'Sullivan, G.A., 2010. Regulation of postsynaptic gephyrin 
cluster size by protein phosphatase 1. Mol Cell Neurosci 44, 201-209. 
Bedet, C., Bruusgaard, J.C., Vergo, S., Groth-Pedersen, L., Eimer, S., Triller, A., Vannier, C., 
2006. Regulation of gephyrin assembly and glycine receptor synaptic stability. J Biol 
Chem 281, 30046-30056. 
Béïque, J.-C., Lin, D.-T., Kang, M.-G., Aizawa, H., Takamiya, K., Huganir, R.L., 2006. 
Synapse-specific regulation of AMPA receptor function by PSD-95. Proc Natl Acad Sci 
USA 103, 19535-19540. 
Bezakova, G., Helm, J.P., Francolini, M., Lomo, T., 2001. Effects of purified recombinant 
neural and muscle agrin on skeletal muscle fibers in vivo. J Cell Biol 153, 1441-1452. 
Biederer, T., Kaeser, P.S., Blanpied, T.A., 2017. Transcellular Nanoalignment of Synaptic 
Function. Neuron 96, 680-696. 
Bijata, M., Wlodarczyk, J., Figiel, I., 2015. Dystroglycan controls dendritic morphogenesis of 
hippocampal neurons in vitro. Front Cell Neurosci 9, 199. 
Blom, N., Gammeltoft, S., Brunak, S., 1999. Sequence and structure-based prediction of 
eukaryotic protein phosphorylation sites. J Mol Biol 294, 1351-1362. 
Blom, N., Sicheritz-Ponten, T., Gupta, R., Gammeltoft, S., Brunak, S., 2004. Prediction of post-
translational glycosylation and phosphorylation of proteins from the amino acid 
sequence. Proteomics 4, 1633-1649. 
Bose, C.M., Qiu, D., Bergamaschi, A., Gravante, B., Bossi, M., Villa, A., Rupp, F., Malgaroli, 
A., 2000. Agrin controls synaptic differentiation in hippocampal neurons. J Neurosci 20, 
9086-9095. 
Brady, M.L., Jacob, T.C., 2015. Synaptic localization of alpha5 GABA (A) receptors via 
gephyrin interaction regulates dendritic outgrowth and spine maturation. Dev Neurobiol 
75, 1241-1251. 
Bresler, T., Shapira, M., Boeckers, T., Dresbach, T., Futter, M., Garner, C.C., Rosenblum, K., 
Gundelfinger, E.D., Ziv, N.E., 2004. Postsynaptic density assembly is fundamentally 
different from presynaptic active zone assembly. J Neurosci 24, 1507-1520. 
Brodeur, J., Theriault, C., Lessard-Beaudoin, M., Marcil, A., Dahan, S., Lavoie, C., 2012. 
LDLR-related protein 10 (LRP10) regulates amyloid precursor protein (APP) trafficking 
and processing: evidence for a role in Alzheimer's disease. Mol Neurodegener 7, 31. 
Burgess, R.W., Dickman, D.K., Nunez, L., Glass, D.J., Sanes, J.R., 2002. Mapping sites 
responsible for interactions of agrin with neurons. J Neurochem 83, 271-284. 
Burgess, R.W., Nguyen, Q.T., Son, Y.J., Lichtman, J.W., Sanes, J.R., 1999. Alternatively 
spliced isoforms of nerve- and muscle-derived agrin: their roles at the neuromuscular 
junction. Neuron 23, 33-44. 
 92 
 
Burgess, R.W., Skarnes, W.C., Sanes, J.R., 2000. Agrin isoforms with distinct amino termini: 
differential expression, localization, and function. J Cell Biol 151, 41-52. 
Burk, K., Desoeuvre, A., Boutin, C., Smith, M.A., Kröger, S., Bosio, A., Tiveron, M.C., 
Cremer, H., 2012. Agrin-signaling is necessary for the integration of newly generated 
neurons in the adult olfactory bulb. J Neurosci 32, 3759-3764. 
Cane, M., Maco, B., Knott, G., Holtmaat, A., 2014. The relationship between PSD-95 clustering 
and spine stability in vivo. J Neurosci 34, 2075-2086. 
Carlin, R.K., Grab, D.J., Cohen, R.S., Siekevitz, P., 1980. Isolation and characterization of 
postsynaptic densities from various brain regions: enrichment of different types of 
postsynaptic densities. J Cell Biol 86, 831-845. 
Cartaud, A., Stetzkowski-Marden, F., Maoui, A., Cartaud, J., 2011. Agrin triggers the clustering 
of raft-associated acetylcholine receptors through actin cytoskeleton reorganization. 
Biology of the cell 103, 287-301. 
Chen, L., Chetkovich, D.M., Petralia, R.S., Sweeney, N.T., Kawasaki, Y., Wenthold, R.J., 
Bredt, D.S., Nicoll, R.A., 2000. Stargazin regulates synaptic targeting of AMPA receptors 
by two distinct mechanisms. Nature 408, 936-943. 
Chen, W.J., Goldstein, J.L., Brown, M.S., 1990. NPXY, a sequence often found in cytoplasmic 
tails, is required for coated pit-mediated internalization of the low density lipoprotein 
receptor. J Biol Chem 265, 3116-3123. 
Choi, H.Y., Liu, Y., Tennert, C., Sugiura, Y., Karakatsani, A., Kröger, S., Johnson, E.B., 
Hammer, R.E., Lin, W., Herz, J., 2013. APP interacts with LRP4 and agrin to coordinate 
the development of the neuromuscular junction in mice. Elife 2, e00220. 
Coba, M.P., Pocklington, A.J., Collins, M.O., Kopanitsa, M.V., Uren, R.T., Swamy, S., 
Croning, M.D., Choudhary, J.S., Grant, S.G., 2009. Neurotransmitters drive 
combinatorial multistate postsynaptic density networks. Sci Signal 2(68):ra19 
Colonnier, M., 1968. Synaptic patterns on different cell types in the different laminae of the cat 
visual cortex. An electron microscope study. Brain Res 9, 268-287. 
Cotman, S.L., Halfter, W., Cole, G.J., 2000. Agrin binds to beta-amyloid (Abeta), accelerates 
abeta fibril formation, and is localized to Abeta deposits in Alzheimer's disease brain. 
Mol Cell Neurosci 15, 183-198. 
Couteaux, R., Pecot-Dechavassine, M., 1970. [Synaptic vesicles and pouches at the level of 
"active zones" of the neuromuscular junction]. Comptes rendus hebdomadaires des 
seances de l'Academie des sciences. Serie D: Sciences naturelles 271, 2346-2349. 
Craig, A.M., Graf, E.R., Linhoff, M.W., 2006. How to build a central synapse: clues from cell 
culture. Trends Neurosci 29, 8-20. 
Daniels, M.P., 2012. The role of agrin in synaptic development, plasticity and signaling in the 
central nervous system. Neurochem Int 61, 848-853. 
De Roo, M., Klauser, P., Garcia, P.M., Poglia, L., Muller, D., 2008a. Spine dynamics and 
synapse remodeling during LTP and memory processes. Prog Brain Res 169, 199-207. 
De Roo, M., Klauser, P., Mendez, P., Poglia, L., Muller, D., 2008b. Activity-dependent PSD 
formation and stabilization of newly formed spines in hippocampal slice cultures. 
Cerebral Cortex (New York, N.Y. : 1991) 18, 151-161. 
De Roo, M., Klauser, P., Muller, D., 2008c. LTP promotes a selective long-term stabilization 
and clustering of dendritic spines. PLoS Biology 6, e219. 
DeChiara, T.M., Bowen, D.C., Valenzuela, D.M., Simmons, M.V., Poueymirou, W.T., 
Thomas, S., Kinetz, E., Compton, D.L., Rojas, E., Park, J.S., Smith, C., DiStefano, P.S., 
Glass, D.J., Burden, S.J., Yancopoulos, G.D., 1996. The receptor tyrosine kinase MuSK 
is required for neuromuscular junction formation in vivo. Cell 85, 501-512. 
Dejanovic, B., Semtner, M., Ebert, S., Lamkemeyer, T., Neuser, F., Luscher, B., Meier, J.C., 
Schwarz, G., 2014. Palmitoylation of gephyrin controls receptor clustering and plasticity 
of GABAergic synapses. PLoS biology 12, e1001908. 
 93 
 
Denzer, A.J., Hauser, D.M., Gesemann, M., Ruegg, M.A., 1997. Synaptic differentiation: the 
role of agrin in the formation and maintenance of the neuromuscular junction. Cell Tissue 
Res 290, 357-365. 
Dong, Y.N., Waxman, E.A., Lynch, D.R., 2004. Interactions of Postsynaptic Density-95 and 
the NMDA Receptor 2 Subunit Control Calpain-Mediated Cleavage of the NMDA 
Receptor. J Neurosci 24, 11035-11045. 
Dudas, B., Rose, M., Cornelli, U., Pavlovich, A., Hanin, I., 2008. Neuroprotective properties 
of glycosaminoglycans: potential treatment for neurodegenerative disorders. Neuro-
degenerative diseases 5, 200-205. 
Ehlers, M.D., 2003. Activity level controls postsynaptic composition and signaling via the 
ubiquitin-proteasome system. Nat Neurosci 6, 231-242. 
Ehrlich, I., Klein, M., Rumpel, S., Malinow, R., 2007. PSD-95 is required for activity-driven 
synapse stabilization. Proc Natl Acad Sci USA 104, 4176-4181. 
El-Husseini, A.E., Schnell, E., Chetkovich, D.M., Nicoll, R.A., Bredt, D.S., 2000. PSD-95 
involvement in maturation of excitatory synapses. Science 290, 1364-1368. 
Elias, G.M., Elias, L.A., Apostolides, P.F., Kriegstein, A.R., Nicoll, R.A., 2008. Differential 
trafficking of AMPA and NMDA receptors by SAP102 and PSD-95 underlies synapse 
development. Proc Natl Acad Sci USA 105, 20953-20958. 
Erdmann, G., Schutz, G., Berger, S., 2007. Inducible gene inactivation in neurons of the adult 
mouse forebrain. BMC Neurosci 8, 63. 
Ethell, I.M., Pasquale, E.B., 2005. Molecular mechanisms of dendritic spine development and 
remodeling. Prog Neurobiol 75, 161-205. 
Falo, M.C., Reeves, T.M., Phillips, L.L., 2008. Agrin expression during synaptogenesis induced 
by traumatic brain injury. J Neurotrauma 25, 769-783. 
Feng, G., Tintrup, H., Kirsch, J., Nichol, M.C., Kuhse, J., Betz, H., Sanes, J.R., 1998. Dual 
requirement for gephyrin in glycine receptor clustering and molybdoenzyme activity. 
Science 282, 1321-1324. 
Ferns, M., Deiner, M., Hall, Z., 1996. Agrin-induced acetylcholine receptor clustering in 
mammalian muscle requires tyrosine phosphorylation. J Cell Biol 132, 937-944. 
Ferreira, A., 1999. Abnormal synapse formation in agrin-depleted hippocampal neurons. J Cell 
Sci 112 ( Pt 24), 4729-4738. 
Fischer, F., Kneussel, M., Tintrup, H., Haverkamp, S., Rauen, T., Betz, H., Wassle, H., 2000. 
Reduced synaptic clustering of GABA and glycine receptors in the retina of the gephyrin 
null mutant mouse. J Comp Neurol427, 634-648. 
Fuhrmann, J.C., Kins, S., Rostaing, P., El Far, O., Kirsch, J., Sheng, M., Triller, A., Betz, H., 
Kneussel, M., 2002. Gephyrin interacts with Dynein light chains 1 and 2, components of 
motor protein complexes. J Neurosci 22, 5393-5402. 
Funke, L., Dakoji, S., Bredt, D.S., 2005. Membrane-associated guanylate kinases regulate 
adhesion and plasticity at cell junctions. Annu Rev Biochem 74, 219-245. 
Furshpan, E.J., Potter, D.D., 1957. Mechanism of nerve-impulse transmission at a crayfish 
synapse. Nature 180, 342-343. 
Garcia-Osta, A., Tsokas, P., Pollonini, G., Landau, E.M., Blitzer, R., Alberini, C.M., 2006. 
MuSK expressed in the brain mediates cholinergic responses, synaptic plasticity, and 
memory formation. J Neurosci 26, 7919-7932. 
Gardiol, A., Racca, C., Triller, A., 1999. Dendritic and postsynaptic protein synthetic 
machinery. J Neurosci 19, 168-179. 
Gautam, M., DeChiara, T.M., Glass, D.J., Yancopoulos, G.D., Sanes, J.R., 1999. Distinct 
phenotypes of mutant mice lacking agrin, MuSK, or rapsyn. Brain research. Dev Brain 
Res 114, 171-178. 
 94 
 
Gautam, M., Noakes, P.G., Moscoso, L., Rupp, F., Scheller, R.H., Merlie, J.P., Sanes, J.R., 
1996. Defective neuromuscular synaptogenesis in agrin-deficient mutant mice. Cell 85, 
525-535. 
Gerrow, K., El-Husseini, A., 2006. Cell adhesion molecules at the synapse. Frontiers 
Bioscience 11, 2400-2419. 
Gerrow, K., Romorini, S., Nabi, S.M., Colicos, M.A., Sala, C., El-Husseini, A., 2006. A 
preformed complex of postsynaptic proteins is involved in excitatory synapse 
development. Neuron 49, 547-562. 
Gesemann, M., Brancaccio, A., Schumacher, B., Ruegg, M.A., 1998. Agrin is a high-affinity 
binding protein of dystroglycan in non-muscle tissue. J Biol Chem 273, 600-605. 
Gesemann, M., Cavalli, V., Denzer, A.J., Brancaccio, A., Schumacher, B., Ruegg, M.A., 1996. 
Alternative splicing of agrin alters its binding to heparin, dystroglycan, and the putative 
agrin receptor. Neuron 16, 755-767. 
Gesemann, M., Denzer, A.J., Ruegg, M.A., 1995. Acetylcholine receptor-aggregating activity 
of agrin isoforms and mapping of the active site. J Cell Biol 128, 625-636. 
Glass, D.J., Bowen, D.C., Stitt, T.N., Radziejewski, C., Bruno, J., Ryan, T.E., Gies, D.R., Shah, 
S., Mattsson, K., Burden, S.J., DiStefano, P.S., Valenzuela, D.M., DeChiara, T.M., 
Yancopoulos, G.D., 1996a. Agrin acts via a MuSK receptor complex. Cell 85, 513-523. 
Glass, D.J., DeChiara, T.M., Stitt, T.N., DiStefano, P.S., Valenzuela, D.M., Yancopoulos, G.D., 
1996b. The receptor tyrosine kinase MuSK is required for neuromuscular junction 
formation and is a functional receptor for agrin. Cold Spring Harb Symp Quant Biol 61, 
435-444. 
Gomez, A.M., Froemke, R.C., Burden, S.J., 2014. Synaptic plasticity and cognitive function 
are disrupted in the absence of Lrp4. Elife 3, e04287. 
Gotthardt, M., Trommsdorff, M., Nevitt, M.F., Shelton, J., Richardson, J.A., Stockinger, W., 
Nimpf, J., Herz, J., 2000. Interactions of the low density lipoprotein receptor gene family 
with cytosolic adaptor and scaffold proteins suggest diverse biological functions in 
cellular communication and signal transduction. J Biol Chem 275, 25616-25624. 
Grady, R.M., Zhou, H., Cunningham, J.M., Henry, M.D., Campbell, K.P., Sanes, J.R., 2000. 
Maturation and maintenance of the neuromuscular synapse: genetic evidence for roles of 
the dystrophin--glycoprotein complex. Neuron 25, 279-293. 
Graf, E.R., Zhang, X., Jin, S.X., Linhoff, M.W., Craig, A.M., 2004. Neurexins induce 
differentiation of GABA and glutamate postsynaptic specializations via neuroligins. Cell 
119, 1013-1026. 
Gramolini, A.O., Burton, E.A., Tinsley, J.M., Ferns, M.J., Cartaud, A., Cartaud, J., Davies, 
K.E., Lunde, J.A., Jasmin, B.J., 1998. Muscle and neural isoforms of agrin increase 
utrophin expression in cultured myotubes via a transcriptional regulatory mechanism. J 
Biol Chem 273, 736-743. 
Gray, E.G., 1959. Axo-somatic and axo-dendritic synapses of the cerebral cortex: an electron 
microscope study. J Anat 93, 420-433. 
Grutzendler, J., Kasthuri, N., Gan, W.B., 2002. Long-term dendritic spine stability in the adult 
cortex. Nature 420, 812-816. 
Handara, G., Hetsch, F.J.A., Juttner, R., Schick, A., Haupt, C., Rathjen, F.G., Kröger, S., 2019. 
The role of agrin, Lrp4 and MuSK during dendritic arborization and synaptogenesis in 
cultured embryonic CNS neurons. Dev Biol. 1;445(1):54-67. 
Harris, K.M., Jensen, F.E., Tsao, B., 1992. Three-dimensional structure of dendritic spines and 
synapses in rat hippocampus (CA1) at postnatal day 15 and adult ages: implications for 
the maturation of synaptic physiology and long-term potentiation. J Neurosci 12, 2685-
2705. 
Herculano-Houzel, S., 2009. The human brain in numbers: a linearly scaled-up primate brain. 
Front Hum Neurosci 3, 31. 
 95 
 
Hiester, B.G., Galati, D.F., Salinas, P.C., Jones, K.R., 2013. Neurotrophin and Wnt signaling 
cooperatively regulate dendritic spine formation. Mol Cell Neurosci 56, 115-127. 
Holtmaat, A., De Paola, V., Wilbrecht, L., Knott, G.W., 2008. Imaging of experience-
dependent structural plasticity in the mouse neocortex in vivo. Behav Brain Res 192, 20-
25. 
Holtmaat, A.J., Trachtenberg, J.T., Wilbrecht, L., Shepherd, G.M., Zhang, X., Knott, G.W., 
Svoboda, K., 2005. Transient and persistent dendritic spines in the neocortex in vivo. 
Neuron 45, 279-291. 
Hopf, C., Hoch, W., 1996. Agrin binding to alpha-dystroglycan. Domains of agrin necessary to 
induce acetylcholine receptor clustering are overlapping but not identical to the alpha-
dystroglycan-binding region. J Biol Chem 271, 5231-5236. 
Hopf, C., Hoch, W., 1998. Tyrosine phosphorylation of the muscle-specific kinase is 
exclusively induced by acetylcholine receptor-aggregating agrin fragments. Eur J 
Biochem / FEBS 253, 382-389. 
Hormuzdi, S.G., Filippov, M.A., Mitropoulou, G., Monyer, H., Bruzzone, R., 2004. Electrical 
synapses: a dynamic signaling system that shapes the activity of neuronal networks. 
Biochimica Biophysica Acta 1662, 113-137. 
Huganir, R.L., Delcour, A.H., Greengard, P., Hess, G.P., 1986. Phosphorylation of the nicotinic 
acetylcholine receptor regulates its rate of desensitization. Nature 321, 774-776. 
Huganir, R.L., Greengard, P., 1983. cAMP-dependent protein kinase phosphorylates the 
nicotinic acetylcholine receptor. Proc Natl Acad Sci USA 80, 1130-1134. 
Huganir, R.L., Miles, K., 1989. Protein phosphorylation of nicotinic acetylcholine receptors. 
Crit Rev Biochem Mol Biol 24, 183-215. 
Iki, J., Inoue, A., Bito, H., Okabe, S., 2005. Bi-directional regulation of postsynaptic cortactin 
distribution by BDNF and NMDA receptor activity. Eur J Neurosci 22, 2985-2994. 
Inoue, A., Sanes, J.R., 1997. Lamina-specific connectivity in the brain: regulation by N-
cadherin, neurotrophins, and glycoconjugates. Science 276, 1428-1431. 
Irie, M., Hata, Y., Takeuchi, M., Ichtchenko, K., Toyoda, A., Hirao, K., Takai, Y., Rosahl, 
T.W., Sudhof, T.C., 1997. Binding of neuroligins to PSD-95. Science 277, 1511-1515. 
Jan, Y.N., Jan, L.Y., 2010. Branching out: mechanisms of dendritic arborization. Nat Rev 
Neurosci 11, 316-328. 
Janin, J., 1979. Surface and inside volumes in globular proteins. Nature 277, 491-492. 
Jedlicka, P., Papadopoulos, T., Deller, T., Betz, H., Schwarzacher, S.W., 2009. Increased 
network excitability and impaired induction of long-term potentiation in the dentate gyrus 
of collybistin-deficient mice in vivo. Mol Cell Neurosci 41, 94-100. 
Jennings, C.G., Dyer, S.M., Burden, S.J., 1993. Muscle-specific trk-related receptor with a 
kringle domain defines a distinct class of receptor tyrosine kinases. Proc Natl Acad Sci 
USA 90, 2895-2899. 
Jing, L., Lefebvre, J.L., Gordon, L.R., Granato, M., 2009. Wnt signals organize synaptic 
prepattern and axon guidance through the zebrafish unplugged/MuSK receptor. Neuron 
61, 721-733. 
Ju, W., Morishita, W., Tsui, J., Gaietta, G., Deerinck, T.J., Adams, S.R., Garner, C.C., Tsien, 
R.Y., Ellisman, M.H., Malenka, R.C., 2004. Activity-dependent regulation of dendritic 
synthesis and trafficking of AMPA receptors. Nat Neurosci 7, 244-253. 
Kang, J.S., Bae, G.U., Yi, M.J., Yang, Y.J., Oh, J.E., Takaesu, G., Zhou, Y.T., Low, B.C., 
Krauss, R.S., 2008. A Cdo-Bnip-2-Cdc42 signaling pathway regulates p38alpha/beta 
MAPK activity and myogenic differentiation. J Cell Biol 182, 497-507. 
Karakatsani, A., Marichal, N., Urban, S., Kalamakis, G., Ghanem, A., Schick, A., Zhang, Y., 
Conzelmann, K.K., Ruegg, M.A., Berninger, B., de Almodovar, C.R., Gascon, S., 
Kröger, S., 2017. Neuronal LRP4 regulates synapse formation in the developing CNS. 
Development. 
 96 
 
Kasai, H., Matsuzaki, M., Noguchi, J., Yasumatsu, N., Nakahara, H., 2003. Structure-stability-
function relationships of dendritic spines. Trends Neurosci 26, 360-368. 
Kennedy, M.B., 2000. Signal-processing machines at the postsynaptic density. Science 290, 
750-754. 
Kennedy, M.J., Ehlers, M.D., 2006. Organelles and trafficking machinery for postsynaptic 
plasticity. Annu Rev Neurosci 29, 325-362. 
Khan, A.A., Bose, C., Yam, L.S., Soloski, M.J., Rupp, F., 2001. Physiological regulation of the 
immunological synapse by agrin. Science 292, 1681-1686. 
Kim, E.Y., Schrader, N., Smolinsky, B., Bedet, C., Vannier, C., Schwarz, G., Schindelin, H., 
2006. Deciphering the structural framework of glycine receptor anchoring by gephyrin. 
EMBO 25, 1385-1395. 
Kim, N., Stiegler, A.L., Cameron, T.O., Hallock, P.T., Gomez, A.M., Huang, J.H., Hubbard, 
S.R., Dustin, M.L., Burden, S.J., 2008. Lrp4 is a receptor for Agrin and forms a complex 
with MuSK. Cell 135, 334-342. 
Kins, S., Betz, H., Kirsch, J., 2000. Collybistin, a newly identified brain-specific GEF, induces 
submembrane clustering of gephyrin. Nat Neurosci 3, 22-29. 
Kirsch, J., Wolters, I., Triller, A., Betz, H., 1993. Gephyrin antisense oligonucleotides prevent 
glycine receptor clustering in spinal neurons. Nature 366, 745-748. 
Klenowski, P.M., Fogarty, M.J., Belmer, A., Noakes, P.G., Bellingham, M.C., Bartlett, S.E., 
2015. Structural and functional characterization of dendritic arbors and GABAergic 
synaptic inputs on interneurons and principal cells in the rat basolateral amygdala. J 
Neurophysiol 114, 942-957. 
Kneussel, M., Haverkamp, S., Fuhrmann, J.C., Wang, H., Wassle, H., Olsen, R.W., Betz, H., 
2000. The gamma-aminobutyric acid type A receptor (GABAAR)-associated protein 
GABARAP interacts with gephyrin but is not involved in receptor anchoring at the 
synapse. Proc Natl Acad Sci USA 97, 8594-8599. 
Kornau, H.C., Schenker, L.T., Kennedy, M.B., Seeburg, P.H., 1995. Domain interaction 
between NMDA receptor subunits and the postsynaptic density protein PSD-95. Science 
269, 1737-1740. 
Koulen, P., Honig, L.S., Fletcher, E.L., Kröger, S., 1999. Expression, distribution and 
ultrastructural localization of the synapse-organizing molecule agrin in the mature avian 
retina. Eur J Neurosci 11, 4188-4196. 
Kröger, S., Pfister, H., 2009. Agrin in the nervous system: synaptogenesis and beyond. Future 
Neurology 4, 67-86. 
Ksiazek, I., Burkhardt, C., Lin, S., Seddik, R., Maj, M., Bezakova, G., Jucker, M., Arber, S., 
Caroni, P., Sanes, J.R., Bettler, B., Ruegg, M.A., 2007. Synapse loss in cortex of agrin-
deficient mice after genetic rescue of perinatal death. J Neurosci 27, 7183-7195. 
Kuhse, J., Kalbouneh, H., Schlicksupp, A., Mukusch, S., Nawrotzki, R., Kirsch, J., 2012. 
Phosphorylation of gephyrin in hippocampal neurons by cyclin-dependent kinase CDK5 
at Ser-270 is dependent on collybistin. J Biol Chem 287, 30952-30966. 
Lane-Donovan, C., Philips, G.T., Herz, J., 2014. More than cholesterol transporters: lipoprotein 
receptors in CNS function and neurodegeneration. Neuron 83, 771-787. 
Langosch, D., Hoch, W., Betz, H., 1992. The 93 kDa protein gephyrin and tubulin associated 
with the inhibitory glycine receptor are phosphorylated by an endogenous protein kinase. 
FEBS Lett 298, 113-117. 
Lardi-Studler, B., Smolinsky, B., Petitjean, C.M., Koenig, F., Sidler, C., Meier, J.C., Fritschy, 
J.M., Schwarz, G., 2007. Vertebrate-specific sequences in the gephyrin E-domain 
regulate cytosolic aggregation and postsynaptic clustering. J Cell Sci 120, 1371-1382. 
Lein, E.S., Hawrylycz, M.J., Ao, N., Ayres, M., Bensinger, A., Bernard, A., Boe, A.F., Boguski, 
M.S., Brockway, K.S., Byrnes, E.J., Chen, L., Chen, L., Chen, T.M., Chin, M.C., Chong, 
J., Crook, B.E., Czaplinska, A., Dang, C.N., Datta, S., Dee, N.R., Desaki, A.L., Desta, T., 
 97 
 
Diep, E., Dolbeare, T.A., Donelan, M.J., Dong, H.W., Dougherty, J.G., Duncan, B.J., 
Ebbert, A.J., Eichele, G., Estin, L.K., Faber, C., Facer, B.A., Fields, R., Fischer, S.R., 
Fliss, T.P., Frensley, C., Gates, S.N., Glattfelder, K.J., Halverson, K.R., Hart, M.R., 
Hohmann, J.G., Howell, M.P., Jeung, D.P., Johnson, R.A., Karr, P.T., Kawal, R., Kidney, 
J.M., Knapik, R.H., Kuan, C.L., Lake, J.H., Laramee, A.R., Larsen, K.D., Lau, C., 
Lemon, T.A., Liang, A.J., Liu, Y., Luong, L.T., Michaels, J., Morgan, J.J., Morgan, R.J., 
Mortrud, M.T., Mosqueda, N.F., Ng, L.L., Ng, R., Orta, G.J., Overly, C.C., Pak, T.H., 
Parry, S.E., Pathak, S.D., Pearson, O.C., Puchalski, R.B., Riley, Z.L., Rockett, H.R., 
Rowland, S.A., Royall, J.J., Ruiz, M.J., Sarno, N.R., Schaffnit, K., Shapovalova, N.V., 
Sivisay, T., Slaughterbeck, C.R., Smith, S.C., Smith, K.A., Smith, B.I., Sodt, A.J., 
Stewart, N.N., Stumpf, K.R., Sunkin, S.M., Sutram, M., Tam, A., Teemer, C.D., Thaller, 
C., Thompson, C.L., Varnam, L.R., Visel, A., Whitlock, R.M., Wohnoutka, P.E., Wolkey, 
C.K., Wong, V.Y., Wood, M., Yaylaoglu, M.B., Young, R.C., Youngstrom, B.L., Yuan, 
X.F., Zhang, B., Zwingman, T.A., Jones, A.R., 2007. Genome-wide atlas of gene 
expression in the adult mouse brain. Nature 445, 168-176. 
Lepeta, K., Lourenco, M.V., Schweitzer, B.C., Martino Adami, P.V., Banerjee, P., Catuara-
Solarz, S., de La Fuente Revenga, M., Guillem, A.M., Haidar, M., Ijomone, O.M., 
Nadorp, B., Qi, L., Perera, N.D., Refsgaard, L.K., Reid, K.M., Sabbar, M., Sahoo, A., 
Schaefer, N., Sheean, R.K., Suska, A., Verma, R., Vicidomini, C., Wright, D., Zhang, 
X.D., Seidenbecher, C., 2016. Synaptopathies: synaptic dysfunction in neurological 
disorders - A review from students to students. J Neurochem 138, 785-805. 
Levi, S., Logan, S.M., Tovar, K.R., Craig, A.M., 2004. Gephyrin is critical for glycine receptor 
clustering but not for the formation of functional GABAergic synapses in hippocampal 
neurons. J Neurosci 24, 207-217. 
Li, Y., Pawlik, B., Elcioglu, N., Aglan, M., Kayserili, H., Yigit, G., Percin, F., Goodman, F., 
Nurnberg, G., Cenani, A., Urquhart, J., Chung, B.D., Ismail, S., Amr, K., Aslanger, A.D., 
Becker, C., Netzer, C., Scambler, P., Eyaid, W., Hamamy, H., Clayton-Smith, J., 
Hennekam, R., Nurnberg, P., Herz, J., Temtamy, S.A., Wollnik, B., 2010. LRP4 
mutations alter Wnt/beta-catenin signaling and cause limb and kidney malformations in 
Cenani-Lenz syndrome. Am J Hum Genet 86, 696-706. 
Li, Z., Hilgenberg, L.G., O'Dowd, D.K., Smith, M.A., 1999. Formation of functional synaptic 
connections between cultured cortical neurons from agrin-deficient mice. J Neurobiol 39, 
547-557. 
Li, Z., Massengill, J.L., O'Dowd, D.K., Smith, M.A., 1997. Agrin gene expression in mouse 
somatosensory cortical neurons during development in vivo and in cell culture. 
Neuroscience 79, 191-201. 
Li, Z., Okamoto, K., Hayashi, Y., Sheng, M., 2004. The importance of dendritic mitochondria 
in the morphogenesis and plasticity of spines and synapses. Cell 119, 873-887. 
Lin, W., Burgess, R.W., Dominguez, B., Pfaff, S.L., Sanes, J.R., Lee, K.-F., 2001. Distinct roles 
of nerve and muscle in postsynaptic differentiation of the neuromuscular synapse. Nature 
410, 1057. 
Lohmann, C., Bonhoeffer, T., 2008. A role for local calcium signaling in rapid synaptic partner 
selection by dendritic filopodia. Neuron 59, 253-260. 
Luscher, C., Nicoll, R.A., Malenka, R.C., Muller, D., 2000. Synaptic plasticity and dynamic 
modulation of the postsynaptic membrane. Nat Neurosci 3, 545-550. 
Mantych, K.B., Ferreira, A., 2001. Agrin differentially regulates the rates of axonal and 
dendritic elongation in cultured hippocampal neurons. J Neurosci 21, 6802-6809. 
Marques, M.J., Conchello, J.A., Lichtman, J.W., 2000. From plaque to pretzel: fold formation 
and acetylcholine receptor loss at the developing neuromuscular junction. J Neurosci 20, 
3663-3675. 
 98 
 
Marrs, G.S., Green, S.H., Dailey, M.E., 2001. Rapid formation and remodeling of postsynaptic 
densities in developing dendrites. Nat Neurosci 4, 1006-1013. 
Mascarenhas, J.B., Ruegg, M.A., Sasaki, T., Eble, J.A., Engel, J., Stetefeld, J., 2005. Structure 
and laminin-binding specificity of the NtA domain expressed in eukaryotic cells. Matrix 
Biol 23, 507-513. 
Matthews-Bellinger, J.A., Salpeter, M.M., 1983. Fine structural distribution of acetylcholine 
receptors at developing mouse neuromuscular junctions. J Neurosci 3, 644-657. 
McCroskery, S., Bailey, A., Lin, L., Daniels, M.P., 2009. Transmembrane agrin regulates 
dendritic filopodia and synapse formation in mature hippocampal neuron cultures. 
Neuroscience 163, 168-179. 
McCroskery, S., Chaudhry, A., Lin, L., Daniels, M.P., 2006. Transmembrane agrin regulates 
filopodia in rat hippocampal neurons in culture. Mol Cell Neurosci 33, 15-28. 
McMahan, U.J., 1990. The agrin hypothesis. Cold Spring Harb Symp Quant Biol 55, 407-418. 
Meier, T., Hauser, D.M., Chiquet, M., Landmann, L., Ruegg, M.A., Brenner, H.R., 1997. 
Neural Agrin Induces Ectopic Postsynaptic Specializations in Innervated Muscle Fibers. 
J Neurosci 17, 6534-6544. 
Messeant, J., Dobbertin, A., Girard, E., Delers, P., Manuel, M., Mangione, F., Schmitt, A., Le 
Denmat, D., Molgo, J., Zytnicki, D., Schaeffer, L., Legay, C., Strochlic, L., 2015. MuSK 
frizzled-like domain is critical for mammalian neuromuscular junction formation and 
maintenance. J Neurosci 35, 4926-4941. 
Metzger, D., Clifford, J., Chiba, H., Chambon, P., 1995. Conditional site-specific 
recombination in mammalian cells using a ligand-dependent chimeric Cre recombinase. 
Proc Natl Acad Sci USA 92, 6991-6995. 
Meyer, G., Kirsch, J., Betz, H., Langosch, D., 1995. Identification of a gephyrin binding motif 
on the glycine receptor beta subunit. Neuron 15, 563-572. 
Miermans, C.A., Kusters, R.P., Hoogenraad, C.C., Storm, C., 2017. Biophysical model of the 
role of actin remodeling on dendritic spine morphology. PLoS One 12, e0170113. 
Miyata, S., Mori, Y., Fujiwara, T., Ikenaka, K., Matsuzaki, S., Oono, K., Katayama, T., 
Tohyama, M., 2005. Local protein synthesis by BDNF is potentiated in hippocampal 
neurons exposed to ephrins. Brain research. Mol Brain Res 134, 333-337. 
Mosca, T.J., Luginbuhl, D.J., Wang, I.E., Luo, L., 2017. Presynaptic LRP4 promotes synapse 
number and function of excitatory CNS neurons. Elife 6. 
Mukherjee, J., Kretschmannova, K., Gouzer, G., Maric, H.M., Ramsden, S., Tretter, V., 
Harvey, K., Davies, P.A., Triller, A., Schindelin, H., Moss, S.J., 2011. The residence time 
of GABA(A)Rs at inhibitory synapses is determined by direct binding of the receptor 
alpha1 subunit to gephyrin. J Neurosci 31, 14677-14687. 
Nakagawa, T., Engler, J.A., Sheng, M., 2004. The dynamic turnover and functional roles of 
alpha-actinin in dendritic spines. Neuropharmacol 47, 734-745. 
Neumann, F.R., Bittcher, G., Annies, M., Schumacher, B., Kröger, S., Ruegg, M.A., 2001. An 
alternative amino-terminus expressed in the central nervous system converts agrin to a 
type II transmembrane protein. Mol Cell Neurosci 17, 208-225. 
Nikonenko, I., Boda, B., Steen, S., Knott, G., Welker, E., Muller, D., 2008. PSD-95 promotes 
synaptogenesis and multiinnervated spine formation through nitric oxide signaling. J Cell 
Biol 183, 1115-1127. 
Nitkin, R.M., Smith, M.A., Magill, C., Fallon, J.R., Yao, Y.M., Wallace, B.G., McMahan, U.J., 
1987. Identification of agrin, a synaptic organizing protein from Torpedo electric organ. 
J Cell Biol 105, 2471-2478. 
Nusser, Z., Lujan, R., Laube, G., Roberts, J.D., Molnar, E., Somogyi, P., 1998. Cell type and 
pathway dependence of synaptic AMPA receptor number and variability in the 
hippocampus. Neuron 21, 545-559. 
 99 
 
O'Connor, L.T., Lauterborn, J.C., Gall, C.M., Smith, M.A., 1994. Localization and alternative 
splicing of agrin mRNA in adult rat brain: transcripts encoding isoforms that aggregate 
acetylcholine receptors are not restricted to cholinergic regions. J Neurosci 14, 1141-
1152. 
O'Connor, L.T., Lauterborn, J.C., Smith, M.A., Gall, C.M., 1995. Expression of agrin mRNA 
is altered following seizures in adult rat brain. Brain research. Mol Brain Res 33, 277-
287. 
Okabe, S., Miwa, A., Okado, H., 2001. Spine formation and correlated assembly of presynaptic 
and postsynaptic molecules. J Neurosci 21, 6105-6114. 
Okada, K., Inoue, A., Okada, M., Murata, Y., Kakuta, S., Jigami, T., Kubo, S., Shiraishi, H., 
Eguchi, K., Motomura, M., Akiyama, T., Iwakura, Y., Higuchi, O., Yamanashi, Y., 2006. 
The muscle protein Dok-7 is essential for neuromuscular synaptogenesis. Science 312, 
1802-1805. 
Ostroff, L.E., Fiala, J.C., Allwardt, B., Harris, K.M., 2002. Polyribosomes redistribute from 
dendritic shafts into spines with enlarged synapses during LTP in developing rat 
hippocampal slices. Neuron 35, 535-545. 
Papadopoulos, T., Eulenburg, V., Reddy-Alla, S., Mansuy, I.M., Li, Y., Betz, H., 2008. 
Collybistin is required for both the formation and maintenance of GABAergic 
postsynapses in the hippocampus. Mol Cell Neurosci 39, 161-169. 
Paradis, S., Harrar, D.B., Lin, Y., Koon, A.C., Hauser, J.L., Griffith, E.C., Zhu, L., Brass, L.F., 
Chen, C., Greenberg, M.E., 2007. An RNAi-based approach identifies molecules required 
for glutamatergic and GABAergic synapse development. Neuron 53, 217-232. 
Parker, J.M., Guo, D., Hodges, R.S., 1986. New hydrophilicity scale derived from high-
performance liquid chromatography peptide retention data: correlation of predicted 
surface residues with antigenicity and X-ray-derived accessible sites. Biochemistry 25, 
5425-5432. 
Petralia, R.S., Sans, N., Wang, Y.X., Wenthold, R.J., 2005. Ontogeny of postsynaptic density 
proteins at glutamatergic synapses. Mol Cell Neurosci 29, 436-452. 
Petrini, E.M., Ravasenga, T., Hausrat, T.J., Iurilli, G., Olcese, U., Racine, V., Sibarita, J.B., 
Jacob, T.C., Moss, S.J., Benfenati, F., Medini, P., Kneussel, M., Barberis, A., 2014. 
Synaptic recruitment of gephyrin regulates surface GABAA receptor dynamics for the 
expression of inhibitory LTP. Nat Commun 5, 3921. 
Pfeiffer, F., Graham, D., Betz, H., 1982. Purification by affinity chromatography of the glycine 
receptor of rat spinal cord. J Biol Chem 257, 9389-9393. 
Pierce, J.P., van Leyen, K., McCarthy, J.B., 2000. Translocation machinery for synthesis of 
integral membrane and secretory proteins in dendritic spines. Nat Neurosci 3, 311-313. 
Pohlkamp, T., Durakoglugil, M., Lane-Donovan, C., Xian, X., Johnson, E.B., Hammer, R.E., 
Herz, J., 2015. Lrp4 domains differentially regulate limb/brain development and synaptic 
plasticity. PLoS One 10, e0116701. 
Porten, E., Seliger, B., Schneider, V.A., Woll, S., Stangel, D., Ramseger, R., Kröger, S., 2010. 
The process-inducing activity of transmembrane agrin requires follistatin-like domains. J 
Biol Chem 285, 3114-3125. 
Prange, O., Murphy, T.H., 2001. Modular transport of postsynaptic density-95 clusters and 
association with stable spine precursors during early development of cortical neurons. J 
Neurosci 21, 9325-9333. 
Prior, P., Schmitt, B., Grenningloh, G., Pribilla, I., Multhaup, G., Beyreuther, K., Maulet, Y., 
Werner, P., Langosch, D., Kirsch, J., et al., 1992. Primary structure and alternative splice 
variants of gephyrin, a putative glycine receptor-tubulin linker protein. Neuron 8, 1161-
1170. 
Qu, Z., Huganir, R.L., 1994. Comparison of innervation and agrin-induced tyrosine 
phosphorylation of the nicotinic acetylcholine receptor. J Neurosci 14, 6834-6841.  
 100 
 
Qu, Z., Apel, E.D., Doherty, C.A., Hoffman, P.W., Merlie, J.P., Huganir, R.L., 1996. The 
synapse-associated protein rapsyn regulates tyrosine phosphorylation of proteins 
colocalized at nicotinic acetylcholine receptor clusters. Mol Cel Neurosci 8, 171-184. 
Ramseger, R., White, R., Kröger, S., 2009. Transmembrane form agrin-induced process 
formation requires lipid rafts and the activation of Fyn and MAPK. J Biol Chem 284, 
7697-7705. 
Reist, N.E., Magill, C., McMahan, U.J., 1987. Agrin-like molecules at synaptic sites in normal, 
denervated, and damaged skeletal muscles. J Cell Biol 105, 2457-2469. 
Remedio, L., Gribble, K.D., Lee, J.K., Kim, N., Hallock, P.T., Delestree, N., Mentis, G.Z., 
Froemke, R.C., Granato, M., Burden, S.J., 2016. Diverging roles for Lrp4 and Wnt 
signaling in neuromuscular synapse development during evolution. Genes & 
Development 30, 1058-1069. 
Ruegg, M.A., Tsim, K.W., Horton, S.E., Kröger, S., Escher, G., Gensch, E.M., McMahan, U.J., 
1992. The agrin gene codes for a family of basal lamina proteins that differ in function 
and distribution. Neuron 8, 691-699. 
Rupp, F., Ozcelik, T., Linial, M., Peterson, K., Francke, U., Scheller, R., 1992. Structure and 
chromosomal localization of the mammalian agrin gene. J Neurosci 12, 3535-3544. 
Rupp, F., Payan, D.G., Magill-Solc, C., Cowan, D.M., Scheller, R.H., 1991. Structure and 
expression of a rat agrin. Neuron 6, 811-823. 
Sabre, L., Evoli, A., Punga, A.R., 2019. Cognitive dysfunction in mice with passively induced 
MuSK antibody seropositive myasthenia gravis. J Neurol Sci 399, 15-21. 
Sakmann, B., Brenner, H.R., 1978. Change in synaptic channel gating during neuromuscular 
development. Nature 276, 401-402. 
Samuel, M.A., Valdez, G., Tapia, J.C., Lichtman, J.W., Sanes, J.R., 2012. Agrin and synaptic 
laminin are required to maintain adult neuromuscular junctions. PLoS One 7, e46663. 
Savtchenko, L.P., Rusakov, D.A., 2007. The optimal height of the synaptic cleft. Proc Natl 
Acad Sci USA 104, 1823-1828. 
Schick, A., 2018. Overexpression of transmembrane-agrin in the murine central nervous 
system, Dissertation, LMU München. LMU Munich, Munich. 
Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T., Preibisch, 
S., Rueden, C., Saalfeld, S., Schmid, B., Tinevez, J.Y., White, D.J., Hartenstein, V., 
Eliceiri, K., Tomancak, P., Cardona, A., 2012. Fiji: an open-source platform for 
biological-image analysis. Nature methods 9, 676-682. 
Schnell, E., Sizemore, M., Karimzadegan, S., Chen, L., Bredt, D.S., Nicoll, R.A., 2002. Direct 
interactions between PSD-95 and stargazin control synaptic AMPA receptor number. 
Proc Natl Acad Sci USA 99, 13902-13907. 
Schrader, N., Kim, E.Y., Winking, J., Paulukat, J., Schindelin, H., Schwarz, G., 2004. 
Biochemical characterization of the high affinity binding between the glycine receptor 
and gephyrin. J Biol Chem 279, 18733-18741. 
Schwenk, F., Kuhn, R., Angrand, P.O., Rajewsky, K., Stewart, A.F., 1998. Temporally and 
spatially regulated somatic mutagenesis in mice. Nucleic Acids Res 26, 1427-1432. 
Scotton, P., Bleckmann, D., Stebler, M., Sciandra, F., Brancaccio, A., Meier, T., Stetefeld, J., 
Ruegg, M.A., 2006. Activation of muscle-specific receptor tyrosine kinase and binding 
to dystroglycan are regulated by alternative mRNA splicing of agrin. J Biol Chem 281, 
36835-36845. 
Serpinskaya, A.S., Feng, G., Sanes, J.R., Craig, A.M., 1999. Synapse formation by 
hippocampal neurons from agrin-deficient mice. Dev Biol 205, 65-78. 
Setou, M., Nakagawa, T., Seog, D.H., Hirokawa, N., 2000. Kinesin superfamily motor protein 
KIF17 and mLin-10 in NMDA receptor-containing vesicle transport. Science 288, 1796-
1802. 
 101 
 
Shapira, M., Zhai, R.G., Dresbach, T., Bresler, T., Torres, V.I., Gundelfinger, E.D., Ziv, N.E., 
Garner, C.C., 2003. Unitary assembly of presynaptic active zones from Piccolo-Bassoon 
transport vesicles. Neuron 38, 237-252. 
Sharma, K., Fong, D.K., Craig, A.M., 2006. Postsynaptic protein mobility in dendritic spines: 
long-term regulation by synaptic NMDA receptor activation. Mol Cell Neurosci 31, 702-
712. 
Singh, S., Narang, A.S., Mahato, R.I., 2011. Subcellular fate and off-target effects of siRNA, 
shRNA, and miRNA. Pharmaceutical Res 28, 2996-3015. 
Sjostrom, P.J., Rancz, E.A., Roth, A., Hausser, M., 2008. Dendritic excitability and synaptic 
plasticity. Physiol Rev 88, 769-840. 
Smith, M.A., Magill-Solc, C., Rupp, F., Yao, Y.M., Schilling, J.W., Snow, P., McMahan, U.J., 
1992. Isolation and characterization of a cDNA that encodes an agrin homolog in the 
marine ray. Mol Cell Neurosci 3, 406-417. 
Spacek, J., Harris, K.M., 1997. Three-dimensional organization of smooth endoplasmic 
reticulum in hippocampal CA1 dendrites and dendritic spines of the immature and mature 
rat. J Neurosci 17, 190-203. 
Steiner, E., Enzmann, G.U., Lyck, R., Lin, S., Ruegg, M.A., Kröger, S., Engelhardt, B., 2014. 
The heparan sulfate proteoglycan agrin contributes to barrier properties of mouse brain 
endothelial cells by stabilizing adherens junctions. Cell Tissue Res 358, 465-479. 
Steward, O., Schuman, E.M., 2001. Protein synthesis at synaptic sites on dendrites. Annu Rev 
Neurosci 24, 299-325. 
Sudhof, T.C., 2018. Towards an Understanding of Synapse Formation. Neuron 100, 276-293. 
Sun, X.D., Li, L., Liu, F., Huang, Z.H., Bean, J.C., Jiao, H.F., Barik, A., Kim, S.M., Wu, H., 
Shen, C., Tian, Y., Lin, T.W., Bates, R., Sathyamurthy, A., Chen, Y.J., Yin, D.M., Xiong, 
L., Lin, H.P., Hu, J.X., Li, B.M., Gao, T.M., Xiong, W.C., Mei, L., 2016. Lrp4 in 
astrocytes modulates glutamatergic transmission. Nat Neurosci 19, 1010-1018. 
Sutton, M.A., Schuman, E.M., 2006. Dendritic protein synthesis, synaptic plasticity, and 
memory. Cell 127, 49-58. 
Takeichi, M., Abe, K., 2005. Synaptic contact dynamics controlled by cadherin and catenins. 
Trends Cell Biol 15, 216-221. 
Tian, Q.B., Suzuki, T., Yamauchi, T., Sakagami, H., Yoshimura, Y., Miyazawa, S., Nakayama, 
K., Saitoh, F., Zhang, J.P., Lu, Y., Kondo, H., Endo, S., 2006. Interaction of LDL 
receptor-related protein 4 (LRP4) with postsynaptic scaffold proteins via its C-terminal 
PDZ domain-binding motif, and its regulation by Ca/calmodulin-dependent protein 
kinase II. Eur J Neurosci 23, 2864-2876. 
Tiffany, A.M., Manganas, L.N., Kim, E., Hsueh, Y.P., Sheng, M., Trimmer, J.S., 2000. PSD-
95 and SAP97 exhibit distinct mechanisms for regulating K(+) channel surface 
expression and clustering. J Cell Biol 148, 147-158. 
Till, J.H., Becerra, M., Watty, A., Lu, Y., Ma, Y., Neubert, T.A., Burden, S.J., Hubbard, S.R., 
2002. Crystal structure of the MuSK tyrosine kinase: insights into receptor 
autoregulation. Structure 10, 1187-1196. 
Tintignac, L.A., Brenner, H.R., Ruegg, M.A., 2015. Mechanisms Regulating Neuromuscular 
Junction Development and Function and Causes of Muscle Wasting. Physiol Rev 95, 809-
852. 
Trachtenberg, J.T., Chen, B.E., Knott, G.W., Feng, G., Sanes, J.R., Welker, E., Svoboda, K., 
2002. Long-term in vivo imaging of experience-dependent synaptic plasticity in adult 
cortex. Nature 420, 788-794. 
Tretter, V., Jacob, T.C., Mukherjee, J., Fritschy, J.M., Pangalos, M.N., Moss, S.J., 2008. The 
clustering of GABA(A) receptor subtypes at inhibitory synapses is facilitated via the 
direct binding of receptor alpha 2 subunits to gephyrin. J Neurosci 28, 1356-1365. 
 102 
 
Tretter, V., Kerschner, B., Milenkovic, I., Ramsden, S.L., Ramerstorfer, J., Saiepour, L., Maric, 
H.M., Moss, S.J., Schindelin, H., Harvey, R.J., Sieghart, W., Harvey, K., 2011. Molecular 
basis of the gamma-aminobutyric acid A receptor alpha3 subunit interaction with the 
clustering protein gephyrin. J Biol Chem 286, 37702-37711. 
Tsen, G., Halfter, W., Kröger, S., Cole, G.J., 1995. Agrin is a heparan sulfate proteoglycan. J 
Biol Chem 270, 3392-3399. 
Tsim, K.W., Ruegg, M.A., Escher, G., Kröger, S., McMahan, U.J., 1992. cDNA that encodes 
active agrin. Neuron 8, 677-689. 
Tyagarajan, S.K., Ghosh, H., Yevenes, G.E., Nikonenko, I., Ebeling, C., Schwerdel, C., Sidler, 
C., Zeilhofer, H.U., Gerrits, B., Muller, D., Fritschy, J.M., 2011. Regulation of 
GABAergic synapse formation and plasticity by GSK3beta-dependent phosphorylation 
of gephyrin. Proc Natl Acad Sci USA 108, 379-384. 
van Zundert, B., Yoshii, A., Constantine-Paton, M., 2004. Receptor compartmentalization and 
trafficking at glutamate synapses: a developmental proposal. Trends Neurosci 27, 428-
437. 
Waites, C.L., Craig, A.M., Garner, C.C., 2005. Mechanisms of vertebrate synaptogenesis. Annu 
Rev Neurosci 28, 251-274. 
Wallace, B.G., Qu, Z., Huganir, R.L., 1991. Agrin induces phosphorylation of the nicotinic 
acetylcholine receptor. Neuron 6, 869-878. 
Washbourne, P., Bennett, J.E., McAllister, A.K., 2002. Rapid recruitment of NMDA receptor 
transport packets to nascent synapses. Nat Neurosci 5, 751-759. 
Weatherbee, S.D., Anderson, K.V., Niswander, L.A., 2006. LDL-receptor-related protein 4 is 
crucial for formation of the neuromuscular junction. Development 133, 4993-5000. 
Wierenga, C.J., 2017. Live imaging of inhibitory axons: Synapse formation as a dynamic trial-
and-error process. Brain Res Bull 129, 43-49. 
Wierenga, C.J., Becker, N., Bonhoeffer, T., 2008. GABAergic synapses are formed without the 
involvement of dendritic protrusions. Nat Neurosci 11, 1044-1052. 
Winzen, U., Cole, G.J., Halfter, W., 2003. Agrin is a chimeric proteoglycan with the attachment 
sites for heparan sulfate/chondroitin sulfate located in two multiple serine-glycine 
clusters. J Biol Chem 278, 30106-30114. 
Woods, G.F., Oh, W.C., Boudewyn, L.C., Mikula, S.K., Zito, K., 2011. Loss of PSD-95 
enrichment is not a prerequisite for spine retraction. J Neurosci 31, 12129-12138. 
Xu, H.T., Pan, F., Yang, G., Gan, W.B., 2007. Choice of cranial window type for in vivo 
imaging affects dendritic spine turnover in the cortex. Nat Neurosci 10, 549-551. 
Yao, I., Iida, J., Nishimura, W., Hata, Y., 2003. Synaptic localization of SAPAP1, a synaptic 
membrane-associated protein. Genes Cells 8, 121-129. 
Yuste, R., Bonhoeffer, T., 2004. Genesis of dendritic spines: insights from ultrastructural and 
imaging studies. Nat Rev Neurosci 5, 24-34. 
Zambrowicz, B.P., Imamoto, A., Fiering, S., Herzenberg, L.A., Kerr, W.G., Soriano, P., 1997. 
Disruption of overlapping transcripts in the ROSA beta geo 26 gene trap strain leads to 
widespread expression of beta-galactosidase in mouse embryos and hematopoietic cells. 
Proc Natl Acad Sci USA 94, 3789-3794. 
Zhai, R.G., Vardinon-Friedman, H., Cases-Langhoff, C., Becker, B., Gundelfinger, E.D., Ziv, 
N.E., Garner, C.C., 2001. Assembling the presynaptic active zone: a characterization of 
an active one precursor vesicle. Neuron 29, 131-143. 
Zhang, B., Luo, S., Wang, Q., Suzuki, T., Xiong, W.C., Mei, L., 2008. LRP4 serves as a 
coreceptor of agrin. Neuron 60, 285-297. 
Zhang, W., Coldefy, A.S., Hubbard, S.R., Burden, S.J., 2011. Agrin binds to the N-terminal 
region of Lrp4 protein and stimulates association between Lrp4 and the first 
immunoglobulin-like domain in muscle-specific kinase (MuSK). J Biol Chem 286, 
40624-40630. 
 103 
 
Ziv, N.E., Garner, C.C., 2001. Principles of glutamatergic synapse formation: seeing the forest 
for the trees. Curr Opin Neurobiol 11, 536-543. 
Ziv, N.E., Smith, S.J., 1996. Evidence for a role of dendritic filopodia in synaptogenesis and 
spine formation. Neuron 17, 91-102. 
Zong, Y., Zhang, B., Gu, S., Lee, K., Zhou, J., Yao, G., Figueiredo, D., Perry, K., Mei, L., Jin, 
R., 2012. Structural basis of agrin-LRP4-MuSK signaling. Genes & Development 26, 
247-258. 
Zuo, Y., Yang, G., Kwon, E., Gan, W.B., 2005. Long-term sensory deprivation prevents 
dendritic spine loss in primary somatosensory cortex. Nature 436, 261-265. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 104 
 
Annexes 
List of abbreviations 
nAChRs : nicotinic acetylcholine receptors 
AMPAR : α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor 
bp  : basepairs 
BLASTp  : basic local alignment search tool for protein 
BSA  : bovine serum albumin  
CAG   : chicken-beta-actin 
CamKIIa : Calcium/Calmodulin dependent protein kinase II alpha 
cDNA  : complementary deoxyribonucleic acid 
CMV  : cytomegalovirus 
DAPI  : 4’,6-diamidino-2-phenylindole 
DIV  : day in vitro 
E  : embryonic day 
GABA  : γ-aminobutyric acid 
GFP  : green fluorescent protein 
HA  : human influenza hemagglutinin 
HEK  : human embryonic kidney 
HSPG  : heparan sulfate proteoglycan 
ICC  : immunocytochemistry 
IHC  : immunohistochemistry 
IRES  : internal ribosome entry site 
kD  : kilo Daltons 
Lrp4  : low-density lipoprotein receptor-related protein 4 
mEPSCs  : miniature excitatory postsynaptic currents 
mIPSCs  : miniature inhibitory postsynaptic currents 
MuSK  : muscle-specific tyrosine kinase 
NMJ  : neuromuscular junction 
NMDAR : N-Methyl-D-aspartat receptor 
PDL  : poly‐D‐lysine 
PFA  : paraformaldehyde 
PSD-95 : postsynaptic density protein-95 
qRT-PCR : quantitative real time polymerase chain reaction 
RFP  : red fluorescent protein 
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RT  : room temperature 
SEM  : standard error of the mean 
TM-agrin  : transmembrane-form of agrin 
WB  : Western blotting 
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